The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
The continuous turnover of BONE MATRIX and mineral that involves first an increase in BONE RESORPTION (osteoclastic activity) and later, reactive BONE FORMATION (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium HOMEOSTASIS. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS.
Bone marrow diseases are disorders that affect the production of blood cells in the bone marrow.
Removal of bone marrow and evaluation of its histologic picture.
Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.
Progenitor cells from which all blood cells derive.
The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS.
Bone loss due to osteoclastic activity.
Techniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION.
The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY).
Tumors or cancer located in bone tissue or specific BONES.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
C57BL mice are a commonly used strain of laboratory mice that are inbred to produce consistent and predictable results in scientific research.
Diseases of BONES.
A cytologic technique for measuring the functional capacity of stem cells by assaying their activity.
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
Renewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms.
Transplantation of an individual's own tissue from one site to another site.
An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient's cells which would otherwise reject the donor cells.
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
The process of bone formation. Histogenesis of bone including ossification.
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.
The grafting of bone from a donor site to a recipient site.
Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.
Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.
An encapsulated lymphatic organ through which venous blood filters.
Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.
A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
An organism that, as a result of transplantation of donor tissue or cells, consists of two or more cell lines descended from at least two zygotes. This state may result in the induction of donor-specific TRANSPLANTATION TOLERANCE.
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Cell separation is the process of isolating specific cells from a mixture of cells, often for the purpose of further study or treatment.
Elements of limited time intervals, contributing to particular results or situations.
Synthetic or natural materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue.
Bone diseases, metabolic are disorders that affect the normal metabolism of bone, leading to abnormalities in bone structure and strength.
Very large BONE MARROW CELLS which release mature BLOOD PLATELETS.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.
BALB/C is a commonly used strain of inbred mice in medical research, known for their genetic uniformity and susceptibility to various diseases.
The developmental history of specific differentiated cell types as traced back to the original STEM CELLS in the embryo.
Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
The longest and largest bone of the skeleton, it is situated between the hip and the knee.
Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.
A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines.
Breaks in bones.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
A potent osteoinductive protein that plays a critical role in the differentiation of osteoprogenitor cells into OSTEOBLASTS.
Bone-marrow-derived, non-hematopoietic cells that support HEMATOPOETIC STEM CELLS. They have also been isolated from other organs and tissues such as UMBILICAL CORD BLOOD, umbilical vein subendothelium, and WHARTON JELLY. These cells are considered to be a source of multipotent stem cells because they include subpopulations of mesenchymal stem cells.
The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells.
The number of CELLS of a specific kind, usually measured per unit volume or area of sample.
The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.
The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.
A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.
An individual that contains cell populations derived from different zygotes.
The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.
Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.
Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.
The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)
Antibodies produced by a single clone of cells.
Benign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.
Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20)
An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.
Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF).
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS).
Transplantation between genetically identical individuals, i.e., members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
A CXC chemokine that is chemotactic for T-LYMPHOCYTES and MONOCYTES. It has specificity for CXCR4 RECEPTORS. Two isoforms of CXCL12 are produced by alternative mRNA splicing.
Disorders of the blood and blood forming tissues.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
Formation of LYMPHOCYTES and PLASMA CELLS from the lymphoid stem cells which develop from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW. These lymphoid stem cells differentiate into T-LYMPHOCYTES; B-LYMPHOCYTES; PLASMA CELLS; or NK-cells (KILLER CELLS, NATURAL) depending on the organ or tissues (LYMPHOID TISSUE) to which they migrate.
An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
C3H mice are a strain of inbred mice commonly used in medical research due to their genetic homogeneity and susceptibility to various diseases.
Either of a pair of compound bones forming the lateral (left and right) surfaces and base of the skull which contains the organs of hearing. It is a large bone formed by the fusion of parts: the squamous (the flattened anterior-superior part), the tympanic (the curved anterior-inferior part), the mastoid (the irregular posterior portion), and the petrous (the part at the base of the skull).
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed)
Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.
Therapeutic act or process that initiates a response to a complete or partial remission level.
Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
Disease having a short and relatively severe course.
The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states.
Proteins prepared by recombinant DNA technology.
One of a pair of irregularly shaped quadrilateral bones situated between the FRONTAL BONE and OCCIPITAL BONE, which together form the sides of the CRANIUM.
White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
The cells in the erythroid series derived from MYELOID PROGENITOR CELLS or from the bi-potential MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS which eventually give rise to mature RED BLOOD CELLS. The erythroid progenitor cells develop in two phases: erythroid burst-forming units (BFU-E) followed by erythroid colony-forming units (CFU-E); BFU-E differentiate into CFU-E on stimulation by ERYTHROPOIETIN, and then further differentiate into ERYTHROBLASTS when stimulated by other factors.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
A hematopoietic growth factor and the ligand of the cell surface c-kit protein (PROTO-ONCOGENE PROTEINS C-KIT). It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS.
The return of a sign, symptom, or disease after a remission.
The largest of three bones that make up each half of the pelvic girdle.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B and OSTEOPROTEGERIN. It plays an important role in regulating OSTEOCLAST differentiation and activation.
A general term for various neoplastic diseases of the lymphoid tissue.
Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation.
High-molecular weight glycoproteins uniquely expressed on the surface of LEUKOCYTES and their hemopoietic progenitors. They contain a cytoplasmic protein tyrosine phosphatase activity which plays a role in intracellular signaling from the CELL SURFACE RECEPTORS. The CD45 antigens occur as multiple isoforms that result from alternative mRNA splicing and differential usage of three exons.
Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.
A group of lymphocyte surface antigens located on mouse LYMPHOCYTES. Specific Ly antigens are useful markers for distinguishing subpopulations of lymphocytes.
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.
Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice.
Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.
Stem cells derived from HEMATOPOIETIC STEM CELLS. Derived from these myeloid progenitor cells are the MEGAKARYOCYTES; ERYTHROID CELLS; MYELOID CELLS; and some DENDRITIC CELLS.
The formation and development of blood cells outside the BONE MARROW, as in the SPLEEN; LIVER; or LYMPH NODES.
Mature osteoblasts that have become embedded in the BONE MATRIX. They occupy a small cavity, called lacuna, in the matrix and are connected to adjacent osteocytes via protoplasmic projections called canaliculi.
Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
X-RAY COMPUTERIZED TOMOGRAPHY with resolution in the micrometer range.
The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.
Formation of MYELOID CELLS from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via MYELOID STEM CELLS. Myelopoiesis generally refers to the production of leukocytes in blood, such as MONOCYTES and GRANULOCYTES. This process also produces precursor cells for MACROPHAGE and DENDRITIC CELLS found in the lymphoid tissue.
Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Methods for maintaining or growing CELLS in vitro.
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
Resorption or wasting of the tooth-supporting bone (ALVEOLAR PROCESS) in the MAXILLA or MANDIBLE.
The number of PLATELETS per unit volume in a sample of venous BLOOD.
Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES).
A subnormal level of BLOOD PLATELETS.
Remnant of a tumor or cancer after primary, potentially curative therapy. (Dr. Daniel Masys, written communication)
An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.
Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.
White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).
Established cell cultures that have the potential to propagate indefinitely.
Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PRECURSOR CELLS and precedes formation of RETICULOCYTES. The normal series is called normoblasts. Cells called MEGALOBLASTS are a pathologic series of erythroblasts.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
Mice bearing mutant genes which are phenotypically expressed in the animals.
The process of generating white blood cells (LEUKOCYTES) from the pluripotent HEMATOPOIETIC STEM CELLS of the BONE MARROW. There are two significant pathways to generate various types of leukocytes: MYELOPOIESIS, in which leukocytes in the blood are derived from MYELOID STEM CELLS, and LYMPHOPOIESIS, in which leukocytes of the lymphatic system (LYMPHOCYTES) are generated from lymphoid stem cells.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Adherence of cells to surfaces or to other cells.
A humoral factor that stimulates the production of thrombocytes (BLOOD PLATELETS). Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS.
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.
Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.
Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Lymphocyte progenitor cells that are restricted in their differentiation potential to the B lymphocyte lineage. The pro-B cell stage of B lymphocyte development precedes the pre-B cell stage.
A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.
The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles.
A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
The physiological renewal, repair, or replacement of tissue.
Specialized stem cells that are committed to give rise to cells that have a particular function; examples are MYOBLASTS; MYELOID PROGENITOR CELLS; and skin stem cells. (Stem Cells: A Primer [Internet]. Bethesda (MD): National Institutes of Health (US); 2000 May [cited 2002 Apr 5]. Available from: http://www.nih.gov/news/stemcell/primer.htm)
Mapping of the KARYOTYPE of a cell.
Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
CBA mice are a strain of inbred mice commonly used in medical research due to their genetic homogeneity and susceptibility to various diseases.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A mononuclear phagocyte colony-stimulating factor (M-CSF) synthesized by mesenchymal cells. The compound stimulates the survival, proliferation, and differentiation of hematopoietic cells of the monocyte-macrophage series. M-CSF is a disulfide-bonded glycoprotein dimer with a MW of 70 kDa. It binds to a specific high affinity receptor (RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR).
They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
DBA mice are a strain of inbred mice commonly used in medical research due to their susceptibility to a variety of diseases and genetic disorders.
A classification of B-lymphocytes based on structurally or functionally different populations of cells.
Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.
Protein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.
CXCR receptors with specificity for CXCL12 CHEMOKINE. The receptors may play a role in HEMATOPOIESIS regulation and can also function as coreceptors for the HUMAN IMMUNODEFICIENCY VIRUS.

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. (1/9035)

Immunohistochemical, cytochemical and ultrastructural data showing vivid angiogenesis and numerous mast cells (MCs) in the bone marrow of 24 patients with active multiple myeloma (MM) compared with 34 patients with non-active MM and 22 patients with monoclonal gammopathy of undetermined significance (MGUS) led us to hypothesize that angiogenesis parallels progression of MM, and that MCs participate in its induction via angiogenic factors in their secretory granules.  (+info)

Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation. (2/9035)

Although young mice homozygous for the osteopetrosis (op) mutation usually developed prominent osteopetrosis, its severity was markedly reduced in aged op/op mice. This age-associated reversal of osteopetrosis was accompanied by the expansion of bone marrow cavities and increased numbers of tartrate-resistant acid phosphatase (TRAP)-positive cells and of macrophages in the bone marrow. The TRAP-positive cells were mononuclear and developed ruffled borders and numerous vesicles, vacuoles, and granules. Enzyme-linked immunosorbent assay demonstrated a significant elevation of serum granulocyte/ macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-3 levels in the aged op/op mice. To examine whether GM-CSF and/or IL-3 could correct osteopetrosis in young op/op mice, 5 ng of recombinant murine (rm)GM-CSF and/or 100 ng of rmIL-3 were injected daily into young op/op mice. In these treated young op/op mice, the bone marrow cavities were expanded significantly at 2 weeks after administration, associated with significantly increased numbers of TRAP-positive cells and bone marrow macrophages. TRAP-positive cells increased in number with days after injection. These results suggest that GM-CSF and IL-3 induce the development of osteoclasts to correct osteopetrosis in the op/op mice with aging.  (+info)

Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by Ex vivo expansion. (3/9035)

Hematopoietic reconstitution of ablated recipients requires that intravenously (IV) transplanted stem and progenitor cells "home" to organs that support their proliferation and differentiation. To examine the possible relationship between homing properties and subsequent engraftment potential, murine bone marrow (BM) cells were labeled with fluorescent PKH26 dye and injected into lethally irradiated hosts. PKH26(+) cells homing to marrow or spleen were then isolated by fluorescence-activated cell sorting and assayed for in vitro colony-forming cells (CFCs). Progenitors accumulated rapidly in the spleen, but declined to only 6% of input numbers after 24 hours. Although egress from this organ was accompanied by a simultaneous accumulation of CFCs in the BM (plateauing at 6% to 8% of input after 3 hours), spleen cells remained enriched in donor CFCs compared with marrow during this time. To determine whether this differential homing of clonogenic cells to the marrow and spleen influenced their contribution to short-term or long-term hematopoiesis in vivo, PKH26(+) cells were sorted from each organ 3 hours after transplantation and injected into lethally irradiated Ly-5 congenic mice. Cells that had homed initially to the spleen regenerated circulating leukocytes (20% of normal counts) approximately 2 weeks faster than cells that had homed to the marrow, or PKH26-labeled cells that had not been selected by a prior homing step. Both primary (17 weeks) and secondary (10 weeks) recipients of "spleen-homed" cells also contained approximately 50% higher numbers of CFCs per femur than recipients of "BM-homed" cells. To examine whether progenitor homing was altered upon ex vivo expansion, highly enriched Sca-1(+)c-kit+Lin- cells were cultured for 9 days in serum-free medium containing interleukin (IL)-6, IL-11, granulocyte colony-stimulating factor, stem cell factor, flk-2/flt3 ligand, and thrombopoietin. Expanded cells were then stained with PKH26 and assayed as above. Strikingly, CFCs generated in vitro exhibited a 10-fold reduction in homing capacity compared with fresh progenitors. These studies demonstrate that clonogenic cells with differential homing properties contribute variably to early and late hematopoiesis in vivo. The dramatic decline in the homing capacity of progenitors generated in vitro underscores critical qualitative changes that may compromise their biologic function and potential clinical utility, despite their efficient numerical expansion.  (+info)

Bone marrow ribonucleic acid polymerase. Effect of testosterone on nucleotide incorporation into nuclear RNA. (4/9035)

The incorporation of 3H-UTP into RNA by isolated rat bone marrow nuclei is stimulated by testosterone. This effect is hormone and tissue specific. Using alpha-amanitine and different ionic strength conditions it was found that testosterone enhances preferentially RNA polymerase I activity. The sedimentation pattern of RNA isolated from bone marrow nuclei shows that the synthesis of RNA species within the 14-30 S range is mainly stimulated by the hormone.  (+info)

In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes, determine immune responsiveness of antiviral cytotoxic T cells. (5/9035)

The H-2 haplotype of the chimeric host determines the responder phenotype of maturing T cells. Spleen cells of chimeric mice formed when (K(k) nonresponder to D(b) x K(b) responder to D(b) plus vaccinia)F(1) bone marrow cells were used to reconstitute K(b)D(b) (C57BL/6 D(b) responder) irradiated recipients generated high levels of D(b) plus vaccinia virus-specific cytotoxic T cells. The same stem cells used to reconstitute K(k)D(b) (B10.A (2R) D(b) nonresponder) irradiated recipients resulted in spleen cells that responded well to K plus vaccinia, but responsiveness to D(b) was low. A generally low response to D(k) plus vaccinia, which seems to be regulated by D(k), was confirmed in chimeras. Thus, K(d)D(d) (D(d) plus vaccinia responder) stem cells differentiating in a K(d)D(k) chimeric host failed to generate a measurable response to D(k) plus vaccinia. In contrast, stem cells from K(d)D(k) (D(k) plus vaccinia low responders) differentiating in a K(d)D(d) (K(d) and D(d) high responders to vaccinia) host do generate responsiveness to D(d) plus vaccinia. These results indicate that in chimeras, the Ir phenotype is independent of the donor T cell's Ir genotype, and that thymic selection of a T cell's restriction specificity for a particular H-2 allele of the chimeric host also defines that T cell's/r phenotype.  (+info)

Hydroxyapatite-coated femoral stems. Histology and histomorphometry around five components retrieved at post mortem. (6/9035)

We performed a histological and histomorphometric examination in five cadaver specimens of the femoral and acetabular components and the associated tissue which had been recovered between 3.3 and 6.2 years after primary total hip arthroplasty (THA) using a proximal hydroxyapatite (HA)-coated titanium alloy implant. All had functioned well during the patients' life. All the stems were fixed in the femur and showed osseointegration of both the proximal and distal parts. The amount of residual HA was greatest in the distal metaphyseal sections, indicating that the rate of bone remodelling may be the main factor causing loss of HA. The level of activity of the patient was the only clinical factor which correlated with loss of coating. The percentage of bone-implant osseointegration was almost constant, regardless of the amount of HA residue, periprosthetic bone density or the time of implantation. HA debris was seldom observed and if present did not cause any adverse or inflammatory reaction. Partial debonding did occur in one case as a result of a polyethylene-induced inflammatory reaction.  (+info)

Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. (7/9035)

Mutations that activate the N-ras oncogene are among the most frequently detected genetic alterations in human acute myeloid leukemias (AMLs), Philadelphia chromosome-negative myeloproliferative disorders (MPDs), and myelodysplastic syndromes (MDSs). However, because N-ras has not been shown to induce these disorders in an in vivo model, the role of N-ras in the evolution of myeloid leukemia is unclear. To investigate the potential of N-ras to induce myeloid leukemia, lethally irradiated mice were reconstituted with bone marrow (BM) cells infected with a retroviral vector carrying activated N-ras. Approximately 60% of these mice developed hematopoietic disorders, including severe MPDs resembling human chronic myelogenous leukemia (CML) or AML with differentiation (French-American-British [FAB] classification M2). Other reconstituted mice succumbed to hematopoietic defects that were pathologically similar to human MDSs. The latter disorders appeared to be due to a myeloid impairment that was demonstrated by enumeration of day-12 colony-forming units-spleen (CFU-S) and by in vitro colony assays. A high level of apoptosis associated with thymic atrophy and peripheral blood (PB) lymphopenia was also evident in N-ras reconstituted mice. Our results are consistent with a model in which antiproliferative effects are a primary consequence of N-ras mutations and secondary transforming events are necessary for the development of myeloid leukemia. This is the first report of an in vivo model for N-ras induced MPD and leukemia.  (+info)

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. (8/9035)

PURPOSE: Previous reports have indicated that reverse transcriptase polymerase chain reaction (RT-PCR) for cytokeratin 19 (CK-19) may be useful in the management of patients with breast cancer. However, the specificity of this technique is low, principally because of a high rate of false-positive results. To improve the specificity of this assay, we developed a quantitative RT-PCR methodology that enables an estimate to be made of the number of CK-19 transcripts in blood and bone marrow samples. PATIENTS AND METHODS: We examined 45 peripheral-blood samples and 30 bone marrow samples from patients with a variety of nonneoplastic conditions using nested RT-PCR for CK-19. We also examined bone marrow and peripheral-blood samples from 23 patients with primary breast cancer and peripheral-blood samples from 37 patients with metastatic breast cancer. The number of CK-19 transcripts was estimated in positive specimens by competitive PCR and normalized to the number of ABL transcripts as an internal control for the quality and quantity of cDNA. RT-PCR results were compared with the numbers of CK-19-positive cells detected by immunocytochemistry. RESULTS: Analysis of samples from patients without cancer enabled us to define an upper limit for the background ratio of CK-19 to ABL transcripts (1:1,000 for blood samples and 1:1,600 for bone marrow samples). Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer. Only three of 23 (13%) primary breast cancer peripheral-blood samples and none of the control samples were positive by these criteria. Only two of 23 patients (9%) with primary breast cancer showed immunocytochemically detectable cells in the blood; 10 of 23 (43%) showed immunocytochemically detectable cells in the bone marrow. Of 36 patients with metastatic breast cancer, eight (22%) showed positive events. CONCLUSION: Quantitative RT-PCR for CK-19 detects a percentage of patients with breast cancer and may enable the progression or regression of the disease to be monitored.  (+info)

Bone marrow is a soft, spongy tissue found inside the bones of most mammals, including humans. It is responsible for producing blood cells, including red blood cells, white blood cells, and platelets. Red blood cells are responsible for carrying oxygen throughout the body, white blood cells help fight infections and diseases, and platelets are involved in blood clotting. The bone marrow is divided into two main types: red bone marrow and yellow bone marrow. Red bone marrow is responsible for producing all types of blood cells, while yellow bone marrow is primarily responsible for producing fat cells. In some cases, the bone marrow can be damaged or diseased, leading to conditions such as leukemia, lymphoma, or aplastic anemia. In these cases, bone marrow transplantation may be necessary to replace damaged or diseased bone marrow with healthy bone marrow from a donor.

Bone marrow cells are the cells found in the bone marrow, which is the soft, spongy tissue found in the center of bones. These cells are responsible for producing blood cells, including red blood cells, white blood cells, and platelets. There are two types of bone marrow cells: hematopoietic stem cells and progenitor cells. Hematopoietic stem cells are capable of dividing and differentiating into any type of blood cell, while progenitor cells are capable of dividing and differentiating into specific types of blood cells. In the medical field, bone marrow cells are often used in the treatment of blood disorders, such as leukemia and lymphoma, as well as in the transplantation of bone marrow to replace damaged or diseased bone marrow. In some cases, bone marrow cells may also be used in research to study the development and function of blood cells.

Bone marrow transplantation (BMT) is a medical procedure in which healthy bone marrow is transplanted into a patient who has damaged or diseased bone marrow. The bone marrow is the spongy tissue found inside bones that produces blood cells, including red blood cells, white blood cells, and platelets. There are two main types of bone marrow transplantation: autologous and allogeneic. Autologous BMT involves transplanting bone marrow from the patient's own body, usually after it has been harvested and stored before the patient undergoes high-dose chemotherapy or radiation therapy to destroy their diseased bone marrow. Allogeneic BMT involves transplanting bone marrow from a donor who is a genetic match for the patient. BMT is used to treat a variety of conditions, including leukemia, lymphoma, multiple myeloma, sickle cell anemia, and some inherited blood disorders. The procedure can also be used to treat certain immune system disorders and some genetic diseases. The success of BMT depends on several factors, including the type and stage of the patient's disease, the patient's overall health, and the availability of a suitable donor. The procedure can be complex and may involve several stages, including preparatory treatment, the actual transplantation, and post-transplantation care.

In the medical field, "bone and bones" typically refers to the skeletal system, which is made up of bones, cartilage, ligaments, tendons, and other connective tissues. The skeletal system provides support and structure to the body, protects vital organs, and allows for movement through the use of muscles. Bones are the main component of the skeletal system and are responsible for providing support and protection to the body. There are 206 bones in the human body, which are classified into four types: long bones, short bones, flat bones, and irregular bones. Long bones, such as the femur and humerus, are cylindrical in shape and are found in the arms and legs. Short bones, such as the carpals and tarsals, are cube-shaped and are found in the wrists and ankles. Flat bones, such as the skull and ribs, are thin and flat and provide protection to vital organs. Irregular bones, such as the vertebrae and pelvis, have complex shapes that allow for specific functions. Overall, the bone and bones of the skeletal system play a crucial role in maintaining the health and function of the human body.

Bone remodeling is a continuous process that occurs in the human body to maintain the strength and integrity of bones. It involves the coordinated activity of bone-forming cells called osteoblasts and bone-resorbing cells called osteoclasts. During bone remodeling, osteoclasts break down old or damaged bone tissue, releasing minerals and other components into the bloodstream. Osteoblasts then lay down new bone tissue to replace the old bone that was removed. This process of bone resorption followed by bone formation is a dynamic equilibrium that helps to maintain the balance between bone strength and bone density. Bone remodeling is influenced by a variety of factors, including hormones, mechanical stress, and age. For example, during childhood and adolescence, bone remodeling is stimulated by growth hormones and physical activity, leading to increased bone density and strength. In older adults, bone remodeling slows down, leading to a decrease in bone density and an increased risk of fractures. Disruptions in the bone remodeling process can lead to a variety of bone disorders, including osteoporosis, osteogenesis imperfecta, and Paget's disease. Understanding the mechanisms of bone remodeling is important for developing effective treatments for these conditions.

Bone marrow diseases refer to a group of disorders that affect the bone marrow, which is the spongy tissue inside bones that produces blood cells. The bone marrow produces red blood cells, white blood cells, and platelets, which are essential for the proper functioning of the immune system, oxygen transport, and blood clotting, respectively. There are several types of bone marrow diseases, including: 1. Leukemia: A type of cancer that affects the bone marrow and blood cells. It is characterized by the uncontrolled growth and division of abnormal white blood cells. 2. Lymphoma: A type of cancer that affects the lymphatic system, which is part of the immune system. It can also affect the bone marrow and produce abnormal white blood cells. 3. Myelodysplastic syndromes (MDS): A group of disorders that affect the bone marrow's ability to produce healthy blood cells. MDS can progress to leukemia. 4. Multiple myeloma: A type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies. It is characterized by the overproduction of abnormal plasma cells in the bone marrow. 5. Polycythemia vera: A type of blood disorder that causes the bone marrow to produce too many red blood cells. 6. Thalassemia: A group of genetic disorders that affect the production of hemoglobin, a protein found in red blood cells that carries oxygen throughout the body. Treatment for bone marrow diseases depends on the specific type and severity of the disorder. It may include chemotherapy, radiation therapy, stem cell transplantation, or supportive care to manage symptoms and complications.

Bone marrow examination is a medical test that involves removing a sample of bone marrow from a patient's bone and examining it under a microscope. The bone marrow is the soft, spongy tissue found inside the bones, and it is responsible for producing blood cells, including red blood cells, white blood cells, and platelets. There are several different types of bone marrow examinations, including aspiration, biopsy, and trephination. During an aspiration, a small amount of bone marrow is removed using a needle and syringe. During a biopsy, a larger sample of bone marrow is removed using a biopsy needle. During trephination, a small piece of bone is removed, along with the bone marrow. Bone marrow examination is used to diagnose a variety of medical conditions, including anemia, leukemia, lymphoma, and multiple myeloma. It can also be used to monitor the effectiveness of treatment for these conditions, and to detect any complications that may arise during treatment.

Bone marrow neoplasms are abnormal growths of cells in the bone marrow, which is the spongy tissue inside bones that produces blood cells. These neoplasms can be either benign (non-cancerous) or malignant (cancerous), and they can affect the production of different types of blood cells, including red blood cells, white blood cells, and platelets. Some common types of bone marrow neoplasms include: 1. Myelodysplastic syndromes (MDS): A group of blood disorders characterized by abnormal blood cell production and an increased risk of developing leukemia. 2. Multiple myeloma: A type of cancer that affects plasma cells, a type of white blood cell that produces antibodies. 3. Leukemia: A type of cancer that affects the blood and bone marrow, causing the production of abnormal white blood cells. 4. Lymphoma: A type of cancer that affects the lymphatic system, which is part of the immune system. 5. Polycythemia vera: A type of blood disorder characterized by an overproduction of red blood cells. 6. Myelofibrosis: A type of bone marrow disorder characterized by the formation of scar tissue in the bone marrow, which can lead to anemia and other complications. Treatment for bone marrow neoplasms depends on the specific type and stage of the condition, as well as the patient's overall health. Treatment options may include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies.

Bone density is a measure of the amount of bone mineral content (BMC) in a specific area of the body, usually expressed in grams per cubic centimeter (g/cm³). It is an important indicator of bone health and strength, and is commonly used to diagnose and monitor osteoporosis, a condition characterized by low bone density and increased risk of fractures. Bone density is typically measured using dual-energy X-ray absorptiometry (DXA), which involves passing two low-energy X-ray beams through the body and measuring the amount of X-ray energy absorbed by the bones. The difference in the amount of energy absorbed by the bones at different energies is used to calculate bone density. Normal bone density is considered to be within a certain range, and bone density measurements below this range are considered to be low or osteoporotic. Low bone density is a risk factor for fractures, particularly of the spine, hip, and wrist. Treatment for low bone density may include lifestyle changes, such as regular exercise and a healthy diet, as well as medications to increase bone density or prevent further bone loss.

Bone resorption is a process in which bone tissue is broken down and removed by osteoclasts, which are specialized cells in the bone marrow. This process is a normal part of bone remodeling, which is the continuous process of bone formation and resorption that occurs throughout life. Bone resorption is necessary for the growth and development of bones, as well as for the repair of damaged bone tissue. However, excessive bone resorption can lead to a number of medical conditions, including osteoporosis, which is a condition characterized by weak and brittle bones that are prone to fractures. Other conditions that can be caused by excessive bone resorption include Paget's disease of bone, which is a disorder that causes the bones to become abnormally thick and weak, and hyperparathyroidism, which is a condition in which the parathyroid glands produce too much parathyroid hormone, which can lead to increased bone resorption. Bone resorption can also be caused by certain medications, such as corticosteroids, and by certain medical conditions, such as cancer and rheumatoid arthritis. In these cases, bone resorption can lead to a loss of bone mass and density, which can increase the risk of fractures and other complications.

Bone marrow purging is a medical procedure used to remove cancer cells or other abnormal cells from the bone marrow. It is typically performed in patients with certain types of blood cancers, such as leukemia or lymphoma, before they receive a bone marrow or stem cell transplant. During the procedure, a chemotherapy drug or a combination of drugs is given to the patient to kill the cancer cells in the bone marrow. The patient's blood is then removed from their body and the chemotherapy is given directly to the bone marrow through a special catheter. After the chemotherapy has been given, the patient's blood is returned to their body. The goal of bone marrow purging is to remove as many cancer cells as possible from the bone marrow, so that the transplanted cells can engraft and grow without being attacked by the patient's immune system. The procedure is typically followed by a bone marrow or stem cell transplant, which replaces the patient's diseased bone marrow with healthy bone marrow or stem cells.

Bone neoplasms are abnormal growths or tumors that develop in the bones. They can be either benign (non-cancerous) or malignant (cancerous). Benign bone neoplasms are usually slow-growing and do not spread to other parts of the body, while malignant bone neoplasms can be invasive and spread to other parts of the body through the bloodstream or lymphatic system. There are several types of bone neoplasms, including osteosarcoma, Ewing's sarcoma, chondrosarcoma, and multiple myeloma. These tumors can affect any bone in the body, but they are most commonly found in the long bones of the arms and legs, such as the femur and tibia. Symptoms of bone neoplasms may include pain, swelling, and tenderness in the affected bone, as well as bone fractures that do not heal properly. Diagnosis typically involves imaging tests such as X-rays, MRI scans, and CT scans, as well as a biopsy to examine a sample of the tumor tissue. Treatment for bone neoplasms depends on the type and stage of the tumor, as well as the patient's overall health. Options may include surgery to remove the tumor, radiation therapy to kill cancer cells, chemotherapy to shrink the tumor, and targeted therapy to block the growth of cancer cells. In some cases, a combination of these treatments may be used.

Bone development, also known as osteogenesis, is the process by which bones grow and mature. It involves the differentiation of mesenchymal stem cells into osteoblasts, which are specialized cells that produce bone matrix. The bone matrix is a composite of collagen fibers and minerals, including calcium and phosphate, that give bones their strength and rigidity. During bone development, osteoblasts secrete bone matrix, which is then mineralized with calcium and phosphate. As the bone matrix mineralizes, osteoblasts differentiate into osteocytes, which are mature bone cells that are embedded within the bone matrix. Osteocytes are responsible for maintaining bone health by regulating bone resorption and formation. Bone development occurs throughout life, with the highest rates of bone growth occurring during childhood and adolescence. However, bone development is not complete until the early 20s, and bone continues to be remodeled and strengthened throughout life through a process called bone remodeling. Disruptions in bone development can lead to a variety of bone disorders, including osteogenesis imperfecta, which is a genetic disorder characterized by brittle bones, and rickets, which is a vitamin D deficiency that can lead to soft and weak bones.

Bone diseases refer to a group of medical conditions that affect the structure, strength, and function of bones. These diseases can be caused by a variety of factors, including genetics, hormonal imbalances, vitamin and mineral deficiencies, infections, and injuries. Some common bone diseases include osteoporosis, osteogenesis imperfecta, Paget's disease, and bone cancer. Osteoporosis is a condition characterized by weak and brittle bones that are prone to fractures, especially in the spine, hip, and wrist. Osteogenesis imperfecta is a genetic disorder that causes bones to be abnormally weak and brittle, leading to frequent fractures and deformities. Paget's disease is a chronic disorder that causes bones to become thickened and misshapen due to excessive bone remodeling. Bone cancer, also known as skeletal sarcoma, is a rare type of cancer that starts in the bone or bone marrow. Treatment for bone diseases depends on the specific condition and its severity. It may include medications, lifestyle changes, physical therapy, and in some cases, surgery. Early detection and treatment are important for preventing complications and improving outcomes.

A Colony-Forming Units (CFU) Assay is a method used to determine the number of viable bacterial cells present in a sample. The assay involves plating a known volume of the sample onto a solid growth medium and incubating the plate for a specific period of time. The number of colonies that grow on the plate is then counted and used to calculate the number of CFUs per milliliter of the original sample. This information is important in the medical field for monitoring the effectiveness of antibiotics, assessing the quality of water and food, and diagnosing and tracking the spread of bacterial infections.

Cell differentiation is the process by which cells acquire specialized functions and characteristics during development. It is a fundamental process that occurs in all multicellular organisms, allowing cells to differentiate into various types of cells with specific functions, such as muscle cells, nerve cells, and blood cells. During cell differentiation, cells undergo changes in their shape, size, and function, as well as changes in the proteins and other molecules they produce. These changes are controlled by a complex network of genes and signaling pathways that regulate the expression of specific genes in different cell types. Cell differentiation is a critical process for the proper development and function of tissues and organs in the body. It is also involved in tissue repair and regeneration, as well as in the progression of diseases such as cancer, where cells lose their normal differentiation and become cancerous.

Bone regeneration is the process by which the body repairs and replaces damaged or lost bone tissue. This process involves the formation of new bone cells, or osteoblasts, which secrete a matrix of collagen and minerals that eventually hardens into bone. Bone regeneration is a natural process that occurs throughout life, but it can also be stimulated by medical treatments such as bone grafts or growth factors. In some cases, bone regeneration may be necessary to treat conditions such as fractures, osteoporosis, or bone tumors.

In the medical field, "Cells, Cultured" refers to cells that have been grown and maintained in a controlled environment outside of their natural biological context, typically in a laboratory setting. This process is known as cell culture and involves the isolation of cells from a tissue or organism, followed by their growth and proliferation in a nutrient-rich medium. Cultured cells can be derived from a variety of sources, including human or animal tissues, and can be used for a wide range of applications in medicine and research. For example, cultured cells can be used to study the behavior and function of specific cell types, to develop new drugs and therapies, and to test the safety and efficacy of medical products. Cultured cells can be grown in various types of containers, such as flasks or Petri dishes, and can be maintained at different temperatures and humidity levels to optimize their growth and survival. The medium used to culture cells typically contains a combination of nutrients, growth factors, and other substances that support cell growth and proliferation. Overall, the use of cultured cells has revolutionized medical research and has led to many important discoveries and advancements in the field of medicine.

Graft-versus-host disease (GVHD) is a condition that can occur after a bone marrow or stem cell transplant. It happens when the transplanted cells (the graft) attack the recipient's (the host) tissues and organs. This can cause a range of symptoms, including skin rash, diarrhea, liver problems, and inflammation of the lungs, gut, and blood vessels. GVHD can be a serious and potentially life-threatening complication of transplantation, but it can also be treated with medications and other therapies.

Anemia, aplastic is a rare and serious medical condition characterized by a decrease in the number of red blood cells (RBCs) produced by the bone marrow. The bone marrow is the spongy tissue inside bones that produces blood cells. In aplastic anemia, the bone marrow fails to produce enough RBCs, leading to a decrease in the number of oxygen-carrying red blood cells in the body. Aplastic anemia can be caused by a variety of factors, including exposure to certain chemicals or medications, radiation therapy, viral infections, autoimmune disorders, and genetic factors. Symptoms of aplastic anemia may include fatigue, weakness, shortness of breath, pale skin, and an increased risk of infections. Treatment for aplastic anemia typically involves medications to stimulate the production of blood cells in the bone marrow, such as immunosuppressive drugs or growth factors. In severe cases, a bone marrow transplant may be necessary to replace the damaged bone marrow with healthy bone marrow from a donor.

Leukemia is a type of cancer that affects the blood and bone marrow. It is characterized by the abnormal production of white blood cells, which can interfere with the normal functioning of the immune system and other parts of the body. There are several different types of leukemia, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Treatment for leukemia typically involves chemotherapy, radiation therapy, and/or stem cell transplantation.

In the medical field, the bone matrix is the non-cellular component of bone tissue. It is a complex network of proteins and minerals that provides the structural support and strength to the bone. The bone matrix is composed of two main components: the organic matrix and the inorganic matrix. The organic matrix is made up of collagen fibers, which are the most abundant protein in the bone matrix. Collagen fibers provide flexibility and tensile strength to the bone. The inorganic matrix is made up of hydroxyapatite crystals, which are mineralized calcium phosphate. Hydroxyapatite crystals provide rigidity and compressive strength to the bone. The bone matrix is constantly being remodeled through a process called bone turnover. This process involves the removal of old bone matrix by osteoclasts (bone-resorbing cells) and the formation of new bone matrix by osteoblasts (bone-forming cells). This process is essential for maintaining the health and strength of bone tissue.

Bone transplantation is a surgical procedure in which a piece of healthy bone is taken from one part of the body and transplanted to another part of the body where there is a deficiency or damage to the bone. The transplanted bone can be used to replace a missing bone, to repair a broken bone, or to stabilize a bone that is at risk of breaking. There are several types of bone transplantation, including autografts, allografts, and synthetic bone grafts. Autografts involve taking bone from one part of the body and transplanting it to another part of the body. Allografts involve taking bone from a donor and transplanting it to the recipient. Synthetic bone grafts are made from materials such as ceramics or polymers and are used when there is not enough healthy bone available for transplantation. Bone transplantation is typically performed under general anesthesia and may require a hospital stay for several days. After the procedure, the transplanted bone will need time to heal and integrate with the surrounding tissue. Physical therapy may be recommended to help the patient regain strength and mobility in the affected area.

CD34 is a protein found on the surface of certain cells in the body, including hematopoietic stem cells, progenitor cells, and endothelial cells. In the medical field, CD34 is often used as a marker to identify and isolate these cells for various purposes, such as in bone marrow transplantation or in research studies. Antigens, CD34 refers to the specific portion of the CD34 protein that serves as an antigen, or a substance that triggers an immune response in the body. Antigens, CD34 can be used as a diagnostic tool to detect the presence of certain diseases or conditions, such as certain types of leukemia or myelodysplastic syndromes. They can also be used in the development of targeted therapies for these conditions.

Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight infections. In multiple myeloma, these plasma cells become abnormal and start to multiply uncontrollably, leading to the formation of tumors in the bone marrow and other parts of the body. The abnormal plasma cells also produce large amounts of abnormal antibodies, which can damage healthy tissues and cause a variety of symptoms, including bone pain, fatigue, weakness, and frequent infections. Multiple myeloma can also cause anemia, kidney damage, and hypercalcemia (high levels of calcium in the blood). Treatment for multiple myeloma typically involves a combination of chemotherapy, radiation therapy, and targeted therapies, as well as supportive care to manage symptoms and prevent complications. In some cases, a stem cell transplant may also be recommended. The prognosis for multiple myeloma varies depending on the stage of the disease and other factors, but with appropriate treatment, many people with multiple myeloma can live for many years.

Pancytopenia is a medical condition characterized by a decrease in all three types of blood cells: red blood cells (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia). This can lead to a variety of symptoms, including fatigue, weakness, shortness of breath, bruising, and an increased risk of infections. Pancytopenia can be caused by a variety of factors, including bone marrow disorders, exposure to toxins, certain medications, and autoimmune diseases. Treatment for pancytopenia depends on the underlying cause and may include medications, blood transfusions, or bone marrow transplantation.

Acute Myeloid Leukemia (AML) is a type of cancer that affects the bone marrow and blood cells. It is characterized by the rapid growth of abnormal white blood cells, called myeloid cells, in the bone marrow. These abnormal cells do not function properly and can crowd out healthy blood cells, leading to a variety of symptoms such as fatigue, weakness, and frequent infections. AML can occur in people of all ages, but it is most common in adults over the age of 60. Treatment for AML typically involves chemotherapy, radiation therapy, and/or stem cell transplantation.

In the medical field, cell separation refers to the process of isolating specific types of cells from a mixture of cells. This can be done for a variety of reasons, such as to study the properties and functions of a particular cell type, to prepare cells for transplantation, or to remove unwanted cells from a sample. There are several methods for cell separation, including centrifugation, fluorescence-activated cell sorting (FACS), and magnetic bead separation. Centrifugation involves spinning a sample of cells at high speeds to separate them based on their size and density. FACS uses lasers to excite fluorescent markers on the surface of cells, allowing them to be sorted based on their fluorescence intensity. Magnetic bead separation uses magnetic beads coated with antibodies to bind to specific cell surface markers, allowing them to be separated from other cells using a magnetic field. Cell separation is an important technique in many areas of medicine, including cancer research, stem cell biology, and immunology. It allows researchers to study specific cell types in detail and to develop new treatments for diseases based on a better understanding of cell biology.

In the medical field, bone substitutes are materials that are used to replace or repair damaged or diseased bone tissue. These materials can be used in a variety of surgical procedures, including fracture repair, spinal fusion, and dental implants. Bone substitutes can be classified into two main categories: autografts and allografts. Autografts are bone grafts taken from the patient's own body, while allografts are bone grafts taken from a donor. There are also synthetic bone substitutes, which are man-made materials that are designed to mimic the properties of natural bone. These materials can include ceramics, polymers, and composites. The choice of bone substitute depends on the specific surgical procedure and the patient's individual needs. Factors such as the location and severity of the bone damage, the patient's age and overall health, and the availability of autografts or allografts may all influence the choice of bone substitute.

Bone diseases, metabolic, refer to a group of disorders that affect the normal metabolism of bone tissue, leading to changes in bone structure and strength. These diseases can be caused by a variety of factors, including genetic mutations, hormonal imbalances, vitamin and mineral deficiencies, and certain medications. Some common examples of metabolic bone diseases include: 1. Osteoporosis: A condition characterized by low bone density and increased risk of fractures. 2. Osteogenesis imperfecta: A genetic disorder that causes bones to be weak and brittle, leading to frequent fractures. 3. Hyperparathyroidism: A condition in which the parathyroid glands produce too much parathyroid hormone, leading to increased bone resorption and decreased bone density. 4. Hypoparathyroidism: A condition in which the parathyroid glands produce too little parathyroid hormone, leading to decreased bone resorption and increased bone density. 5. Rickets: A condition that primarily affects children and is characterized by soft, weak bones due to a lack of vitamin D or calcium. 6. Osteomalacia: A condition that primarily affects adults and is characterized by soft, weak bones due to a lack of vitamin D or calcium. Treatment for metabolic bone diseases typically involves addressing the underlying cause of the disorder, such as correcting vitamin or mineral deficiencies, treating hormonal imbalances, or surgically removing or replacing affected bones. In some cases, medications may also be prescribed to help prevent or slow the progression of bone loss.

In the medical field, a cell lineage refers to the developmental history of a cell, tracing its origin back to a common ancestor cell and following its subsequent divisions and differentiation into specialized cell types. Cell lineage is an important concept in the study of stem cells, which have the potential to differentiate into a wide variety of cell types. By understanding the cell lineage of stem cells, researchers can better understand how they develop into specific cell types and how they might be used to treat various diseases. In addition, cell lineage is also important in the study of cancer, as cancer cells often arise from normal cells that have undergone mutations and have begun to divide uncontrollably. By studying the cell lineage of cancer cells, researchers can gain insights into the genetic and molecular changes that have occurred during cancer development and identify potential targets for cancer therapy.

Myelodysplastic syndromes (MDS) are a group of blood disorders that affect the bone marrow, which is the spongy tissue inside bones where blood cells are produced. In MDS, the bone marrow produces abnormal blood cells that do not function properly, leading to a decrease in the number of healthy blood cells in the body. MDS can cause a range of symptoms, including fatigue, weakness, shortness of breath, and an increased risk of infections and bleeding. The severity of MDS can vary widely, and some people with the condition may not experience any symptoms at all. There are several different types of MDS, which are classified based on the specific characteristics of the abnormal blood cells and the severity of the disease. Treatment for MDS depends on the type and severity of the condition, and may include medications, blood transfusions, or bone marrow transplantation.

Granulocyte Colony-Stimulating Factor (G-CSF) is a protein that stimulates the production and differentiation of granulocytes (a type of white blood cell) in the bone marrow. It is primarily used to treat neutropenia (a condition characterized by a low number of neutrophils in the blood), which can occur as a side effect of chemotherapy or radiation therapy for cancer, or as a result of certain infections or autoimmune disorders. G-CSF is typically administered as a daily injection for several days, and it works by binding to specific receptors on the surface of bone marrow cells, which triggers a signaling cascade that leads to the production and release of granulocytes into the bloodstream. This helps to increase the number of neutrophils in the blood and reduce the risk of infection. In addition to its use in treating neutropenia, G-CSF has also been studied for its potential use in other medical conditions, such as bone marrow transplantation, chronic granulomatous disease, and some types of anemia. However, more research is needed to determine its effectiveness and safety in these settings.

Fractures, bone refer to a break or crack in a bone that occurs due to trauma or injury. Fractures can be classified based on their severity, location, and type. There are several types of bone fractures, including: 1. Simple fractures: These are clean breaks in the bone with no displacement of the broken ends. 2. Compound fractures: These are breaks in the bone that involve the skin and/or soft tissues surrounding the bone. 3. Comminuted fractures: These are fractures in which the bone is broken into multiple pieces. 4. Stress fractures: These are small cracks in the bone that occur due to repetitive stress or overuse. 5. Open fractures: These are fractures in which the broken bone pierces through the skin. 6. Closed fractures: These are fractures in which the broken bone is contained within the skin. The treatment for bone fractures depends on the severity and location of the fracture, as well as the patient's overall health. Treatment options may include rest, ice, compression, and elevation (RICE), casting, surgery, or physical therapy.

Leukemia, Myeloid is a type of cancer that affects the myeloid cells in the bone marrow. Myeloid cells are a type of white blood cell that helps fight infections and diseases in the body. In leukemia, myeloid cells grow and divide uncontrollably, leading to an overproduction of these cells in the bone marrow and bloodstream. There are several subtypes of myeloid leukemia, including acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). AML is a rapidly progressing cancer that usually affects older adults, while CML is a slower-growing cancer that is more common in middle-aged and older adults. Symptoms of myeloid leukemia may include fatigue, weakness, fever, night sweats, weight loss, and easy bruising or bleeding. Treatment for myeloid leukemia typically involves chemotherapy, radiation therapy, targeted therapy, and bone marrow transplantation. The prognosis for myeloid leukemia depends on the subtype, age of the patient, and the stage of the disease at diagnosis.

Bone morphogenetic proteins (BMPs) are a group of signaling proteins that play a crucial role in the development and maintenance of bone tissue. They are secreted by various cells in the body, including bone-forming cells called osteoblasts, and are involved in processes such as bone growth, repair, and remodeling. BMPs are also used in medical treatments to promote bone growth and healing. For example, they are sometimes used in orthopedic surgeries to help repair fractures or to stimulate the growth of new bone in areas where bone has been lost, such as in spinal fusion procedures. They may also be used in dental procedures to help promote the growth of new bone in areas where teeth have been lost. BMPs are also being studied for their potential use in other medical applications, such as in the treatment of osteoporosis, a condition characterized by weak and brittle bones, and in the repair of damaged or diseased tissues in other parts of the body.

Cyclophosphamide is an immunosuppressive drug that is commonly used to treat various types of cancer, including lymphoma, leukemia, and multiple myeloma. It works by inhibiting the growth and division of cells, including cancer cells, and by suppressing the immune system. Cyclophosphamide is usually administered intravenously or orally, and its dosage and duration of treatment depend on the type and stage of cancer being treated, as well as the patient's overall health. Side effects of cyclophosphamide can include nausea, vomiting, hair loss, fatigue, and an increased risk of infection. It can also cause damage to the kidneys, bladder, and reproductive organs, and may increase the risk of developing certain types of cancer later in life.

Bone Morphogenetic Protein 2 (BMP2) is a protein that plays a crucial role in bone development and repair. It is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, which are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. In the medical field, BMP2 is used as a therapeutic agent to promote bone growth and regeneration in a variety of conditions, including spinal fusion, non-unions, and osteoporosis. It is typically administered as a bone graft substitute or in combination with other growth factors to enhance bone formation. BMP2 has also been studied for its potential use in tissue engineering and regenerative medicine, where it is used to stimulate the growth of new bone tissue in vitro and in vivo. Additionally, BMP2 has been shown to have anti-inflammatory and anti-cancer effects, making it a promising target for the development of new therapies for a range of diseases.

Blood cells, also known as hematopoietic cells, are the cells that make up the blood. There are three main types of blood cells: red blood cells, white blood cells, and platelets. Red blood cells, also known as erythrocytes, are the most abundant type of blood cell and are responsible for carrying oxygen from the lungs to the body's tissues and removing carbon dioxide from the tissues back to the lungs. They are also responsible for maintaining the body's acid-base balance. White blood cells, also known as leukocytes, are an important part of the immune system and help protect the body against infection and disease. There are several types of white blood cells, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils, each with a specific function in the immune response. Platelets, also known as thrombocytes, are small cell fragments that play a crucial role in blood clotting. When a blood vessel is damaged, platelets stick together to form a plug that helps prevent blood loss. Overall, blood cells are essential for maintaining the body's health and function, and any abnormalities in their production or function can lead to a variety of medical conditions.

In the medical field, "Antigens, CD" refers to a group of proteins found on the surface of certain cells in the immune system. These proteins, known as CD antigens, are recognized by other immune cells and play a crucial role in the immune response to infections and diseases. CD antigens are classified into different families based on their structure and function. Some CD antigens are expressed on the surface of immune cells themselves, while others are found on the surface of cells that are targeted by the immune system, such as cancer cells or cells infected with viruses. The identification and characterization of CD antigens has been important for the development of new diagnostic tests and therapies for a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. For example, monoclonal antibodies that target specific CD antigens have been used in cancer immunotherapy to help the immune system recognize and attack cancer cells.

In the medical field, "cell count" refers to the measurement of the number of cells present in a specific sample of tissue or fluid. This measurement is typically performed using a microscope and a specialized staining technique to distinguish between different types of cells. For example, a complete blood count (CBC) is a common laboratory test that measures the number and types of cells in the blood, including red blood cells, white blood cells, and platelets. Similarly, a urine analysis may include a cell count to measure the number of white blood cells or bacteria present in the urine. Cell counts can be used to diagnose a variety of medical conditions, such as infections, inflammation, or cancer. They can also be used to monitor the effectiveness of treatments or to detect any changes in the body's cellular makeup over time.

Cell division is the process by which a single cell divides into two or more daughter cells. This process is essential for the growth, development, and repair of tissues in the body. There are two main types of cell division: mitosis and meiosis. Mitosis is the process by which somatic cells (non-reproductive cells) divide to produce two identical daughter cells with the same number of chromosomes as the parent cell. This process is essential for the growth and repair of tissues in the body. Meiosis, on the other hand, is the process by which germ cells (reproductive cells) divide to produce four genetically diverse daughter cells with half the number of chromosomes as the parent cell. This process is essential for sexual reproduction. Abnormalities in cell division can lead to a variety of medical conditions, including cancer. In cancer, cells divide uncontrollably and form tumors, which can invade nearby tissues and spread to other parts of the body.

Blood cell count is a medical test that measures the number and types of cells present in a sample of blood. It is a routine diagnostic test that is often performed to evaluate a person's overall health and to diagnose various medical conditions. The blood cell count typically includes measurements of red blood cells (RBCs), white blood cells (WBCs), and platelets. Red blood cells carry oxygen from the lungs to the body's tissues, while white blood cells help fight infections and other diseases. Platelets are responsible for blood clotting. A blood cell count can be performed using a variety of methods, including automated blood cell counters and manual methods. The results of a blood cell count can provide important information about a person's overall health, including their risk of anemia, infection, or bleeding disorders.

Precursor Cell Lymphoblastic Leukemia-Lymphoma (PCLL) is a type of cancer that affects the lymphatic system, which is a part of the immune system. It is a rare and aggressive form of acute lymphoblastic leukemia (ALL), which is a type of cancer that affects the white blood cells in the bone marrow. PCLL is characterized by the rapid growth and proliferation of immature white blood cells, called lymphoblasts, in the bone marrow, blood, and lymphatic system. These cells do not mature properly and are unable to carry out their normal functions, leading to a weakened immune system and an increased risk of infections. PCLL is typically diagnosed in children and young adults, and the symptoms may include fever, fatigue, weight loss, night sweats, and swollen lymph nodes. Treatment for PCLL typically involves chemotherapy, radiation therapy, and stem cell transplantation. The prognosis for PCLL is generally poor, but with appropriate treatment, some people are able to achieve remission and improve their quality of life.

Primary myelofibrosis (PMF) is a type of blood cancer that affects the bone marrow, which is the spongy tissue inside bones where blood cells are produced. In PMF, the bone marrow becomes scarred and fibrotic, leading to a decrease in the production of healthy blood cells. PMF is a myeloproliferative neoplasm, which means that it is a type of cancer that affects the blood-forming cells in the bone marrow. The disease is characterized by an overproduction of abnormal white blood cells, red blood cells, and platelets, which can lead to a variety of symptoms, including fatigue, weakness, shortness of breath, and easy bruising. PMF is typically diagnosed through a combination of blood tests, bone marrow biopsy, and imaging studies. Treatment options for PMF include medications to manage symptoms and slow the progression of the disease, as well as blood transfusions and stem cell transplantation in some cases.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive is a type of cancer that affects the bone marrow and blood cells. It is also known as Chronic Myeloid Leukemia (CML) and is characterized by the presence of an abnormal Philadelphia chromosome, which is caused by a genetic mutation. This mutation results in the production of an abnormal protein called BCR-ABL, which promotes the uncontrolled growth and division of white blood cells. CML is typically diagnosed in adults and is treatable with medications that target the BCR-ABL protein. However, it is a chronic condition that requires lifelong treatment and monitoring.

Busulfan is a chemotherapy drug that is used to treat various types of cancer, including leukemia, lymphoma, and multiple myeloma. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing. Busulfan is usually given orally or intravenously, and it can also be used as a conditioning agent before a bone marrow transplant. The drug can cause side effects such as nausea, vomiting, hair loss, and low blood cell counts. It is important to closely monitor patients who are taking busulfan to ensure that the drug is working as intended and to manage any side effects that may occur.

In the medical field, a chimera refers to a person or animal that has two or more genetically distinct cell lines within their body. This can occur naturally or as a result of medical treatment, such as bone marrow transplantation. For example, a person who has received a bone marrow transplant from a donor with a different blood type may have chimerism, meaning that some of their blood cells are from the donor and some are from their own body. Similarly, a person who has undergone in vitro fertilization and has two or more embryos implanted may have chimerism if the embryos have different genetic profiles. Chimerism can also occur in animals, such as when a twin embryo develops from two separate fertilized eggs and the resulting animal has cells from both embryos. In some cases, chimerism can cause health problems, such as immune system disorders or cancer, but it can also be a natural and harmless condition.

Monoclonal antibodies (mAbs) are laboratory-made proteins that can mimic the immune system's ability to fight off harmful pathogens, such as viruses and bacteria. They are produced by genetically engineering cells to produce large quantities of a single type of antibody, which is specific to a particular antigen (a molecule that triggers an immune response). In the medical field, monoclonal antibodies are used to treat a variety of conditions, including cancer, autoimmune diseases, and infectious diseases. They can be administered intravenously, intramuscularly, or subcutaneously, depending on the condition being treated. Monoclonal antibodies work by binding to specific antigens on the surface of cells or pathogens, marking them for destruction by the immune system. They can also block the activity of specific molecules involved in disease processes, such as enzymes or receptors. Overall, monoclonal antibodies have revolutionized the treatment of many diseases, offering targeted and effective therapies with fewer side effects than traditional treatments.

Bone cysts are fluid-filled cavities that develop in the bones. They are also known as osteocysts or osteolytic cysts. Bone cysts can occur in any bone in the body, but they are most commonly found in the long bones of the arms and legs, such as the femur and tibia. There are several types of bone cysts, including simple bone cysts, aneurysmal bone cysts, unicameral bone cysts, and giant cell tumors. Simple bone cysts are the most common type and are usually benign. They are filled with clear fluid and do not cause any symptoms unless they grow large enough to compress surrounding bone or nerves. Aneurysmal bone cysts are larger and more aggressive than simple bone cysts. They are filled with blood and can cause pain, swelling, and bone deformities. Unicameral bone cysts are also known as solitary bone cysts and are usually found in children. They are filled with clear fluid and do not cause any symptoms unless they grow large enough to compress surrounding bone or nerves. Giant cell tumors are rare and are usually found in adults. They are filled with abnormal cells and can cause pain, swelling, and bone deformities. Treatment for bone cysts depends on the type and size of the cyst, as well as the location and severity of symptoms. Treatment options may include observation, medication, surgery, or radiation therapy.

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) is a protein that plays a critical role in the development and function of white blood cells, particularly granulocytes and macrophages. It is produced by a variety of cells, including bone marrow cells, fibroblasts, and endothelial cells. In the bone marrow, GM-CSF stimulates the proliferation and differentiation of hematopoietic stem cells into granulocytes and macrophages. These cells are important components of the immune system and play a key role in fighting infections and removing damaged or infected cells from the body. GM-CSF also has a number of other functions in the body, including promoting the survival of granulocytes and macrophages, enhancing their ability to phagocytose (engulf and destroy) pathogens, and stimulating the production of cytokines and other signaling molecules that help to coordinate the immune response. In the medical field, GM-CSF is used as a treatment for a variety of conditions, including cancer, bone marrow suppression, and certain immune disorders. It is typically administered as a recombinant protein, either as a standalone therapy or in combination with other treatments.

Colony-stimulating factors (CSFs) are a group of proteins that stimulate the growth and differentiation of certain types of blood cells in the bone marrow. There are several different types of CSFs, including granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), and colony-stimulating factor-1 (CSF-1). CSFs are typically used to treat conditions that affect the production of blood cells, such as chemotherapy-induced neutropenia (a low white blood cell count), and to stimulate the growth of new blood cells in people with certain types of anemia or bone marrow disorders. They may also be used to stimulate the growth of new bone tissue in people with certain types of bone disease. CSFs are usually administered as injections, either under the skin or into a vein. They can cause side effects, such as fever, chills, and flu-like symptoms, and may also increase the risk of infection. It is important to carefully follow the instructions provided by your healthcare provider when using CSFs.

Cell proliferation refers to the process of cell division and growth, which is essential for the maintenance and repair of tissues in the body. In the medical field, cell proliferation is often studied in the context of cancer, where uncontrolled cell proliferation can lead to the formation of tumors and the spread of cancer cells to other parts of the body. In normal cells, cell proliferation is tightly regulated by a complex network of signaling pathways and feedback mechanisms that ensure that cells divide only when necessary and that they stop dividing when they have reached their full capacity. However, in cancer cells, these regulatory mechanisms can become disrupted, leading to uncontrolled cell proliferation and the formation of tumors. In addition to cancer, cell proliferation is also important in other medical conditions, such as wound healing, tissue regeneration, and the development of embryos. Understanding the mechanisms that regulate cell proliferation is therefore critical for developing new treatments for cancer and other diseases.

Chemokine CXCL12, also known as stromal cell-derived factor-1 (SDF-1), is a small protein that plays a crucial role in the recruitment and migration of immune cells to specific areas of the body. It is a member of the chemokine family of proteins, which are responsible for directing the movement of cells in response to chemical signals. CXCL12 is primarily produced by cells in the bone marrow, liver, and other tissues, and it is released in response to various stimuli, including inflammation, injury, and infection. It acts by binding to specific receptors on the surface of immune cells, such as T cells, B cells, and monocytes, and guiding them to the site of injury or infection. CXCL12 is also involved in the development and maintenance of the immune system, as well as in the regulation of angiogenesis (the formation of new blood vessels). It has been implicated in a variety of diseases, including cancer, autoimmune disorders, and infectious diseases, and it is a target for the development of new therapies.

Hematologic diseases refer to disorders that affect the blood and blood-forming organs, such as the bone marrow, spleen, and lymph nodes. These diseases can affect the production, function, or quality of blood cells, leading to a variety of symptoms and complications. Examples of hematologic diseases include: 1. Anemia: A condition characterized by a decrease in the number of red blood cells or hemoglobin levels in the blood. 2. Leukemia: A type of cancer that affects the white blood cells, causing them to grow and divide uncontrollably. 3. Lymphoma: A type of cancer that affects the lymphatic system, which is responsible for fighting infections and diseases. 4. Thalassemia: A genetic disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen. 5. Sickle cell disease: A genetic disorder that affects the shape of red blood cells, making them sickle-shaped and less able to carry oxygen. 6. Hemophilia: A genetic disorder that affects the production of clotting factors in the blood, leading to excessive bleeding. 7. Myelodysplastic syndromes: A group of disorders that affect the bone marrow's ability to produce healthy blood cells. Hematologic diseases can be treated with a variety of approaches, including medications, blood transfusions, chemotherapy, radiation therapy, and stem cell transplantation. Early detection and treatment are crucial for managing these conditions and improving outcomes for patients.

In the medical field, "Disease Models, Animal" refers to the use of animals to study and understand human diseases. These models are created by introducing a disease or condition into an animal, either naturally or through experimental manipulation, in order to study its progression, symptoms, and potential treatments. Animal models are used in medical research because they allow scientists to study diseases in a controlled environment and to test potential treatments before they are tested in humans. They can also provide insights into the underlying mechanisms of a disease and help to identify new therapeutic targets. There are many different types of animal models used in medical research, including mice, rats, rabbits, dogs, and monkeys. Each type of animal has its own advantages and disadvantages, and the choice of model depends on the specific disease being studied and the research question being addressed.

In the medical field, cell movement refers to the ability of cells to move from one location to another within a tissue or organism. This movement can occur through various mechanisms, including crawling, rolling, and sliding, and is essential for many physiological processes, such as tissue repair, immune response, and embryonic development. There are several types of cell movement, including: 1. Chemotaxis: This is the movement of cells in response to chemical gradients, such as the concentration of a signaling molecule. 2. Haptotaxis: This is the movement of cells in response to physical gradients, such as the stiffness or topography of a substrate. 3. Random walk: This is the movement of cells in a seemingly random manner, which can be influenced by factors such as cell adhesion and cytoskeletal dynamics. 4. Amoeboid movement: This is the movement of cells that lack a well-defined cytoskeleton and rely on changes in cell shape and adhesion to move. Understanding cell movement is important for many medical applications, including the development of new therapies for diseases such as cancer, the study of tissue regeneration and repair, and the design of new materials for tissue engineering and regenerative medicine.

Alkaline Phosphatase (ALP) is an enzyme that is found in many tissues throughout the body, including the liver, bone, and intestines. In the medical field, ALP levels are often measured as a diagnostic tool to help identify various conditions and diseases. There are several types of ALP, including tissue-nonspecific ALP (TN-ALP), bone-specific ALP (B-ALP), and liver-specific ALP (L-ALP). Each type of ALP is produced by different tissues and has different functions. In general, elevated levels of ALP can indicate a variety of medical conditions, including liver disease, bone disease, and certain types of cancer. For example, elevated levels of ALP in the blood can be a sign of liver damage or disease, while elevated levels in the urine can be a sign of bone disease or kidney problems. On the other hand, low levels of ALP can also be a cause for concern, as they may indicate a deficiency in certain vitamins or minerals, such as vitamin D or calcium. Overall, ALP is an important biomarker that can provide valuable information to healthcare providers in the diagnosis and management of various medical conditions.

Combined modality therapy (CMT) is a cancer treatment approach that involves using two or more different types of treatments simultaneously or in sequence to achieve a better therapeutic effect than any single treatment alone. The goal of CMT is to increase the effectiveness of cancer treatment while minimizing side effects. The different types of treatments that may be used in CMT include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. The specific combination of treatments used in CMT depends on the type and stage of cancer, as well as the patient's overall health and individual needs. CMT is often used for the treatment of advanced or aggressive cancers, where a single treatment may not be effective. By combining different treatments, CMT can help to destroy cancer cells more completely and prevent the cancer from returning. However, CMT can also have more significant side effects than a single treatment, so it is important for patients to discuss the potential risks and benefits with their healthcare provider before starting treatment.

In the medical field, "clone cells" refers to the process of creating genetically identical copies of a single cell. This is typically done through a technique called cell division, in which a single cell divides into two identical daughter cells. The daughter cells are genetically identical to the parent cell because they inherit the same genetic material. Cloning cells is a common technique used in many areas of medicine, including tissue engineering, regenerative medicine, and cancer research. It can also be used in the production of vaccines and other medical treatments.

B-lymphocytes, also known as B-cells, are a type of white blood cell that plays a crucial role in the immune system. They are responsible for producing antibodies, which are proteins that help the body recognize and fight off foreign substances such as viruses, bacteria, and other pathogens. B-cells are produced in the bone marrow and mature in the spleen and lymph nodes. When a B-cell encounters an antigen (a foreign substance that triggers an immune response), it becomes activated and begins to divide rapidly. The activated B-cell then differentiates into plasma cells, which produce and secrete large amounts of antibodies specific to the antigen. The antibodies produced by B-cells can neutralize pathogens by binding to them and preventing them from infecting cells, or they can mark them for destruction by other immune cells. B-cells also play a role in memory, meaning that they can remember specific antigens and mount a faster and more effective immune response if they encounter the same antigen again in the future. B-cell disorders, such as autoimmune diseases and certain types of cancer, can result from problems with the development, activation, or function of B-cells.

Calcification, physiologic refers to the normal process of calcium deposition in tissues and organs throughout the body. This process is essential for the development and maintenance of many structures, such as bones, teeth, and blood vessels. In the context of the medical field, physiologic calcification is generally considered to be a normal and healthy process. However, excessive or abnormal calcification can lead to a variety of health problems, such as atherosclerosis (hardening of the arteries), kidney stones, and calcification of soft tissues. Physiologic calcification is typically the result of the deposition of calcium and other minerals in response to various stimuli, such as hormonal changes, aging, and injury. It is a complex process that involves the interaction of multiple factors, including calcium and phosphate levels in the blood, vitamin D metabolism, and the activity of various enzymes and proteins. Overall, physiologic calcification is an important aspect of human physiology and plays a critical role in the development and maintenance of many structures and functions throughout the body.

In the medical field, an acute disease is a condition that develops suddenly and progresses rapidly over a short period of time. Acute diseases are typically characterized by severe symptoms and a high degree of morbidity and mortality. Examples of acute diseases include pneumonia, meningitis, sepsis, and heart attacks. These diseases require prompt medical attention and treatment to prevent complications and improve outcomes. In contrast, chronic diseases are long-term conditions that develop gradually over time and may persist for years or even decades.

Osteoporosis is a medical condition characterized by a decrease in bone density and strength, making bones more fragile and prone to fractures. It is a common condition, particularly in older adults, and can affect both men and women. In osteoporosis, the bones become porous and brittle, which can lead to fractures even with minor trauma or falls. The most common sites for osteoporosis-related fractures are the spine, hip, and wrist. Osteoporosis is often diagnosed through a bone density test, which measures the amount of bone mineral density in the hip and spine. Risk factors for osteoporosis include age, gender, family history, smoking, excessive alcohol consumption, and certain medical conditions such as thyroid disease or rheumatoid arthritis. Treatment for osteoporosis typically involves medications to increase bone density and reduce the risk of fractures, as well as lifestyle changes such as regular exercise and a healthy diet rich in calcium and vitamin D.

Coculture techniques refer to the process of growing two or more different cell types together in a single culture dish or flask. This is commonly used in the medical field to study interactions between cells, such as how cancer cells affect normal cells or how immune cells respond to pathogens. Coculture techniques can be used in a variety of ways, including co-culturing cells from different tissues or organs, co-culturing cells with different cell types, or co-culturing cells with microorganisms or other foreign substances. Coculture techniques can also be used to study the effects of drugs or other treatments on cell interactions. Overall, coculture techniques are a valuable tool in the medical field for studying cell interactions and developing new treatments for diseases.

Recombinant proteins are proteins that are produced by genetically engineering bacteria, yeast, or other organisms to express a specific gene. These proteins are typically used in medical research and drug development because they can be produced in large quantities and are often more pure and consistent than proteins that are extracted from natural sources. Recombinant proteins can be used for a variety of purposes in medicine, including as diagnostic tools, therapeutic agents, and research tools. For example, recombinant versions of human proteins such as insulin, growth hormones, and clotting factors are used to treat a variety of medical conditions. Recombinant proteins can also be used to study the function of specific genes and proteins, which can help researchers understand the underlying causes of diseases and develop new treatments.

Lymphoma, Non-Hodgkin (NHL) is a type of cancer that affects the lymphatic system, which is a part of the immune system. NHL is characterized by the abnormal growth of lymphocytes, a type of white blood cell, in the lymph nodes, spleen, and other parts of the body. There are many different types of NHL, and they can vary in their symptoms, progression, and treatment options. Some common symptoms of NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue. NHL is typically diagnosed through a combination of physical examination, blood tests, imaging studies, and a biopsy of the affected tissue. Treatment options for NHL may include chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation, depending on the type and stage of the cancer. Overall, NHL is a serious condition that requires prompt diagnosis and treatment to improve outcomes and quality of life for patients.

In the medical field, RNA, Messenger (mRNA) refers to a type of RNA molecule that carries genetic information from DNA in the nucleus of a cell to the ribosomes, where proteins are synthesized. During the process of transcription, the DNA sequence of a gene is copied into a complementary RNA sequence called messenger RNA (mRNA). This mRNA molecule then leaves the nucleus and travels to the cytoplasm of the cell, where it binds to ribosomes and serves as a template for the synthesis of a specific protein. The sequence of nucleotides in the mRNA molecule determines the sequence of amino acids in the protein that is synthesized. Therefore, changes in the sequence of nucleotides in the mRNA molecule can result in changes in the amino acid sequence of the protein, which can affect the function of the protein and potentially lead to disease. mRNA molecules are often used in medical research and therapy as a way to introduce new genetic information into cells. For example, mRNA vaccines work by introducing a small piece of mRNA that encodes for a specific protein, which triggers an immune response in the body.

Stem cell factor (SCF) is a protein that plays a crucial role in the development and maintenance of blood cells. It is also known as c-kit ligand because it binds to a protein called c-kit, which is found on the surface of certain types of cells, including hematopoietic stem cells. SCF is produced by a variety of cells, including endothelial cells, fibroblasts, and macrophages, and it acts as a growth factor for hematopoietic stem cells. It promotes the proliferation and differentiation of these cells, leading to the production of various types of blood cells, including red blood cells, white blood cells, and platelets. In addition to its role in hematopoiesis, SCF has been implicated in a variety of other biological processes, including angiogenesis, wound healing, and immune function. It has also been studied for its potential therapeutic applications in the treatment of various diseases, including cancer, anemia, and bone marrow failure.

In the medical field, recurrence refers to the reappearance of a disease or condition after it has been treated or has gone into remission. Recurrence can occur in various medical conditions, including cancer, infections, and autoimmune diseases. For example, in cancer, recurrence means that the cancer has come back after it has been treated with surgery, chemotherapy, radiation therapy, or other treatments. Recurrence can occur months, years, or even decades after the initial treatment. In infections, recurrence means that the infection has returned after it has been treated with antibiotics or other medications. Recurrence can occur due to incomplete treatment, antibiotic resistance, or other factors. In autoimmune diseases, recurrence means that the symptoms of the disease return after they have been controlled with medication. Recurrence can occur due to changes in the immune system or other factors. Overall, recurrence is a significant concern for patients and healthcare providers, as it can require additional treatment and can impact the patient's quality of life.

In the medical field, "cell survival" refers to the ability of cells to survive and continue to function despite exposure to harmful stimuli or conditions. This can include exposure to toxins, radiation, or other forms of stress that can damage or kill cells. Cell survival is an important concept in many areas of medicine, including cancer research, where understanding how cells survive and resist treatment is crucial for developing effective therapies. In addition, understanding the mechanisms that regulate cell survival can also have implications for other areas of medicine, such as tissue repair and regeneration.

In the medical field, RANK ligand, also known as osteoprotegerin ligand (OPGL), is a protein that plays a crucial role in bone remodeling and the regulation of bone homeostasis. It is a member of the tumor necrosis factor (TNF) superfamily of cytokines and is primarily produced by osteoblasts, which are cells responsible for bone formation. RANK ligand binds to a receptor called RANK (receptor activator of nuclear factor kappa-B) on the surface of osteoclasts, which are cells responsible for bone resorption or breakdown. The binding of RANK ligand to RANK triggers a signaling cascade that leads to the activation and differentiation of osteoclasts, promoting bone resorption. In addition to its role in bone remodeling, RANK ligand has been implicated in various other physiological and pathological processes, including inflammation, cancer, and autoimmune diseases. Therefore, targeting RANK ligand has become an attractive therapeutic strategy for the treatment of these conditions.

Lymphoma is a type of cancer that affects the lymphatic system, which is a part of the immune system. It occurs when lymphocytes, a type of white blood cell, grow and divide uncontrollably, forming abnormal masses or tumors in the lymph nodes, spleen, bone marrow, or other parts of the body. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. Hodgkin lymphoma is a less common type of lymphoma that typically affects younger adults and has a better prognosis than non-Hodgkin lymphoma. Non-Hodgkin lymphoma is a more common type of lymphoma that can affect people of all ages and has a wide range of outcomes depending on the specific subtype and the stage of the disease. Symptoms of lymphoma can include swollen lymph nodes, fever, night sweats, weight loss, fatigue, and itching. Diagnosis typically involves a combination of physical examination, blood tests, imaging studies, and a biopsy of the affected tissue. Treatment for lymphoma depends on the subtype, stage, and overall health of the patient. It may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches. In some cases, a stem cell transplant may also be necessary.

CD45 is a type of protein found on the surface of many different types of immune cells, including white blood cells. It is also known as leukocyte common antigen or lymphocyte common antigen. CD45 plays an important role in the function of the immune system by helping to regulate the activity of immune cells. It is also used as a marker to identify different types of immune cells in the laboratory. Antigens, CD45 refers to molecules that bind to CD45 on the surface of immune cells and trigger an immune response. These antigens can be found on viruses, bacteria, and other foreign substances, as well as on abnormal cells in the body.

Osteocalcin is a protein that is primarily produced by osteoblasts, which are cells responsible for bone formation. It is a marker of bone formation and is often used as a diagnostic tool in the medical field to assess bone health. Osteocalcin is also involved in regulating glucose metabolism and insulin sensitivity. Studies have shown that low levels of osteocalcin are associated with an increased risk of type 2 diabetes and other metabolic disorders. In addition, osteocalcin has been shown to have anti-inflammatory properties and may play a role in regulating the immune system. It has also been suggested that osteocalcin may have a role in the development of certain types of cancer, although more research is needed to confirm this. Overall, osteocalcin is an important protein in bone health and metabolism, and its study is ongoing in the medical field.

In the medical field, "Antigens, Ly" refers to a group of antigens that are found on the surface of certain types of white blood cells, specifically lymphocytes. These antigens are important for the immune system to recognize and identify lymphocytes as belonging to the body's own cells, and to distinguish them from foreign cells that may be harmful or infectious. The "Ly" antigens are named after the laboratory technique used to identify them, which involves labeling the antigens with a fluorescent dye and then using a microscope to visualize them. There are several different types of Ly antigens, each of which is specific to a particular type of lymphocyte. Understanding the presence and expression of Ly antigens is important in the diagnosis and treatment of certain medical conditions, such as autoimmune diseases and certain types of cancer. It can also be useful in the development of vaccines and other immune therapies.

Hematologic neoplasms are a group of disorders that affect the blood and bone marrow, including the production of blood cells. These disorders are characterized by the abnormal growth and proliferation of blood cells, which can lead to an overproduction of certain types of blood cells (such as leukemias) or a deficiency of certain types of blood cells (such as anemia). Hematologic neoplasms can be either benign (non-cancerous) or malignant (cancerous), and they can affect people of all ages. Some common types of hematologic neoplasms include leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. Treatment for hematologic neoplasms typically involves a combination of chemotherapy, radiation therapy, and/or stem cell transplantation.

Proto-oncogene proteins c-kit, also known as CD117 or c-Kit, are a family of receptor tyrosine kinases that play a critical role in cell growth, differentiation, and survival. They are expressed on various types of cells, including hematopoietic cells, mast cells, and interstitial cells of Cajal in the gastrointestinal tract. In the context of cancer, mutations in the c-kit gene can lead to the activation of the protein, resulting in uncontrolled cell growth and the development of tumors. This is particularly relevant in gastrointestinal stromal tumors (GISTs), which are the most common type of mesenchymal tumor of the gastrointestinal tract. GISTs often express high levels of c-kit, and targeted therapy with drugs that inhibit the activity of the protein has been shown to be effective in treating these tumors. Overall, the study of c-kit and its role in cancer has important implications for the development of new treatments for various types of malignancies.

Bone cements are medical materials that are used to fill bone defects or to attach artificial joints to the bone. They are typically made of a powder and a liquid that are mixed together and then injected into the bone. The powder and liquid react chemically to form a hard, durable material that bonds to the bone and provides support for the artificial joint or implant. Bone cements are commonly used in orthopedic surgery to treat conditions such as fractures, osteoarthritis, and bone tumors. They are also used in dental surgery to anchor dental implants in the jawbone.

Leukemia, Lymphoid is a type of cancer that affects the white blood cells, specifically the lymphocytes. Lymphocytes are a type of white blood cell that plays a crucial role in the immune system by fighting off infections and diseases. In leukemia, lymphoid, the abnormal lymphocytes multiply uncontrollably and crowd out healthy blood cells in the bone marrow and bloodstream. This can lead to a weakened immune system, making the person more susceptible to infections, and can also cause symptoms such as fatigue, fever, night sweats, and weight loss. There are several types of leukemia, lymphoid, including acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and hairy cell leukemia. Treatment for leukemia, lymphoid typically involves chemotherapy, radiation therapy, targeted therapy, and bone marrow transplantation, depending on the type and stage of the cancer.

Erythropoietin (EPO) is a hormone produced by the kidneys and the liver that stimulates the production of red blood cells (erythrocytes) in the bone marrow. It plays a crucial role in maintaining the body's oxygen-carrying capacity by increasing the number of red blood cells in circulation. In the medical field, EPO is used to treat anemia, a condition characterized by a deficiency of red blood cells or hemoglobin, which can lead to fatigue, weakness, and shortness of breath. It is also used in the treatment of certain types of cancer, such as multiple myeloma, and in patients undergoing chemotherapy or radiation therapy, which can cause anemia. EPO is available as a medication and is typically administered by injection. It is important to note that the use of EPO for non-medical purposes, such as enhancing athletic performance, is illegal and can have serious health risks.

Cell culture techniques refer to the methods used to grow and maintain cells in a controlled laboratory environment. These techniques are commonly used in the medical field for research, drug development, and tissue engineering. In cell culture, cells are typically grown in a liquid medium containing nutrients, hormones, and other substances that support their growth and survival. The cells are usually placed in a specialized container called a culture dish or flask, which is incubated in a controlled environment with a specific temperature, humidity, and oxygen level. There are several types of cell culture techniques, including: 1. Monolayer culture: In this technique, cells are grown in a single layer on the surface of the culture dish. This is the most common type of cell culture and is used for many types of research and drug development. 2. Suspension culture: In this technique, cells are grown in a liquid medium and are free to move around. This is commonly used for the cultivation of cells that do not form a monolayer, such as stem cells and cancer cells. 3. Co-culture: In this technique, two or more types of cells are grown together in the same culture dish. This is used to study interactions between different cell types and is commonly used in tissue engineering. 4. 3D culture: In this technique, cells are grown in a three-dimensional matrix, such as a scaffold or hydrogel. This is used to mimic the structure and function of tissues in the body and is commonly used in tissue engineering and regenerative medicine. Overall, cell culture techniques are essential tools in the medical field for advancing our understanding of cell biology, developing new drugs and therapies, and engineering tissues and organs for transplantation.

Antineoplastic Combined Chemotherapy Protocols (ACCP) are a type of chemotherapy treatment used to treat cancer. They involve the use of multiple drugs in combination to target and destroy cancer cells. The drugs used in an ACCP are chosen based on the type and stage of cancer being treated, as well as the patient's overall health. The goal of an ACCP is to shrink the tumor, slow the growth of cancer cells, and improve the patient's quality of life.

Alveolar bone loss is a condition in which the bone that supports the teeth in the jaw (alveolar bone) gradually deteriorates or is lost. This can occur due to a variety of factors, including periodontal disease (gum disease), tooth loss, and certain medical conditions such as osteoporosis or diabetes. Alveolar bone loss can lead to a number of problems, including tooth sensitivity, loose teeth, and even tooth loss. It can also affect the appearance of the face, as the loss of bone can cause the teeth to shift and the jaw to become more prominent. Treatment for alveolar bone loss may include nonsurgical procedures such as scaling and root planing to remove plaque and tartar from the teeth and gums, as well as the use of antibiotics to treat any underlying infections. In some cases, surgery may be necessary to replace lost bone or to stabilize the teeth. It is important to seek treatment for alveolar bone loss as soon as possible to prevent further damage and to maintain good oral health.

Thrombocytopenia is a medical condition characterized by a low number of platelets (thrombocytes) in the blood. Platelets are small, disc-shaped cells that play a crucial role in blood clotting and preventing excessive bleeding. In thrombocytopenia, the number of platelets in the blood is below the normal range, which can lead to an increased risk of bleeding and bruising. The severity of thrombocytopenia can vary widely, ranging from mild to severe, and can be caused by a variety of factors, including infections, autoimmune disorders, certain medications, and bone marrow disorders. Symptoms of thrombocytopenia may include easy bruising, nosebleeds, bleeding gums, and petechiae (small red or purple spots on the skin). Treatment for thrombocytopenia depends on the underlying cause and may include medications to increase platelet production, blood transfusions, or other therapies.

In the medical field, "Neoplasm, Residual" refers to a remaining or persistent tumor or mass after a surgical or other treatment intended to remove it. It is also known as a "recurrent tumor" or "metastatic tumor." Residual neoplasms can occur when the initial treatment was not completely effective in eliminating all cancer cells, or when cancer cells have spread to other parts of the body. Residual neoplasms may require additional treatment, such as radiation therapy or chemotherapy, to prevent the cancer from returning or spreading further.

In the medical field, a cell line refers to a group of cells that have been derived from a single parent cell and have the ability to divide and grow indefinitely in culture. These cells are typically grown in a laboratory setting and are used for research purposes, such as studying the effects of drugs or investigating the underlying mechanisms of diseases. Cell lines are often derived from cancerous cells, as these cells tend to divide and grow more rapidly than normal cells. However, they can also be derived from normal cells, such as fibroblasts or epithelial cells. Cell lines are characterized by their unique genetic makeup, which can be used to identify them and compare them to other cell lines. Because cell lines can be grown in large quantities and are relatively easy to maintain, they are a valuable tool in medical research. They allow researchers to study the effects of drugs and other treatments on specific cell types, and to investigate the underlying mechanisms of diseases at the cellular level.

A biopsy is a medical procedure in which a small sample of tissue is removed from a person's body for examination under a microscope. The sample is usually taken from a lump, growth, or other abnormal area, and is used to help diagnose a medical condition or disease. There are several types of biopsy procedures, including: 1. Fine-needle aspiration biopsy: A sample of tissue is removed using a thin needle inserted into the abnormal area. 2. Core biopsy: A larger sample of tissue is removed using a hollow needle that takes multiple cores of tissue. 3. Excision biopsy: A larger piece of tissue is removed using a scalpel or other surgical instrument. 4. Endoscopic biopsy: A biopsy is performed using a flexible tube with a camera and light on the end, which is inserted into the body through a natural opening or a small incision. Biopsies are commonly used to diagnose cancer, but they can also be used to diagnose other medical conditions, such as infections, autoimmune diseases, and genetic disorders. The results of a biopsy can help guide treatment decisions and provide important information about a person's prognosis.

Cytokines are small proteins that are produced by various cells of the immune system, including white blood cells, macrophages, and dendritic cells. They play a crucial role in regulating immune responses and inflammation, and are involved in a wide range of physiological processes, including cell growth, differentiation, and apoptosis. Cytokines can be classified into different groups based on their function, including pro-inflammatory cytokines, anti-inflammatory cytokines, and regulatory cytokines. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1), promote inflammation and recruit immune cells to the site of infection or injury. Anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-beta), help to dampen the immune response and prevent excessive inflammation. Regulatory cytokines, such as interleukin-4 (IL-4) and interleukin-13 (IL-13), help to regulate the balance between pro-inflammatory and anti-inflammatory responses. Cytokines play a critical role in many diseases, including autoimmune disorders, cancer, and infectious diseases. They are also important in the development of vaccines and immunotherapies.

Hematopoietic cell growth factors (HCGFs) are a group of proteins that regulate the growth, differentiation, and survival of hematopoietic stem cells and their progeny, which include all types of blood cells. These factors are produced by a variety of cells, including stromal cells, endothelial cells, and immune cells, and act on hematopoietic cells through specific receptors on their surface. HCGFs play a critical role in the maintenance of the hematopoietic system, which is responsible for producing all of the blood cells in the body. They are also important in the treatment of certain blood disorders, such as anemia, leukemia, and lymphoma, by promoting the growth and differentiation of blood cells. Some examples of HCGFs include erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and thrombopoietin (TPO). These factors are often used in the clinic to stimulate the production of specific types of blood cells, such as red blood cells, white blood cells, or platelets, in patients with low blood counts or other hematological disorders.

Myeloproliferative disorders (MPDs) are a group of blood disorders characterized by the overproduction of blood cells in the bone marrow. These disorders are caused by genetic mutations that lead to the uncontrolled growth and proliferation of certain types of blood cells, such as red blood cells, white blood cells, or platelets. The most common MPDs are polycythemia vera, essential thrombocythemia, and primary myelofibrosis. These disorders can lead to a variety of symptoms, including fatigue, weakness, shortness of breath, abdominal pain, and bleeding disorders. Treatment for MPDs typically involves medications to control the overproduction of blood cells and manage symptoms. In some cases, a blood transfusion or a stem cell transplant may be necessary. It is important for individuals with MPDs to work closely with their healthcare providers to manage their condition and prevent complications.

In the medical field, cell adhesion refers to the process by which cells stick to each other or to a surface. This is an essential process for the proper functioning of tissues and organs in the body. There are several types of cell adhesion, including: 1. Homophilic adhesion: This occurs when cells adhere to each other through the interaction of specific molecules on their surface. 2. Heterophilic adhesion: This occurs when cells adhere to each other through the interaction of different molecules on their surface. 3. Heterotypic adhesion: This occurs when cells adhere to each other through the interaction of different types of cells. 4. Intercellular adhesion: This occurs when cells adhere to each other through the interaction of molecules within the cell membrane. 5. Intracellular adhesion: This occurs when cells adhere to each other through the interaction of molecules within the cytoplasm. Cell adhesion is important for a variety of processes, including tissue development, wound healing, and the immune response. Disruptions in cell adhesion can lead to a variety of medical conditions, including cancer, autoimmune diseases, and inflammatory disorders.

Thrombopoietin (TPO) is a hormone produced by the liver and kidneys that stimulates the production of platelets, which are essential for blood clotting. TPO binds to receptors on the surface of megakaryocytes, the cells in the bone marrow that produce platelets, and triggers a signaling cascade that leads to the proliferation and differentiation of megakaryocytes into platelets. In the medical field, TPO is used as a diagnostic tool to measure the level of platelets in the blood, which can be an indicator of various medical conditions such as thrombocytopenia (low platelet count) or thrombocytosis (high platelet count). TPO is also used as a treatment for thrombocytopenia, particularly in patients with chronic myeloid leukemia or other blood disorders. In these cases, TPO can stimulate the production of platelets and help increase their count in the blood.

Cytarabine, also known as cytosine arabinoside, is an antineoplastic medication used to treat various types of cancer, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and non-Hodgkin's lymphoma. It works by inhibiting the growth and division of cancer cells, thereby slowing or stopping their growth and spread. Cytarabine is typically administered intravenously or intramuscularly, and its dosage and duration of treatment depend on the type and stage of cancer being treated, as well as the patient's overall health. Common side effects of cytarabine include nausea, vomiting, fatigue, fever, and low blood cell counts, which can increase the risk of infection and bleeding. It is important to note that cytarabine is a chemotherapy drug and can cause serious side effects, so it is typically administered under the supervision of a healthcare professional in a hospital or clinic setting.

In the medical field, antigens are molecules that can trigger an immune response in the body. Surface antigens are antigens that are located on the surface of cells or viruses. They are recognized by the immune system as foreign and can trigger an immune response, leading to the production of antibodies that can neutralize or destroy the antigen. Surface antigens are important for the development of vaccines, as they can be used to stimulate the immune system to produce a protective response against specific diseases. Examples of surface antigens include the spike protein on the surface of the SARS-CoV-2 virus, which is the cause of COVID-19, and the antigens on the surface of cancer cells, which can be targeted by cancer vaccines.

Severe Combined Immunodeficiency (SCID) is a rare genetic disorder that affects the immune system. It is characterized by a severe and combined deficiency of both T cells and B cells, which are essential components of the immune system that help the body fight off infections and diseases. SCID can be caused by mutations in one of several genes that are involved in the development and function of the immune system. These mutations can result in the inability of the body to produce functional T cells and B cells, leaving the individual vulnerable to infections that would normally be easily fought off by a healthy immune system. Symptoms of SCID can include recurrent and severe infections, failure to thrive, and delayed development. Without treatment, SCID can be life-threatening, but it can be managed with bone marrow transplantation or gene therapy.

Biological markers, also known as biomarkers, are measurable indicators of biological processes, pathogenic processes, or responses to therapeutic interventions. In the medical field, biological markers are used to diagnose, monitor, and predict the progression of diseases, as well as to evaluate the effectiveness of treatments. Biological markers can be found in various biological samples, such as blood, urine, tissue, or body fluids. They can be proteins, genes, enzymes, hormones, metabolites, or other molecules that are associated with a specific disease or condition. For example, in cancer, biological markers such as tumor markers can be used to detect the presence of cancer cells or to monitor the response to treatment. In cardiovascular disease, biological markers such as cholesterol levels or blood pressure can be used to assess the risk of heart attack or stroke. Overall, biological markers play a crucial role in medical research and clinical practice, as they provide valuable information about the underlying biology of diseases and help to guide diagnosis, treatment, and monitoring.

Thy-1 is a type of antigen found on the surface of certain cells in the immune system. It is also known as CD90 and is expressed on a variety of cell types, including T cells, B cells, and dendritic cells. The function of Thy-1 is not fully understood, but it is thought to play a role in cell adhesion and migration. In the medical field, Thy-1 is often used as a marker to identify and study specific types of immune cells. It is also used as a target for immunotherapy, a type of cancer treatment that uses the body's immune system to fight cancer cells.

In the medical field, "Antigens, Differentiation" refers to proteins or other molecules that are expressed on the surface of cells and can be recognized by the immune system as foreign or abnormal. These antigens play a crucial role in the process of cell differentiation, which is the process by which cells develop specialized functions and characteristics. There are several types of antigens that are involved in cell differentiation, including surface antigens, cytoplasmic antigens, and nuclear antigens. Surface antigens are located on the surface of cells and are recognized by the immune system as foreign or abnormal. Cytoplasmic antigens are located inside the cytoplasm of cells and are involved in the regulation of cell growth and division. Nuclear antigens are located inside the nucleus of cells and are involved in the regulation of gene expression. Antigens, differentiation are important for the proper functioning of the immune system, as they help to identify and eliminate abnormal or foreign cells. They are also important for the development and maintenance of specialized cell types, as they help to regulate the expression of specific genes and proteins that are necessary for the function of these cells.

Apoptosis is a programmed cell death process that occurs naturally in the body. It is a vital mechanism for maintaining tissue homeostasis and eliminating damaged or unwanted cells. During apoptosis, cells undergo a series of changes that ultimately lead to their death and removal from the body. These changes include chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies, which are engulfed by neighboring cells or removed by immune cells. Apoptosis plays a critical role in many physiological processes, including embryonic development, tissue repair, and immune function. However, when apoptosis is disrupted or dysregulated, it can contribute to the development of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

Bone Morphogenetic Protein 7 (BMP7) is a protein that plays a crucial role in bone development and repair. It is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, which are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. In the medical field, BMP7 is used as a therapeutic agent to promote bone growth and repair in various conditions, such as non-unions (incomplete healing of bone fractures), spinal fusion, and osteoporosis. It is also being investigated for its potential use in tissue engineering and regenerative medicine to create artificial bones and other tissues. BMP7 is typically administered as a recombinant protein, which is produced using genetic engineering techniques. It can be delivered locally to the site of injury or disease, either as a standalone treatment or in combination with other therapies. However, the use of BMP7 in medicine is still in its early stages, and more research is needed to fully understand its potential benefits and risks.

In the medical field, a base sequence refers to the specific order of nucleotides (adenine, thymine, cytosine, and guanine) that make up the genetic material (DNA or RNA) of an organism. The base sequence determines the genetic information encoded within the DNA molecule and ultimately determines the traits and characteristics of an individual. The base sequence can be analyzed using various techniques, such as DNA sequencing, to identify genetic variations or mutations that may be associated with certain diseases or conditions.

Fanconi Anemia (FA) is a rare genetic disorder that affects the body's ability to repair damaged DNA. It is characterized by a range of symptoms, including bone marrow failure, which can lead to anemia, infections, and an increased risk of developing cancer. FA is caused by mutations in one of 19 different genes, and it is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. There is currently no cure for FA, but treatments are available to manage the symptoms and complications of the disease.

Osteopetrosis is a rare genetic disorder that affects the bones. It is also known as "marble bone disease" because the bones become very dense and hard, like marble. This is due to a defect in the bone remodeling process, which normally breaks down old bone and replaces it with new bone. In osteopetrosis, the bone remodeling process is impaired, leading to a buildup of old bone and a lack of new bone formation. There are several different types of osteopetrosis, which are classified based on the severity of the symptoms and the age at which they appear. Some forms of the disorder are very severe and can be life-threatening, while others are milder and may not cause any symptoms until later in life. Symptoms of osteopetrosis can include bone pain, fractures, and deformities. It can also affect other organs, such as the eyes, ears, and kidneys. Treatment for osteopetrosis typically involves managing symptoms and preventing complications. This may include medications to relieve pain, surgery to correct bone deformities, and regular monitoring by a healthcare provider.

Macrophage Colony-Stimulating Factor (M-CSF) is a protein that plays a crucial role in the development and function of macrophages, a type of white blood cell that is an important component of the immune system. M-CSF is produced by a variety of cells, including macrophages, monocytes, and osteoblasts, and it acts on macrophages to stimulate their proliferation and differentiation. M-CSF is also involved in the regulation of the inflammatory response, and it has been shown to play a role in the development of certain types of cancer, such as multiple myeloma and breast cancer. In addition, M-CSF has been used as a therapeutic agent in the treatment of certain types of cancer, such as myelodysplastic syndromes and acute myeloid leukemia. Overall, M-CSF is an important molecule in the immune system and has a number of potential therapeutic applications.

B-lymphocyte subsets refer to the different types of B-lymphocytes, which are a type of white blood cell that plays a crucial role in the immune system. There are several different subsets of B-lymphocytes, each with its own unique characteristics and functions. The main B-lymphocyte subsets are: 1. Naive B-cells: These are B-cells that have not yet been activated by an antigen. They are present in the bone marrow and circulate in the blood. 2. Memory B-cells: These are B-cells that have been activated by an antigen in the past and have developed the ability to respond quickly to the same antigen if it is encountered again in the future. 3. Plasma cells: These are B-cells that have been activated by an antigen and have differentiated into cells that produce antibodies. Antibodies are proteins that recognize and bind to specific antigens, helping to neutralize or eliminate them from the body. 4. Regulatory B-cells: These are B-cells that help to regulate the immune response by suppressing the activity of other immune cells. Understanding the different B-lymphocyte subsets is important for understanding how the immune system works and for developing treatments for diseases that involve the immune system, such as autoimmune disorders and infections.

Preleukemia, also known as premyelocytic leukemia or preleukemic syndrome, is a condition that occurs before the development of acute myeloid leukemia (AML). It is characterized by an increase in the number of immature white blood cells (myelocytes) in the bone marrow and blood. Preleukemia can be classified into two types: 1. Myelodysplastic syndrome (MDS): This is a group of blood disorders characterized by an abnormal production of blood cells in the bone marrow. MDS can progress to AML, and some cases of MDS are considered preleukemia. 2. Myeloproliferative neoplasms (MPNs): These are a group of blood disorders characterized by an overproduction of blood cells. MPNs can also progress to AML, and some cases of MPNs are considered preleukemia. Preleukemia is often diagnosed through blood tests and bone marrow biopsies. Treatment options for preleukemia depend on the underlying cause and severity of the condition. Some cases of preleukemia may be treated with chemotherapy, radiation therapy, or bone marrow transplantation. Others may be monitored closely and treated only if the condition progresses to AML.

Green Fluorescent Proteins (GFPs) are a class of proteins that emit green light when excited by blue or ultraviolet light. They were first discovered in the jellyfish Aequorea victoria and have since been widely used as a tool in the field of molecular biology and bioimaging. In the medical field, GFPs are often used as a marker to track the movement and behavior of cells and proteins within living organisms. For example, scientists can insert a gene for GFP into a cell or organism, allowing them to visualize the cell or protein in real-time using a fluorescent microscope. This can be particularly useful in studying the development and function of cells, as well as in the diagnosis and treatment of diseases. GFPs have also been used to develop biosensors, which can detect the presence of specific molecules or changes in cellular environment. For example, researchers have developed GFP-based sensors that can detect the presence of certain drugs or toxins, or changes in pH or calcium levels within cells. Overall, GFPs have become a valuable tool in the medical field, allowing researchers to study cellular processes and diseases in new and innovative ways.

Receptors, CXCR4 are a type of protein found on the surface of certain cells in the human body. These proteins are known as chemokine receptors, and they play a role in regulating the movement of cells within the body. Specifically, CXCR4 receptors are activated by a chemical messenger called CXCL12, which is produced by cells in various tissues throughout the body. When CXCR4 receptors are activated by CXCL12, they trigger a signaling cascade within the cell that can lead to a variety of cellular responses, including changes in cell migration, proliferation, and survival. In the medical field, CXCR4 receptors and their interactions with CXCL12 are of interest because they have been implicated in a number of different diseases and conditions, including cancer, HIV infection, and cardiovascular disease.

Interleukin-3 (IL-3) is a type of cytokine, which is a signaling molecule that plays a crucial role in regulating the immune system. IL-3 is produced by a variety of cells, including immune cells such as T cells, B cells, and mast cells, as well as by some non-immune cells such as fibroblasts and endothelial cells. In the medical field, IL-3 is primarily used as a therapeutic agent to treat certain types of blood disorders and cancers. For example, IL-3 has been shown to stimulate the growth and differentiation of certain types of blood cells, such as neutrophils and eosinophils, which are important for fighting infections and allergies. It has also been used to treat certain types of leukemia and lymphoma, as well as myelodysplastic syndrome, a group of blood disorders characterized by abnormal blood cell production. However, IL-3 can also have harmful effects if it is produced in excess or if it is not properly regulated. For example, it has been implicated in the development of certain types of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, where the immune system mistakenly attacks healthy cells and tissues. As a result, the use of IL-3 as a therapeutic agent is carefully monitored and regulated to minimize the risk of adverse effects.

Antineoplastic agents, also known as cytotoxic agents or chemotherapeutic agents, are drugs that are used to treat cancer by killing or slowing the growth of cancer cells. These agents work by interfering with the normal processes of cell division and growth, which are necessary for the survival and spread of cancer cells. There are many different types of antineoplastic agents, including alkylating agents, antimetabolites, topoisomerase inhibitors, and monoclonal antibodies, among others. These agents are often used in combination with other treatments, such as surgery and radiation therapy, to provide the most effective treatment for cancer.

Melphalan is a chemotherapy drug that is used to treat various types of cancer, including multiple myeloma, ovarian cancer, and breast cancer. It works by interfering with the production of DNA in cancer cells, which prevents them from dividing and growing. Melphalan is usually given intravenously or orally, and its side effects can include nausea, vomiting, hair loss, fatigue, and an increased risk of infection. It is important to note that Melphalan can be toxic to healthy cells as well, so it is typically used in combination with other medications to minimize side effects and increase its effectiveness.

Interleukin-6 (IL-6) is a cytokine, a type of signaling molecule that plays a crucial role in the immune system. It is produced by a variety of cells, including immune cells such as macrophages, monocytes, and T cells, as well as non-immune cells such as fibroblasts and endothelial cells. IL-6 has a wide range of functions in the body, including regulating the immune response, promoting inflammation, and stimulating the growth and differentiation of immune cells. It is also involved in the regulation of metabolism, bone metabolism, and hematopoiesis (the production of blood cells). In the medical field, IL-6 is often measured as a marker of inflammation and is used to diagnose and monitor a variety of conditions, including autoimmune diseases, infections, and cancer. It is also being studied as a potential therapeutic target for the treatment of these conditions, as well as for the management of chronic pain and other conditions.

ADP-ribosyl cyclase is an enzyme that catalyzes the conversion of NAD+ to cyclic ADP-ribose (cADPR) in the cell. cADPR is a signaling molecule that plays a role in various cellular processes, including calcium signaling, gene expression, and metabolism. ADP-ribosyl cyclase is found in a variety of cell types and tissues, including neurons, muscle cells, and immune cells. In the medical field, ADP-ribosyl cyclase has been studied in relation to various diseases and conditions, including neurodegenerative disorders, cardiovascular disease, and cancer.

CD38 is a protein that is expressed on the surface of certain immune cells, including T cells, B cells, and natural killer cells. It is also found on some non-immune cells, such as endothelial cells and platelets. CD38 plays a role in the regulation of immune cell activation and function. It is involved in the metabolism of certain signaling molecules, such as cyclic adenosine monophosphate (cAMP) and nicotinamide adenine dinucleotide (NAD+), which can affect the activity of immune cells. Antigens, CD38 are molecules that bind to the CD38 protein on the surface of immune cells. These antigens can trigger an immune response, leading to the activation and proliferation of immune cells. CD38 antigens are often used as targets in the development of immunotherapies for various diseases, including cancer and autoimmune disorders.

Anemia, refractory refers to a type of anemia that does not respond to standard treatments or does not respond well to treatment. Refractory anemia is a chronic condition characterized by a low red blood cell count (anemia) that persists despite treatment with iron supplements, folic acid, and vitamin B12. Refractory anemia can be further classified into several subtypes, including refractory anemia with ring sideroblasts (RARS), refractory anemia with excess blasts (RAEB), and refractory anemia with excess blasts in transformation (RAEB-T). These subtypes are differentiated based on the presence of specific genetic abnormalities and the number of blast cells in the bone marrow. Refractory anemia can be caused by a variety of factors, including genetic disorders, autoimmune diseases, infections, and exposure to certain medications or toxins. Treatment options for refractory anemia may include blood transfusions, stem cell transplantation, and targeted therapies that address the underlying cause of the anemia.

Agranulocytosis is a medical condition characterized by a severe decrease in the number of white blood cells, specifically granulocytes, in the blood. Granulocytes are a type of white blood cell that play a crucial role in the body's immune response by fighting off infections and foreign substances. Agranulocytosis can be caused by a variety of factors, including certain medications, infections, autoimmune disorders, and genetic disorders. Symptoms of agranulocytosis may include fever, chills, fatigue, muscle aches, and sore throat. In severe cases, it can lead to life-threatening complications such as sepsis, organ failure, and even death. Treatment for agranulocytosis typically involves identifying and treating the underlying cause, as well as administering medications to stimulate the production of white blood cells. In some cases, patients may need to be hospitalized and receive intravenous fluids and antibiotics to prevent infections. It is important for individuals with agranulocytosis to avoid contact with sick people and to practice good hygiene to reduce the risk of infection.

The cellular microenvironment refers to the local environment surrounding a cell, including the extracellular matrix (ECM), neighboring cells, and various signaling molecules. The ECM is a complex network of proteins and carbohydrates that provides structural support to cells and regulates cell behavior. Neighboring cells can also influence the behavior of a cell through direct contact or through the release of signaling molecules. Additionally, various signaling molecules, such as growth factors and cytokines, can modulate cell behavior and function. The cellular microenvironment plays a critical role in regulating cell growth, differentiation, migration, and survival, and is an important factor in the development and progression of many diseases, including cancer.

Radiation injuries, experimental refer to injuries or damage caused to living tissue as a result of exposure to ionizing radiation in a laboratory or research setting. These injuries can occur intentionally, as part of a scientific study or experiment, or unintentionally, as a result of equipment malfunction or other accidents. The effects of radiation on living tissue can vary depending on the type and amount of radiation exposure, as well as the duration and frequency of exposure. Some common effects of radiation exposure include burns, skin damage, hair loss, nausea, vomiting, and fatigue. In severe cases, radiation exposure can lead to organ damage, tissue necrosis, and even death. Experimental radiation injuries are typically studied in order to better understand the effects of radiation on living tissue and to develop new treatments for radiation-related injuries and illnesses. These studies may involve exposing animals or cells to different types and doses of radiation, and then observing the effects of the radiation on the exposed organisms or cells. The results of these studies can be used to inform the development of new radiation protection measures and treatments for radiation-related injuries and illnesses in humans.

Leukemia, Experimental refers to the study of leukemia using experimental methods, such as laboratory research and animal models, to better understand the disease and develop new treatments. Experimental leukemia research involves investigating the underlying genetic and molecular mechanisms that contribute to the development and progression of leukemia, as well as testing new drugs and therapies in preclinical models before they are tested in humans. This type of research is important for advancing our understanding of leukemia and improving treatment options for patients.

Anemia, refractory with excess of blasts is a type of anemia that does not respond to standard treatments and is characterized by the presence of a high number of immature blood cells, called blasts, in the bone marrow. This condition is often seen in patients with leukemia or other types of blood cancers. It is considered refractory because it does not respond to standard treatments such as blood transfusions, iron supplements, or erythropoiesis-stimulating agents (ESAs). The excess of blasts in the bone marrow indicates that the body is producing too many immature blood cells, which can interfere with the production of normal red blood cells. Treatment for anemia, refractory with excess of blasts typically involves more aggressive therapies such as chemotherapy, radiation therapy, or stem cell transplantation.

Reticulin is a type of collagen fiber that is found in the connective tissue of many organs in the body, including the liver, spleen, and bone marrow. It is a fine, delicate network of fibers that helps to give structure and support to these tissues. In the liver, reticulin is produced by specialized cells called reticulin-producing cells, which are located in the space of Disse, the small spaces between the hepatocytes (liver cells). The reticulin fibers in the liver help to form a network that supports the hepatocytes and helps to maintain the structure of the liver. In the spleen, reticulin is produced by specialized cells called reticulin-producing cells, which are located in the red pulp. The reticulin fibers in the spleen help to form a network that supports the blood vessels and helps to maintain the structure of the spleen. In the bone marrow, reticulin is produced by specialized cells called reticulin-producing cells, which are located in the bone marrow stroma. The reticulin fibers in the bone marrow help to form a network that supports the hematopoietic cells (blood-forming cells) and helps to maintain the structure of the bone marrow. Reticulin is also found in other organs and tissues, including the lungs, kidneys, and pancreas. It plays an important role in maintaining the structure and function of these tissues.

Diphosphonates are a class of medications that are commonly used in the medical field to treat a variety of conditions related to bone health. They work by inhibiting the activity of enzymes that are involved in the breakdown of bone tissue, which can help to slow down the rate of bone loss and reduce the risk of fractures. Diphosphonates are often used to treat osteoporosis, a condition in which the bones become weak and brittle due to a lack of calcium and other minerals. They may also be used to treat Paget's disease of the bone, a condition in which the bones become abnormally thick and weak due to an overproduction of bone tissue. Diphosphonates are typically taken orally in the form of tablets or capsules. They may be prescribed on a short-term or long-term basis, depending on the specific condition being treated and the individual patient's needs. It is important to follow the instructions provided by your healthcare provider carefully when taking diphosphonates, as they can have side effects such as nausea, vomiting, and abdominal pain.

Carmustine is a chemotherapy drug that is used to treat various types of cancer, including brain tumors, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. It is also known by its brand name BCNU. Carmustine works by interfering with the growth and division of cancer cells, which can cause them to die or stop growing. It is usually given intravenously (IV) or as a solution that is injected directly into the tumor. Carmustine can cause side effects, including nausea, vomiting, hair loss, fatigue, and a decreased white blood cell count. It can also cause damage to healthy cells in the brain, which can cause symptoms such as headache, dizziness, and confusion. Carmustine is often used in combination with other chemotherapy drugs or radiation therapy to increase its effectiveness and reduce the risk of side effects. It is important to carefully follow the instructions of a healthcare provider when taking this medication.

Dendritic cells are a type of immune cell that plays a crucial role in the body's immune response. They are found in various tissues throughout the body, including the skin, lymph nodes, and mucous membranes. Dendritic cells are responsible for capturing and processing antigens, which are foreign substances that can trigger an immune response. They do this by engulfing and breaking down antigens, and then presenting them to other immune cells, such as T cells, in a way that activates the immune response. Dendritic cells are also involved in the regulation of immune responses, helping to prevent the body from overreacting to harmless substances and to maintain immune tolerance to self-antigens. In the medical field, dendritic cells are being studied for their potential use in cancer immunotherapy. They can be genetically modified to recognize and attack cancer cells, and are being tested in clinical trials as a way to treat various types of cancer.

Membrane glycoproteins are proteins that are attached to the cell membrane through a glycosyl group, which is a complex carbohydrate. These proteins play important roles in cell signaling, cell adhesion, and cell recognition. They are involved in a wide range of biological processes, including immune response, cell growth and differentiation, and nerve transmission. Membrane glycoproteins can be classified into two main types: transmembrane glycoproteins, which span the entire cell membrane, and peripheral glycoproteins, which are located on one side of the membrane.

Interleukin-7 (IL-7) is a cytokine, a type of signaling molecule, that plays a critical role in the development and maintenance of T cells, a type of white blood cell that is essential for the immune system. IL-7 is produced by various cells in the body, including stromal cells in the bone marrow and epithelial cells in the thymus gland. IL-7 acts on T cells to stimulate their proliferation and differentiation, promoting the production of T cells that are specific to a particular antigen. It also helps to maintain the survival of T cells in the body, particularly memory T cells, which are important for long-term immunity. In the medical field, IL-7 has been studied as a potential therapeutic agent for a variety of conditions, including cancer, autoimmune diseases, and HIV infection. For example, some clinical trials have investigated the use of IL-7 to boost the immune system in patients with cancer, particularly those with advanced or refractory disease. Other studies have explored the use of IL-7 to enhance the function of T cells in patients with autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis.

Anemia is a medical condition characterized by a decrease in the number of red blood cells (RBCs) or a decrease in the amount of hemoglobin in the blood. Hemoglobin is a protein in red blood cells that carries oxygen from the lungs to the body's tissues and carbon dioxide from the tissues back to the lungs. Anemia can be caused by a variety of factors, including iron deficiency, vitamin B12 or folate deficiency, chronic disease, genetic disorders, and certain medications. Symptoms of anemia may include fatigue, weakness, shortness of breath, dizziness, pale skin, and an increased heart rate. Anemia can be diagnosed through a blood test that measures the number of red blood cells and the amount of hemoglobin in the blood. Treatment for anemia depends on the underlying cause and may include dietary changes, supplements, medications, or blood transfusions.

Immunologic Deficiency Syndromes (IDS) are a group of disorders that affect the immune system, which is the body's natural defense against infections and diseases. In individuals with IDS, the immune system is either absent or not functioning properly, making them more susceptible to infections and diseases that would not normally pose a threat to healthy individuals. IDS can be classified into primary and secondary immunodeficiencies. Primary immunodeficiencies are genetic disorders that affect the immune system from birth or early childhood, while secondary immunodeficiencies are acquired later in life due to other medical conditions or treatments such as chemotherapy or radiation therapy. Some common examples of IDS include: * Severe Combined Immunodeficiency (SCID): a rare genetic disorder in which the immune system is severely impaired, making individuals highly susceptible to infections. * Common Variable Immunodeficiency (CVID): a primary immunodeficiency characterized by low levels of antibodies in the blood, making individuals prone to recurrent infections. * Wiskott-Aldrich Syndrome (WAS): a primary immunodeficiency characterized by low levels of platelets and recurrent infections. * X-linked Agammaglobulinemia (XLA): a primary immunodeficiency characterized by low levels of antibodies and recurrent infections. Treatment for IDS typically involves immunoglobulin replacement therapy, antibiotics, and other supportive care to manage infections and complications. In some cases, bone marrow transplantation or gene therapy may be considered as a potential cure.

Osteoprotegerin (OPG) is a protein that plays a critical role in bone metabolism and is involved in the regulation of bone resorption, or the breakdown of bone tissue. It is produced by osteoblasts, which are cells responsible for bone formation, and by other cells in the body, including immune cells and endothelial cells. OPG acts as a decoy receptor for the receptor activator of nuclear factor kappa-B ligand (RANKL), a protein that stimulates osteoclasts, the cells responsible for bone resorption. By binding to RANKL, OPG prevents it from binding to its target receptor on osteoclasts, thereby inhibiting osteoclast activation and bone resorption. In the medical field, OPG has been studied for its potential role in the treatment of osteoporosis, a condition characterized by low bone density and an increased risk of fractures. OPG has also been studied in the context of other bone-related disorders, such as Paget's disease of bone and multiple myeloma, as well as in the regulation of bone metabolism in other organs, such as the kidneys and the lungs.

Mastocytosis is a rare disorder characterized by the proliferation and accumulation of mast cells in various tissues throughout the body. Mast cells are immune cells that play a role in the body's response to injury and infection. In mastocytosis, the excessive number of mast cells can lead to a variety of symptoms and complications, depending on the affected organs and tissues. There are several types of mastocytosis, including: 1. Cutaneous mastocytosis: This form of mastocytosis affects the skin and can cause itchy rashes, hives, and other skin symptoms. 2. Systemic mastocytosis: This form of mastocytosis affects multiple organs and tissues throughout the body and can cause a wide range of symptoms, including fatigue, bone pain, abdominal pain, and anemia. 3. Mast cell leukemia: This is a rare and aggressive form of mastocytosis that affects the bone marrow and can lead to the production of abnormal white blood cells. Mastocytosis can be diagnosed through a combination of physical examination, blood tests, skin biopsies, and imaging studies. Treatment for mastocytosis depends on the type and severity of the disorder, and may include medications to manage symptoms, targeted therapies to reduce the number of mast cells, and in some cases, stem cell transplantation.

Leukemic infiltration refers to the abnormal accumulation of leukocytes (white blood cells) in tissues or organs, which is a hallmark of leukemia. In leukemia, the leukemic cells multiply uncontrollably and accumulate in the bone marrow, where they replace normal blood cells. As the number of leukemic cells increases, they can also infiltrate and accumulate in other tissues and organs, such as the liver, spleen, lymph nodes, brain, spinal cord, and testes. Leukemic infiltration can cause a variety of symptoms, depending on the affected tissue or organ. For example, infiltration of the liver can cause abdominal pain, jaundice, and enlarged liver and spleen. Infiltration of the brain and spinal cord can cause neurological symptoms such as confusion, seizures, and weakness. Infiltration of the testes can cause swelling and pain. Leukemic infiltration is typically diagnosed through a combination of physical examination, blood tests, imaging studies, and biopsy of affected tissues or organs. Treatment for leukemic infiltration depends on the type and stage of leukemia, as well as the location and severity of the infiltration. Common treatments include chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation.

Interleukin-11 (IL-11) is a cytokine, a type of signaling protein, that plays a role in the immune system and regulates the growth and differentiation of various cell types. It is primarily produced by immune cells such as macrophages, dendritic cells, and T cells, as well as by fibroblasts and endothelial cells. IL-11 has several functions in the body, including promoting the growth and survival of hematopoietic stem cells, which are responsible for producing blood cells. It also stimulates the production of other cytokines and growth factors, and has anti-inflammatory effects. In the medical field, IL-11 has been studied for its potential therapeutic applications in various diseases, including cancer, inflammatory bowel disease, and anemia. It has been shown to promote the growth of certain types of cancer cells, and may be useful in treating certain types of anemia by stimulating the production of red blood cells. However, further research is needed to fully understand the potential benefits and risks of using IL-11 as a therapeutic agent.

Neutropenia is a medical condition characterized by a low number of neutrophils, which are a type of white blood cell that plays a crucial role in the body's immune system. Neutrophils are responsible for fighting off infections and are a key component of the body's defense against bacterial, viral, and fungal infections. Neutropenia is typically defined as a neutrophil count of less than 1,500 cells per microliter (µL) of blood. However, the normal range of neutrophil counts can vary depending on the laboratory and the individual's age and sex. Neutropenia can be caused by a variety of factors, including certain medications, infections, autoimmune disorders, and cancer treatments such as chemotherapy and radiation therapy. It can also be a symptom of other medical conditions, such as bone marrow disorders, genetic disorders, and nutritional deficiencies. Neutropenia can increase the risk of infections, as the body has fewer neutrophils to fight off pathogens. Symptoms of neutropenia may include fever, chills, fatigue, and sore throat. Treatment for neutropenia depends on the underlying cause and may include medications to stimulate the production of neutrophils, antibiotics to treat infections, or changes to the individual's medications or treatment plan.

Benzene is a colorless, sweet-smelling liquid that is commonly used as a solvent in various industries, including the production of plastics, rubber, dyes, and detergents. In the medical field, benzene is not typically used as a treatment or medication, but it can be a hazardous substance that can cause health problems if exposure occurs. Long-term exposure to benzene can lead to a range of health problems, including leukemia, a type of cancer that affects the blood and bone marrow. Benzene can also cause damage to the liver, kidneys, and central nervous system, and it can affect the immune system and cause anemia. In the workplace, benzene exposure is regulated by the Occupational Safety and Health Administration (OSHA), which sets limits on the amount of benzene that workers can be exposed to over a certain period of time. Workers who are exposed to benzene may be required to wear protective clothing and equipment, and they may need to take breaks or use respiratory protection to reduce their exposure. In addition to workplace exposure, benzene can also be found in the environment, including in air, water, and soil. People who live in areas with high levels of benzene exposure may be at increased risk of health problems, including cancer and other types of illness.

Neuroblastoma is a type of cancer that develops from immature nerve cells, called neuroblasts, in the sympathetic nervous system. It is most commonly found in children, although it can also occur in adults. Neuroblastoma can occur anywhere in the body where neuroblasts are present, but it most often affects the adrenal glands, the neck, and the chest. The symptoms of neuroblastoma can vary depending on the location and size of the tumor, but they may include abdominal pain, swelling, and a lump or mass in the abdomen or neck. Treatment for neuroblastoma typically involves a combination of surgery, chemotherapy, radiation therapy, and stem cell transplantation.

Methotrexate is a medication that is used to treat a variety of medical conditions, including cancer, autoimmune diseases, and certain skin conditions. It is a chemotherapy drug that works by inhibiting the growth and division of cells, which can slow or stop the progression of cancer or other diseases. Methotrexate is usually given by injection or taken by mouth, and it can have a number of side effects, including nausea, vomiting, and hair loss. It is important to carefully follow the instructions of a healthcare provider when taking methotrexate, as it can be a potent medication that requires careful monitoring.

Absorptiometry, Photon is a medical imaging technique used to measure the amount of light absorbed by different tissues in the body. It is commonly used to measure bone density and diagnose osteoporosis, but it can also be used to measure the density of other tissues, such as muscle and fat. In this technique, a beam of low-energy photons is directed at the body and the amount of light that is absorbed by the tissue is measured. The amount of light absorbed is proportional to the density of the tissue, so by measuring the amount of light absorbed, the density of the tissue can be determined. There are two main types of photon absorptiometry: single-energy absorptiometry and dual-energy absorptiometry. Single-energy absorptiometry uses a single energy level of photons, while dual-energy absorptiometry uses two different energy levels of photons. Dual-energy absorptiometry is more accurate than single-energy absorptiometry, but it is also more complex and expensive. Overall, photon absorptiometry is a useful tool for measuring bone density and diagnosing osteoporosis, as well as for measuring the density of other tissues in the body.

Vincristine is a chemotherapy drug that is used to treat various types of cancer, including leukemia, lymphoma, and neuroblastoma. It works by interfering with the growth and division of cancer cells, which can slow or stop the growth of tumors. Vincristine is usually administered intravenously, and its side effects can include nausea, vomiting, hair loss, and damage to the nerves that control movement. It is also known by the brand name Oncovin.

Bone Morphogenetic Protein 4 (BMP4) is a protein that plays a crucial role in the development and maintenance of bone tissue in the human body. It is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, which are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. In the medical field, BMP4 is used as a therapeutic agent to promote bone growth and regeneration in a variety of conditions, including fractures, osteoporosis, and spinal cord injuries. It is also being studied as a potential treatment for other diseases, such as cancer and diabetes. BMP4 is produced by a variety of cells in the body, including osteoblasts (cells that produce bone tissue) and chondrocytes (cells that produce cartilage). It acts by binding to specific receptors on the surface of cells, which triggers a signaling cascade that leads to changes in gene expression and cellular behavior. Overall, BMP4 is a critical protein for the development and maintenance of bone tissue, and its therapeutic potential is being actively explored in the medical field.

Chimerism is a condition in which an individual has two or more genetically distinct cell lines within their body. This can occur due to the fusion of two or more embryos during early development, resulting in a single individual with cells from two or more genetic sources. Chimerism can be detected through genetic testing, and it can have a variety of effects on an individual's health and development. For example, some cases of chimerism may be asymptomatic, while others may result in physical or developmental abnormalities. In some cases, chimerism may also be associated with certain medical conditions, such as immune system disorders or blood disorders. Chimerism is a relatively rare condition, and it is typically only diagnosed in cases where there is a specific reason to suspect that an individual may have two or more genetically distinct cell lines within their body.

Mastocytosis, systemic, is a rare disorder characterized by the proliferation of mast cells in various tissues throughout the body. Mast cells are immune cells that play a role in the body's response to injury and infection. In systemic mastocytosis, the excessive number of mast cells can lead to a variety of symptoms and complications, including anaphylaxis, skin rashes, abdominal pain, and bone pain. The severity of the symptoms can vary widely depending on the type and extent of the mast cell proliferation. Systemic mastocytosis can be classified into several subtypes, including cutaneous mastocytosis, which affects the skin, and systemic mastocytosis with an associated clonal hematologic disorder, which is associated with the development of blood cancers such as myelofibrosis or acute myeloid leukemia. Treatment for systemic mastocytosis typically involves managing symptoms and addressing any underlying blood disorders.

Hepatic Veno-Occlusive Disease (VOD) is a rare but serious condition that affects the liver. It is also known as sinusoidal obstruction syndrome (SOS) or veno-occlusive disease of the liver (VOD/L). VOD occurs when the small blood vessels in the liver (sinusoids) become blocked or narrowed, leading to liver damage and dysfunction. VOD can be caused by a variety of factors, including chemotherapy, radiation therapy, stem cell transplantation, and exposure to certain toxins or medications. The symptoms of VOD can include jaundice, abdominal pain, nausea, vomiting, fatigue, and loss of appetite. In severe cases, VOD can lead to liver failure and death. Treatment for VOD typically involves managing the symptoms and addressing the underlying cause of the condition. This may include medications to reduce inflammation and improve liver function, as well as supportive care to manage symptoms and prevent complications. In some cases, a liver transplant may be necessary to restore liver function.

Paraproteinemias are a group of disorders characterized by the presence of an abnormal amount of one or more paraproteins in the blood. Paraproteins are abnormal proteins produced by plasma cells, which are a type of white blood cell that normally produce antibodies to fight infections. There are several types of paraproteinemias, including multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance (MGUS). Multiple myeloma is a type of cancer that affects plasma cells and is characterized by the production of large amounts of a single abnormal protein called a monoclonal protein or M protein. Waldenstrom's macroglobulinemia is a type of lymphoma that also produces an abnormal protein, but the protein is smaller than the M protein produced in multiple myeloma. MGUS is a condition in which a single clone of abnormal plasma cells produces a small amount of an abnormal protein, but the cells do not cause any symptoms or damage to organs. Paraproteinemias can cause a variety of symptoms, depending on the type and severity of the disorder. Some common symptoms include fatigue, weakness, bone pain, kidney problems, and anemia. Treatment for paraproteinemias depends on the specific type and severity of the disorder, and may include chemotherapy, radiation therapy, stem cell transplantation, or targeted therapies.

In the medical field, "Culture Media, Conditioned" refers to a type of growth medium that has been prepared by adding nutrients and other components to a basic medium, such as agar, to support the growth of specific microorganisms. The term "conditioned" indicates that the medium has been treated or modified in some way to enhance the growth of the target microorganisms. Conditioned culture media are often used in diagnostic microbiology to isolate and identify specific microorganisms from clinical samples, such as blood, urine, or sputum. The medium may be further conditioned by adding specific supplements or antibiotics to inhibit the growth of unwanted microorganisms and promote the growth of the target organism. Overall, conditioned culture media are an important tool in the diagnosis and treatment of infectious diseases, as they allow healthcare professionals to accurately identify the causative agent and select the most effective antimicrobial therapy.

Technetium Tc 99m Medronate is a radiopharmaceutical used in nuclear medicine for imaging bone metabolism. It is also known as Tc-99m HEDP (hydroxyethylidenediphosphonate) or Tc-99m MDP (methylenediphosphonate). The compound is composed of Technetium-99m (Tc-99m), a short-lived radioactive isotope of Technetium, and Medronate (also known as alpha-Diphosphonate), a bone-seeking agent that binds to bone tissue. When injected into the bloodstream, Tc-99m Medronate accumulates in areas of increased bone turnover, such as fractures, infections, and tumors. The radiopharmaceutical is commonly used in bone scans, which are diagnostic tests that help detect bone abnormalities and evaluate bone health. The scan involves injecting Tc-99m Medronate into a vein and then using a gamma camera to capture images of the distribution of the radiopharmaceutical in the body. The images produced by the scan can help identify areas of bone disease and guide treatment decisions.

Osteolysis is a medical condition characterized by the breakdown and destruction of bone tissue. It can occur in various parts of the body, including the bones of the spine, pelvis, and extremities. Osteolysis can be caused by a variety of factors, including infection, inflammation, trauma, and certain medical conditions such as osteoporosis, cancer, and metabolic disorders. It can also be a complication of certain medical treatments, such as chemotherapy or radiation therapy. The symptoms of osteolysis may include pain, swelling, and tenderness in the affected area, as well as weakness or instability in the affected joint. In severe cases, osteolysis can lead to the formation of bone cysts or tumors, which can cause further complications. Treatment for osteolysis depends on the underlying cause and the severity of the condition. In some cases, medications may be used to manage pain and inflammation, while in other cases, surgery may be necessary to remove damaged bone tissue or stabilize the affected joint. In some cases, physical therapy or other forms of rehabilitation may also be recommended to help improve strength and mobility.

Etoposide is a chemotherapy drug that is used to treat various types of cancer, including small cell lung cancer, ovarian cancer, testicular cancer, and some types of leukemia. It works by interfering with the process of cell division, which is necessary for cancer cells to grow and multiply. Etoposide is usually given intravenously or orally, and its side effects can include nausea, vomiting, hair loss, and an increased risk of infection.

Chromosome aberrations refer to changes or abnormalities in the structure or number of chromosomes in a cell. These changes can occur naturally during cell division or as a result of exposure to mutagens such as radiation or certain chemicals. Chromosome aberrations can be classified into several types, including deletions, duplications, inversions, translocations, and aneuploidy. These changes can have significant effects on the function of the affected cells and can lead to a variety of medical conditions, including cancer, genetic disorders, and birth defects. In the medical field, chromosome aberrations are often studied as a way to understand the genetic basis of disease and to develop new treatments.

Hodgkin disease, also known as Hodgkin lymphoma, is a type of cancer that affects the lymphatic system, which is a part of the immune system. It typically starts in the lymph nodes, which are small, bean-shaped organs that help fight infections and diseases. In Hodgkin disease, abnormal cells called Reed-Sternberg cells grow and multiply uncontrollably in the lymph nodes, causing them to become swollen and painful. The cancer can also spread to other parts of the body, such as the spleen, liver, and bone marrow. There are several different types of Hodgkin disease, which are classified based on the appearance of the Reed-Sternberg cells and the presence of other cells in the affected lymph nodes. Treatment for Hodgkin disease typically involves a combination of chemotherapy, radiation therapy, and/or stem cell transplantation, depending on the stage and type of the cancer.

Blast crisis is a phase of acute myeloid leukemia (AML) that occurs when the cancer cells in the bone marrow produce a large number of immature white blood cells called blasts. These blasts are not fully developed and are unable to function properly, leading to a decrease in the production of normal blood cells. In blast crisis, the number of blasts in the bone marrow can exceed 20% of all cells, and the patient may experience symptoms such as fever, fatigue, weakness, and easy bruising. The blast crisis can also lead to anemia, which is a deficiency in red blood cells, and thrombocytopenia, which is a deficiency in platelets. Blast crisis is a serious complication of AML and requires prompt medical attention. Treatment options may include chemotherapy, radiation therapy, stem cell transplantation, or targeted therapies. The goal of treatment is to reduce the number of blasts in the bone marrow and restore the production of normal blood cells.

In the medical field, cell communication refers to the process by which cells exchange information and signals with each other. This communication is essential for the proper functioning of the body's tissues and organs, as it allows cells to coordinate their activities and respond to changes in their environment. There are several types of cell communication, including direct communication between neighboring cells, as well as communication through the bloodstream or lymphatic system. Some of the key mechanisms of cell communication include the release of signaling molecules, such as hormones and neurotransmitters, as well as the exchange of ions and other small molecules across cell membranes. Disruptions in cell communication can lead to a variety of medical conditions, including cancer, autoimmune diseases, and neurological disorders. Therefore, understanding the mechanisms of cell communication is an important area of research in medicine, with potential applications in the development of new treatments and therapies.

Cytomegalovirus (CMV) infections are a group of viral infections caused by the cytomegalovirus, a member of the herpesvirus family. CMV is a common virus that can infect people of all ages, but it is most commonly transmitted from mother to child during pregnancy or childbirth, or through breast milk. In healthy individuals, CMV infections are usually asymptomatic or cause mild flu-like symptoms. However, in people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, or pregnant women with HIV, CMV infections can cause serious complications, including pneumonia, encephalitis, and retinitis. CMV infections can also be transmitted through blood transfusions, organ transplantation, and from mother to child during pregnancy or childbirth. Treatment for CMV infections typically involves antiviral medications to help control the virus and prevent complications.

Actuarial analysis in the medical field refers to the use of statistical and mathematical techniques to analyze and predict the financial impact of healthcare risks and costs. This type of analysis is typically used by insurance companies, healthcare providers, and government agencies to make informed decisions about pricing, coverage, and resource allocation. In the medical field, actuarial analysis is often used to assess the risk of various medical conditions and the likelihood of individuals requiring medical treatment. This information can be used to determine the appropriate premiums for health insurance policies, as well as to identify areas where resources may be needed to improve healthcare outcomes. Actuarial analysis can also be used to evaluate the financial impact of healthcare reforms and other policy changes. For example, an actuarial analysis may be used to estimate the potential cost savings of a new healthcare policy or to assess the impact of a change in the reimbursement rates for medical services. Overall, actuarial analysis plays an important role in the medical field by providing valuable insights into the financial implications of healthcare risks and costs.

Decalcification technique refers to a process used in the medical field to remove calcium deposits from bones or other hard tissues. This process is often used in forensic pathology to prepare bones for examination or in dental procedures to remove tartar buildup from teeth. There are several methods of decalcification, including chemical decalcification, which involves soaking the bone in a solution that dissolves the calcium, and mechanical decalcification, which involves using a machine to grind away the calcium. Decalcification can also be used in medical research to prepare bones for study, such as in the analysis of bone density or the examination of bone microarchitecture. However, the process of decalcification can also cause damage to the bone tissue, so it must be done carefully and under controlled conditions.

Acid phosphatase is an enzyme that catalyzes the hydrolysis of phosphate esters in the presence of acid. It is found in a variety of tissues and cells throughout the body, including bone, liver, and white blood cells. In the medical field, acid phosphatase levels can be measured in blood, urine, and other body fluids as a diagnostic tool for various conditions, such as bone disorders, liver disease, and certain types of cancer. High levels of acid phosphatase may indicate the presence of bone resorption, liver damage, or cancer, while low levels may indicate bone formation or certain types of anemia.

CD19 is a protein found on the surface of certain types of white blood cells, including B cells. Antigens, CD19 refers to molecules that bind to the CD19 protein on the surface of B cells, triggering an immune response. These antigens can be found on the surface of bacteria, viruses, and other foreign substances, as well as on abnormal cells in the body, such as cancer cells. In the medical field, CD19 antigens are often targeted in the treatment of certain types of blood cancers, such as leukemia and lymphoma, using monoclonal antibodies that bind to the CD19 protein and help the immune system to destroy the cancer cells.

Bone demineralization technique refers to a medical procedure that involves the removal of bone mineral content from a specific area of the body. This technique is typically used to treat conditions such as osteoporosis, which is a disease that causes bones to become weak and brittle, making them more prone to fractures. There are several different methods that can be used to perform bone demineralization, including: 1. Bone biopsy: A small sample of bone is removed from the affected area and analyzed in a laboratory to determine the extent of bone loss. 2. Bone densitometry: This is a non-invasive imaging technique that uses X-rays to measure the density of bone in a specific area of the body. 3. Bone resorption: This is a surgical procedure in which a small amount of bone is removed from the affected area using a special tool. The bone is then replaced with a synthetic material that helps to stimulate the growth of new bone. 4. Bone grafting: This is a surgical procedure in which a piece of bone is taken from another part of the body and transplanted to the affected area. The bone graft helps to stimulate the growth of new bone and can be used to treat a variety of conditions, including osteoporosis. Overall, bone demineralization technique is a useful tool for treating conditions that affect bone density and strength. It can help to improve bone health and reduce the risk of fractures and other complications.

Parathyroid hormone (PTH) is a hormone produced by the parathyroid glands, which are four small glands located in the neck, near the thyroid gland. PTH plays a crucial role in regulating the levels of calcium and phosphorus in the body. PTH acts on the bones, kidneys, and intestines to increase the levels of calcium in the blood. It stimulates the release of calcium from the bones into the bloodstream, increases the reabsorption of calcium by the kidneys, and promotes the absorption of calcium from the intestines. PTH also plays a role in regulating the levels of phosphorus in the body. It stimulates the kidneys to excrete phosphorus in the urine, which helps to maintain the proper balance of calcium and phosphorus in the blood. Abnormal levels of PTH can lead to a variety of medical conditions, including hyperparathyroidism (too much PTH), hypoparathyroidism (too little PTH), and parathyroid cancer. Hyperparathyroidism can cause osteoporosis, kidney stones, and other complications, while hypoparathyroidism can lead to muscle cramps, seizures, and other symptoms.

A biopsy, needle is a medical procedure in which a small sample of tissue is removed from a patient's body using a thin needle. The needle is inserted into the tissue and a small amount of tissue is removed, which is then sent to a laboratory for analysis. This procedure is often used to diagnose cancer or other diseases, as well as to monitor the effectiveness of treatment. Biopsy, needle is a minimally invasive procedure that is generally safe and well-tolerated by patients. It is typically performed in a doctor's office or an outpatient clinic, and patients are usually able to return to their normal activities soon after the procedure.

DNA Nucleotidylexotransferase (DNL) is an enzyme that plays a crucial role in the biosynthesis of DNA. It catalyzes the transfer of a deoxynucleoside triphosphate (dNTP) to the 3' hydroxyl group of a growing DNA chain, resulting in the addition of a new nucleotide to the chain. This process is essential for the replication and repair of DNA, as well as for the transcription of DNA into RNA. Mutations in the gene encoding DNL can lead to various genetic disorders, including Cockayne syndrome and xeroderma pigmentosum.

Leukemia, Myelomonocytic, Acute (M4) is a type of acute myeloid leukemia (AML) that is characterized by the rapid growth of abnormal white blood cells called myelomonocytic cells in the bone marrow and bloodstream. These cells do not function properly and can interfere with the production of healthy blood cells, leading to a range of symptoms such as fatigue, weakness, fever, and easy bruising or bleeding. M4 leukemia is classified based on the specific type of myelomonocytic cell that is affected. In M4 leukemia, the affected cells are called myelomonocytic cells, which are a type of white blood cell that is involved in the immune response and the destruction of bacteria and other foreign substances. Treatment for M4 leukemia typically involves chemotherapy, which is used to kill the abnormal cells and restore normal blood cell production. In some cases, a stem cell transplant may also be recommended, which involves replacing the patient's diseased bone marrow with healthy bone marrow from a donor. The prognosis for M4 leukemia depends on various factors, including the patient's age, overall health, and response to treatment.

Cyclosporine is an immunosuppressive medication that is used to prevent the rejection of transplanted organs, such as the heart, liver, or kidney. It works by suppressing the immune system's response to the transplanted organ, allowing it to integrate into the body without being attacked by the immune system. Cyclosporine is typically administered orally in the form of capsules or tablets. It is also available as an intravenous injection for patients who cannot take it by mouth. Cyclosporine can have side effects, including increased blood pressure, kidney damage, and an increased risk of infections. It is important for patients taking cyclosporine to be closely monitored by their healthcare provider to ensure that the benefits of the medication outweigh the risks.

Hemoglobinuria, paroxysmal is a medical condition characterized by the presence of hemoglobin in the urine. Hemoglobin is a protein found in red blood cells that carries oxygen throughout the body. When hemoglobin is present in the urine, it can cause the urine to appear brown or black. Paroxysmal hemoglobinuria is a rare type of hemoglobinuria that is characterized by episodes of hemoglobinuria that occur suddenly and unpredictably. During an episode, the patient may experience symptoms such as dark urine, abdominal pain, and fatigue. The episodes can last for several hours to several days and may be followed by a period of normal urine output. The exact cause of paroxysmal hemoglobinuria is not fully understood, but it is thought to be related to an abnormality in the red blood cells that causes them to break down and release hemoglobin into the urine. This condition is typically diagnosed through a physical examination, blood tests, and urine tests. Treatment for paroxysmal hemoglobinuria may involve medications to manage symptoms and prevent further episodes. In severe cases, a blood transfusion may be necessary to replace damaged red blood cells. It is important for individuals with paroxysmal hemoglobinuria to receive regular medical monitoring and follow-up care to manage their condition and prevent complications.

Collagen Type I is a protein that is found in the extracellular matrix of connective tissues throughout the body. It is the most abundant type of collagen, making up about 80-90% of the total collagen in the body. Collagen Type I is a strong, flexible protein that provides support and structure to tissues such as skin, bones, tendons, ligaments, and cartilage. It is also involved in wound healing and tissue repair. In the medical field, Collagen Type I is often used in various medical applications such as tissue engineering, regenerative medicine, and cosmetic surgery. It is also used in some dietary supplements and skincare products.

Lymphoproliferative disorders are a group of conditions characterized by the abnormal growth and proliferation of lymphocytes, a type of white blood cell that plays a crucial role in the immune system. These disorders can affect any part of the lymphatic system, including the lymph nodes, spleen, bone marrow, and thymus. Lymphoproliferative disorders can be classified into two main categories: Hodgkin lymphoma and non-Hodgkin lymphoma. Hodgkin lymphoma is a type of cancer that affects the lymphatic system, while non-Hodgkin lymphoma is a more general term that encompasses a wide range of lymphatic system disorders, including lymphoma, leukemia, and myeloma. Lymphoproliferative disorders can be caused by a variety of factors, including viral infections, genetic mutations, and exposure to certain chemicals or radiation. Symptoms of these disorders can vary widely depending on the specific type and location of the affected lymphatic tissue, but may include swelling of the lymph nodes, fatigue, fever, night sweats, and weight loss. Treatment for lymphoproliferative disorders typically involves a combination of chemotherapy, radiation therapy, and/or immunotherapy, depending on the specific type and stage of the disorder. In some cases, a stem cell transplant may also be necessary. The prognosis for lymphoproliferative disorders varies depending on the specific type and stage of the disorder, as well as the age and overall health of the patient.

Cell transplantation is a medical treatment that involves the transfer of healthy cells from one part of the body to another to replace damaged or diseased cells. The cells can be derived from the patient's own body or from a donor. There are several types of cell transplantation, including bone marrow transplantation, cord blood transplantation, and stem cell transplantation. These treatments are used to treat a variety of conditions, including leukemia, lymphoma, multiple sclerosis, Parkinson's disease, and spinal cord injuries. During cell transplantation, the healthy cells are typically harvested from the donor or the patient's own body and then infused into the recipient's bloodstream or directly into the affected area. The cells then migrate to the damaged or diseased area and begin to replace the damaged cells. Cell transplantation is a complex and often risky procedure, and it is typically reserved for patients with severe or life-threatening conditions. However, it has the potential to provide significant benefits to patients who are not responsive to other treatments.

Receptor Activator of Nuclear Factor-kappa B (RANK) is a protein that plays a critical role in the regulation of bone remodeling and the development of osteoclasts, which are cells responsible for breaking down bone tissue. RANK is expressed on the surface of osteoclast precursors and is activated by binding to its ligand, RANKL (Receptor Activator of Nuclear Factor-kappa B Ligand), which is produced by osteoblasts and other cells in the bone microenvironment. Activation of RANK by RANKL leads to the recruitment and activation of the transcription factor NF-kappaB, which promotes the differentiation and survival of osteoclasts. Dysregulation of RANK/RANKL signaling has been implicated in a number of bone disorders, including osteoporosis, osteopetrosis, and rheumatoid arthritis.

Splenomegaly is a medical condition characterized by an enlargement of the spleen, which is a vital organ in the body that plays a crucial role in the immune system. The spleen is responsible for filtering blood, removing old or damaged red blood cells, and producing white blood cells that help fight infections. Splenomegaly can be caused by a variety of factors, including infections, autoimmune disorders, blood disorders, and certain types of cancer. In some cases, the cause of splenomegaly may be unknown. Symptoms of splenomegaly may include abdominal pain, discomfort, and fullness, as well as fatigue, weakness, and anemia. In severe cases, splenomegaly can lead to complications such as bleeding, infection, and organ failure. Diagnosis of splenomegaly typically involves a physical examination, blood tests, imaging studies such as ultrasound or CT scans, and in some cases, a biopsy of the spleen. Treatment of splenomegaly depends on the underlying cause and may include medications, surgery, or other therapies.

Waldenstrom Macroglobulinemia (WM) is a rare type of cancer that affects the bone marrow and produces abnormal antibodies called immunoglobulin M (IgM). These antibodies can accumulate in the blood and cause a variety of symptoms, including fatigue, weakness, and frequent infections. WM is typically diagnosed through a combination of blood tests, imaging studies, and a bone marrow biopsy. Treatment options for WM include chemotherapy, targeted therapy, and stem cell transplantation. While WM is a serious condition, it is generally slow-growing and can be managed with effective treatment.

Adipogenesis is the process by which precursor cells differentiate into mature adipocytes, which are specialized cells that store energy in the form of fat. This process is regulated by various signaling pathways and transcription factors, and is influenced by a variety of factors including hormones, nutrients, and physical activity. Adipogenesis plays a critical role in maintaining energy homeostasis in the body, and is also involved in the development of obesity and other metabolic disorders.

Lymphoma, B-Cell is a type of cancer that affects the B cells, which are a type of white blood cell that plays a crucial role in the immune system. B cells are responsible for producing antibodies that help the body fight off infections and diseases. In lymphoma, B cells grow and divide uncontrollably, forming tumors in the lymph nodes, bone marrow, and other parts of the body. There are several subtypes of B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and chronic lymphocytic leukemia (CLL). The symptoms of B-cell lymphoma can vary depending on the subtype and the location of the tumors, but may include swollen lymph nodes, fatigue, fever, night sweats, and weight loss. Treatment for B-cell lymphoma typically involves a combination of chemotherapy, radiation therapy, and targeted therapies. The specific treatment plan will depend on the subtype of lymphoma, the stage of the disease, and the overall health of the patient. In some cases, a stem cell transplant may also be recommended.

Membrane proteins are proteins that are embedded within the lipid bilayer of a cell membrane. They play a crucial role in regulating the movement of substances across the membrane, as well as in cell signaling and communication. There are several types of membrane proteins, including integral membrane proteins, which span the entire membrane, and peripheral membrane proteins, which are only in contact with one or both sides of the membrane. Membrane proteins can be classified based on their function, such as transporters, receptors, channels, and enzymes. They are important for many physiological processes, including nutrient uptake, waste elimination, and cell growth and division.

Fusion proteins, specifically BCR-ABL, are a type of abnormal protein that occurs as a result of a genetic mutation in certain types of leukemia and other blood disorders. The BCR-ABL fusion protein is formed when two separate genes, BCR (breakpoint cluster region) and ABL (abelson murine leukemia virus), fuse together and become a single gene. This fusion gene is then expressed as a single protein, which is known as BCR-ABL. BCR-ABL is a tyrosine kinase, which is an enzyme that is involved in regulating cell growth and division. In the case of BCR-ABL, the abnormal activity of the fusion protein leads to uncontrolled cell growth and division, which can result in the development of leukemia or other blood disorders. BCR-ABL is typically diagnosed through a blood test that detects the presence of the fusion protein in the blood. Treatment for BCR-ABL-positive leukemia typically involves the use of targeted therapies, such as tyrosine kinase inhibitors, which are designed to specifically block the activity of the BCR-ABL fusion protein and prevent it from promoting uncontrolled cell growth and division.

In the medical field, neoplasms refer to abnormal growths or tumors of cells that can occur in any part of the body. These growths can be either benign (non-cancerous) or malignant (cancerous). Benign neoplasms are usually slow-growing and do not spread to other parts of the body. They can cause symptoms such as pain, swelling, or difficulty moving the affected area. Examples of benign neoplasms include lipomas (fatty tumors), hemangiomas (vascular tumors), and fibromas (fibrous tumors). Malignant neoplasms, on the other hand, are cancerous and can spread to other parts of the body through the bloodstream or lymphatic system. They can cause a wide range of symptoms, depending on the location and stage of the cancer. Examples of malignant neoplasms include carcinomas (cancers that start in epithelial cells), sarcomas (cancers that start in connective tissue), and leukemias (cancers that start in blood cells). The diagnosis of neoplasms typically involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy (the removal of a small sample of tissue for examination under a microscope). Treatment options for neoplasms depend on the type, stage, and location of the cancer, as well as the patient's overall health and preferences.

DNA, or deoxyribonucleic acid, is a molecule that carries genetic information in living organisms. It is composed of four types of nitrogen-containing molecules called nucleotides, which are arranged in a specific sequence to form the genetic code. In the medical field, DNA is often studied as a tool for understanding and diagnosing genetic disorders. Genetic disorders are caused by changes in the DNA sequence that can affect the function of genes, leading to a variety of health problems. By analyzing DNA, doctors and researchers can identify specific genetic mutations that may be responsible for a particular disorder, and develop targeted treatments or therapies to address the underlying cause of the condition. DNA is also used in forensic science to identify individuals based on their unique genetic fingerprint. This is because each person's DNA sequence is unique, and can be used to distinguish one individual from another. DNA analysis is also used in criminal investigations to help solve crimes by linking DNA evidence to suspects or victims.

Prednisone is a synthetic corticosteroid medication that is used to treat a variety of medical conditions, including allergies, autoimmune disorders, inflammatory diseases, and certain types of cancer. It works by reducing inflammation and suppressing the immune system, which can help to reduce symptoms and slow the progression of the disease. Prednisone is available in both oral and injectable forms, and it is typically prescribed in doses that are gradually increased or decreased over time, depending on the patient's response to the medication and the specific condition being treated. While prednisone can be effective in treating a wide range of medical conditions, it can also have side effects, including weight gain, mood changes, and increased risk of infections. Therefore, it is important for patients to work closely with their healthcare provider to monitor their response to the medication and adjust the dosage as needed.

In the medical field, "Neoplastic Cells, Circulating" refers to cancer cells that have detached from a primary tumor and entered the bloodstream or lymphatic system. These cells are also known as circulating tumor cells (CTCs) or circulating neoplastic cells (CNCs). When cancer cells enter the bloodstream, they can travel to distant parts of the body and form new tumors, a process known as metastasis. The presence of circulating neoplastic cells is an indicator of the potential for metastasis and can be used as a biomarker for cancer progression and treatment response. The detection and enumeration of circulating neoplastic cells is typically performed using specialized laboratory techniques, such as flow cytometry or immunohistochemistry. These tests can help doctors monitor the progression of cancer and guide treatment decisions.

Tumor Necrosis Factor-alpha (TNF-alpha) is a cytokine, a type of signaling protein, that plays a crucial role in the immune response and inflammation. It is produced by various cells in the body, including macrophages, monocytes, and T cells, in response to infection, injury, or other stimuli. TNF-alpha has multiple functions in the body, including regulating the immune response, promoting cell growth and differentiation, and mediating inflammation. It can also induce programmed cell death, or apoptosis, in some cells, which can be beneficial in fighting cancer. However, excessive or prolonged TNF-alpha production can lead to chronic inflammation and tissue damage, which can contribute to the development of various diseases, including autoimmune disorders, inflammatory bowel disease, and certain types of cancer. In the medical field, TNF-alpha is often targeted in the treatment of these conditions. For example, drugs called TNF inhibitors, such as infliximab and adalimumab, are used to block the action of TNF-alpha and reduce inflammation in patients with rheumatoid arthritis, Crohn's disease, and other inflammatory conditions.

Translocation, genetic refers to a type of chromosomal rearrangement in which a segment of one chromosome breaks off and attaches to a different chromosome or to a different part of the same chromosome. This can result in a variety of genetic disorders, depending on the specific genes that are affected by the translocation. Some examples of genetic disorders that can be caused by translocations include leukemia, lymphoma, and certain types of congenital heart defects. Translocations can be detected through genetic testing, such as karyotyping, and can be important for diagnosing and treating genetic disorders.

Leukocytosis is a medical condition characterized by an abnormally high number of white blood cells (leukocytes) in the blood. The normal range of white blood cells in the blood is typically between 4,000 and 11,000 cells per microliter (µL) of blood. When the number of white blood cells exceeds this range, it is considered leukocytosis. Leukocytosis can be caused by a variety of factors, including infections, inflammation, stress, and certain medications. In some cases, leukocytosis may be a normal response to an infection or injury, but in other cases, it may be a sign of a more serious underlying condition. Leukocytosis can be classified into two types: absolute leukocytosis and relative leukocytosis. Absolute leukocytosis refers to an increase in the actual number of white blood cells in the blood, while relative leukocytosis refers to an increase in the proportion of white blood cells in the blood compared to other types of blood cells. Leukocytosis can be detected through a complete blood count (CBC) test, which measures the number and types of cells in the blood. Treatment for leukocytosis depends on the underlying cause and may include antibiotics, anti-inflammatory medications, or other therapies.

Strontium radioisotopes are radioactive isotopes of the element strontium that are used in medical applications. These isotopes emit radiation that can be detected and measured, and they are used in a variety of medical procedures, including: 1. Bone scanning: Strontium-89 and strontium-90 are used in bone scanning to detect bone metastases (cancer that has spread to the bones) and to monitor the effectiveness of treatment. 2. Cardiac imaging: Strontium-82 is used in cardiac imaging to assess blood flow to the heart and to diagnose and monitor heart disease. 3. Cancer treatment: Strontium-89 and strontium-90 are also used in cancer treatment, particularly for bone metastases, by delivering targeted radiation to the affected area. Strontium radioisotopes are typically produced in nuclear reactors and are then purified and formulated for medical use. They are administered to patients through intravenous injection or inhalation, and the radiation they emit is detected using specialized imaging equipment.

Osteosclerosis is a medical condition characterized by the hardening and thickening of bones. It is a type of bone disease that occurs when the normal process of bone remodeling is disrupted, leading to an excess of bone formation and a decrease in bone resorption. In osteosclerosis, the bones become dense and brittle, making them more prone to fractures. The condition can affect any bone in the body, but it is most commonly seen in the spine, pelvis, and skull. There are several types of osteosclerosis, including primary osteosclerosis, which is a genetic disorder, and secondary osteosclerosis, which is caused by other medical conditions such as kidney disease, hyperparathyroidism, or vitamin D deficiency. Treatment for osteosclerosis depends on the underlying cause and the severity of the condition. In some cases, lifestyle changes such as a healthy diet and regular exercise may be sufficient to manage the symptoms. In more severe cases, medications or surgery may be necessary to prevent fractures and improve mobility.

Calcium phosphates are a group of minerals that are commonly found in the human body, particularly in bones and teeth. They are also used in medical applications, such as in the production of bone grafts and dental implants. Calcium phosphates are composed of calcium and phosphorus ions, and they are typically crystalline in structure. There are several different types of calcium phosphates, including hydroxyapatite, octacalcium phosphate, and brushite. In the medical field, calcium phosphates are often used as a source of calcium and phosphorus for patients who are unable to obtain these nutrients from their diet. They are also used in the treatment of bone diseases, such as osteoporosis, and in the repair of bone fractures. In addition, calcium phosphates are used in the production of medical devices, such as dental implants and bone grafts, because of their biocompatibility and ability to support bone growth.

Bone Morphogenetic Protein 6 (BMP6) is a protein that plays a crucial role in bone development and repair. It is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, which are involved in a wide range of cellular processes, including cell proliferation, differentiation, and migration. In the medical field, BMP6 is used as a therapeutic agent to promote bone growth and repair in various conditions, such as non-unions, spinal fusion, and osteoporosis. It is also being studied for its potential use in tissue engineering and regenerative medicine. BMP6 is produced by a variety of cells, including osteoblasts (bone-forming cells) and chondrocytes (cartilage-forming cells). It acts by binding to specific receptors on the surface of target cells, triggering a signaling cascade that leads to the activation of various genes involved in bone formation and repair. Overall, BMP6 is a promising therapeutic agent for the treatment of bone-related diseases and injuries, and ongoing research is aimed at optimizing its use and understanding its mechanisms of action.

DNA primers are short, single-stranded DNA molecules that are used in a variety of molecular biology techniques, including polymerase chain reaction (PCR) and DNA sequencing. They are designed to bind to specific regions of a DNA molecule, and are used to initiate the synthesis of new DNA strands. In PCR, DNA primers are used to amplify specific regions of DNA by providing a starting point for the polymerase enzyme to begin synthesizing new DNA strands. The primers are complementary to the target DNA sequence, and are added to the reaction mixture along with the DNA template, nucleotides, and polymerase enzyme. The polymerase enzyme uses the primers as a template to synthesize new DNA strands, which are then extended by the addition of more nucleotides. This process is repeated multiple times, resulting in the amplification of the target DNA sequence. DNA primers are also used in DNA sequencing to identify the order of nucleotides in a DNA molecule. In this application, the primers are designed to bind to specific regions of the DNA molecule, and are used to initiate the synthesis of short DNA fragments. The fragments are then sequenced using a variety of techniques, such as Sanger sequencing or next-generation sequencing. Overall, DNA primers are an important tool in molecular biology, and are used in a wide range of applications to study and manipulate DNA.

Leukopenia is a medical condition characterized by a low number of white blood cells (leukocytes) in the blood. The normal range of white blood cells in the blood is typically between 4,500 and 11,000 cells per microliter (µL) of blood. When the number of white blood cells falls below 4,000 cells/µL, it is considered leukopenia. Leukopenia can be caused by a variety of factors, including infections, autoimmune disorders, certain medications, radiation therapy, chemotherapy, and bone marrow disorders. It can also be a symptom of more serious underlying conditions, such as leukemia, lymphoma, or other blood disorders. Symptoms of leukopenia may include fatigue, weakness, fever, chills, and an increased susceptibility to infections. Treatment for leukopenia depends on the underlying cause and may include medications to stimulate the production of white blood cells, antibiotics to treat infections, or other therapies to address the underlying condition.

Anemia, sideroblastic is a type of anemia characterized by the presence of abnormal red blood cells (erythrocytes) that contain excessive amounts of iron (siderosis) in the form of hemosiderin. This type of anemia is caused by defects in the enzymes involved in the metabolism of iron in the bone marrow, which leads to the accumulation of iron in the mitochondria of red blood cells. Sideroblastic anemia can be inherited or acquired, and it can be classified into several subtypes based on the specific enzyme defect involved. Some common symptoms of sideroblastic anemia include fatigue, weakness, shortness of breath, pale skin, and an enlarged spleen. Treatment for sideroblastic anemia typically involves addressing the underlying cause of the condition, such as treating an underlying infection or removing a source of excess iron. In some cases, iron chelation therapy may be used to remove excess iron from the body.

Cytotoxicity, immunologic refers to the ability of immune cells, such as T cells and natural killer (NK) cells, to directly kill or damage other cells in the body. This process is an important part of the immune response and is involved in the elimination of infected or cancerous cells. Cytotoxic T cells, for example, recognize and kill cells that are infected with viruses or have mutated in a way that makes them cancerous. NK cells can also recognize and kill abnormal cells, such as those that are missing the normal "self" markers on their surface. Cytotoxicity, immunologic can be measured in the laboratory using various assays, such as the lactate dehydrogenase (LDH) release assay or the chromium release assay.

In the medical field, culture media refers to a nutrient-rich substance used to support the growth and reproduction of microorganisms, such as bacteria, fungi, and viruses. Culture media is typically used in diagnostic laboratories to isolate and identify microorganisms from clinical samples, such as blood, urine, or sputum. Culture media can be classified into two main types: solid and liquid. Solid media is usually a gel-like substance that allows microorganisms to grow in a three-dimensional matrix, while liquid media is a broth or solution that provides nutrients for microorganisms to grow in suspension. The composition of culture media varies depending on the type of microorganism being cultured and the specific needs of that organism. Culture media may contain a variety of nutrients, including amino acids, sugars, vitamins, and minerals, as well as antibiotics or other agents to inhibit the growth of unwanted microorganisms. Overall, culture media is an essential tool in the diagnosis and treatment of infectious diseases, as it allows healthcare professionals to identify the specific microorganisms causing an infection and select the most appropriate treatment.

Polycythemia vera is a rare blood disorder that occurs when the bone marrow produces too many red blood cells. This leads to an overproduction of blood, which can cause a variety of symptoms and complications. In polycythemia vera, the bone marrow produces too many red blood cells, white blood cells, and platelets. This can lead to thick, sticky blood that is more prone to clotting. The extra red blood cells can also cause the blood vessels to become narrow, which can lead to high blood pressure and an increased risk of heart attack and stroke. Symptoms of polycythemia vera can include fatigue, shortness of breath, headaches, dizziness, and itching. In some cases, the condition can also cause skin changes, such as redness or warmth, and an increased risk of bleeding or bruising. Treatment for polycythemia vera typically involves medications to lower the number of red blood cells in the blood, as well as regular monitoring to check for complications. In some cases, a procedure called phlebotomy may be used to remove excess blood from the body. In severe cases, a bone marrow transplant may be necessary.

A cell line, tumor is a type of cell culture that is derived from a cancerous tumor. These cell lines are grown in a laboratory setting and are used for research purposes, such as studying the biology of cancer and testing potential new treatments. They are typically immortalized, meaning that they can continue to divide and grow indefinitely, and they often exhibit the characteristics of the original tumor from which they were derived, such as specific genetic mutations or protein expression patterns. Cell lines, tumor are an important tool in cancer research and have been used to develop many of the treatments that are currently available for cancer patients.

Blotting, Western is a laboratory technique used to detect specific proteins in a sample by transferring proteins from a gel to a membrane and then incubating the membrane with a specific antibody that binds to the protein of interest. The antibody is then detected using an enzyme or fluorescent label, which produces a visible signal that can be quantified. This technique is commonly used in molecular biology and biochemistry to study protein expression, localization, and function. It is also used in medical research to diagnose diseases and monitor treatment responses.

Neoplasm metastasis refers to the spread of cancer cells from a primary tumor to other parts of the body. This occurs when cancer cells break away from the primary tumor, enter the bloodstream or lymphatic system, and travel to distant organs or tissues, where they can form new tumors. Metastasis is a major cause of cancer-related deaths, as it makes the disease more difficult to treat and increases the risk of complications. The ability of cancer cells to metastasize is a key factor in determining the prognosis for patients with cancer.

Neoplasm proteins are proteins that are produced by cancer cells. These proteins are often abnormal and can contribute to the growth and spread of cancer. They can be detected in the blood or other body fluids, and their presence can be used as a diagnostic tool for cancer. Some neoplasm proteins are also being studied as potential targets for cancer treatment.

Cell- and tissue-based therapy, also known as regenerative medicine, is a medical approach that involves the use of cells, tissues, or organs to repair or replace damaged or diseased tissues in the body. This approach is based on the principle that cells have the ability to divide and differentiate into different types of cells, which can be used to regenerate damaged tissues. Cell-based therapy involves the use of cells, such as stem cells, to repair or replace damaged tissues. Stem cells are undifferentiated cells that have the ability to differentiate into different types of cells, such as muscle cells, nerve cells, or blood cells. Stem cells can be obtained from various sources, including embryos, adult tissues, and umbilical cord blood. Tissue-based therapy involves the use of tissues, such as skin, bone, or cartilage, to repair or replace damaged tissues. Tissue engineering is a technique used to create functional tissues in the laboratory by combining cells, scaffolds, and growth factors. These engineered tissues can then be implanted into the body to replace damaged or diseased tissues. Cell- and tissue-based therapy has the potential to treat a wide range of medical conditions, including heart disease, diabetes, spinal cord injuries, and cancer. However, this approach is still in the early stages of development, and more research is needed to fully understand its potential benefits and risks.

Breast neoplasms refer to abnormal growths or tumors in the breast tissue. These growths can be benign (non-cancerous) or malignant (cancerous). Benign breast neoplasms are usually not life-threatening, but they can cause discomfort or cosmetic concerns. Malignant breast neoplasms, on the other hand, can spread to other parts of the body and are considered a serious health threat. Some common types of breast neoplasms include fibroadenomas, ductal carcinoma in situ (DCIS), invasive ductal carcinoma, and invasive lobular carcinoma.

The cell cycle is the series of events that a cell undergoes from the time it is born until it divides into two daughter cells. It is a highly regulated process that is essential for the growth, development, and repair of tissues in the body. The cell cycle consists of four main phases: interphase, prophase, metaphase, and anaphase. During interphase, the cell grows and replicates its DNA in preparation for cell division. In prophase, the chromatin condenses into visible chromosomes, and the nuclear envelope breaks down. In metaphase, the chromosomes align at the center of the cell, and in anaphase, the sister chromatids separate and move to opposite poles of the cell. The cell cycle is tightly regulated by a complex network of proteins that ensure that the cell only divides when it is ready and that the daughter cells receive an equal share of genetic material. Disruptions in the cell cycle can lead to a variety of medical conditions, including cancer.

Dyskeratosis congenita (DC) is a rare genetic disorder that affects the skin, nails, and mucous membranes. It is characterized by abnormal skin pigmentation, nail abnormalities, and abnormal growth of the blood vessels in the mouth and nose. DC is caused by mutations in genes that are involved in the production of a protein called dyskerin, which is important for the normal functioning of cells in the body. The disorder is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. DC can lead to an increased risk of developing certain types of cancer, including skin cancer, bone marrow cancer, and lung cancer. Treatment for DC typically involves managing the symptoms and complications of the disorder, and may include medications, surgery, and other therapies.

Leukemia, Lymphocytic, Chronic, B-Cell (CLL) is a type of cancer that affects the white blood cells, specifically the B-lymphocytes. It is a slow-growing cancer that typically progresses over a long period of time, and it is the most common type of leukemia in adults. In CLL, the affected B-lymphocytes do not mature properly and continue to multiply uncontrollably, leading to an overproduction of these cells in the bone marrow and bloodstream. This can cause a variety of symptoms, including fatigue, weakness, fever, night sweats, and swollen lymph nodes. Treatment for CLL typically involves a combination of chemotherapy, targeted therapy, and immunotherapy, and the specific approach will depend on the individual patient's age, overall health, and the stage and severity of their disease. Some patients may also be eligible for stem cell transplantation.

Collagen is a protein that is found in the extracellular matrix of connective tissues throughout the body. It is the most abundant protein in the human body and is responsible for providing strength and support to tissues such as skin, bones, tendons, ligaments, and cartilage. In the medical field, collagen is often used in various medical treatments and therapies. For example, it is used in dermal fillers to plump up wrinkles and improve skin texture, and it is also used in wound healing to promote tissue regeneration and reduce scarring. Collagen-based products are also used in orthopedic and dental applications, such as in the production of artificial joints and dental implants. In addition, collagen is an important biomarker for various medical conditions, including osteoporosis, rheumatoid arthritis, and liver disease. It is also used in research to study the mechanisms of tissue repair and regeneration, as well as to develop new treatments for various diseases and conditions.

Blood platelets, also known as thrombocytes, are small, disc-shaped cells that play a crucial role in the blood clotting process. They are produced in the bone marrow and are essential for maintaining hemostasis, which is the body's ability to stop bleeding. Platelets are too small to be seen under a light microscope, but they are abundant in the blood, with an average of 150,000 to 450,000 platelets per microliter of blood. When a blood vessel is damaged, platelets are among the first cells to arrive at the site of injury. They adhere to the damaged vessel wall and release chemicals that attract more platelets and initiate the formation of a blood clot. Platelets also play a role in the immune response by releasing chemicals that attract immune cells to the site of infection or injury. They are involved in the formation of blood clots that prevent the spread of infection and help to repair damaged tissue. Abnormalities in platelet function or number can lead to bleeding disorders, such as thrombocytopenia (low platelet count) or thrombocytosis (high platelet count). Platelet disorders can be caused by a variety of factors, including genetic mutations, autoimmune disorders, and certain medications.

Cytogenetics is the study of the structure and function of chromosomes, the genetic material that carries the instructions for the development, function, and reproduction of living organisms. In the medical field, cytogenetics is used to diagnose and treat genetic disorders, such as cancer, by analyzing changes in the chromosomes of cells. This can involve looking for specific abnormalities, such as deletions, duplications, or rearrangements of chromosomes, or for changes in the number of chromosomes in a cell. Cytogenetic techniques can also be used to identify genetic markers that are associated with certain diseases or conditions, and to study the inheritance of genetic traits.

Antibody formation, also known as immunoglobulin production, is a process in the immune system where specialized cells called B cells produce antibodies in response to the presence of foreign substances, such as bacteria, viruses, or toxins, in the body. When a foreign substance enters the body, it is recognized by the immune system as foreign and triggers an immune response. B cells are activated and begin to divide and differentiate into plasma cells, which are specialized cells that produce antibodies. These antibodies are proteins that are designed to recognize and bind to specific antigens, which are molecules found on the surface of foreign substances. Once the antibodies bind to the antigens, they can neutralize the foreign substance, mark it for destruction by other immune cells, or activate the complement system, which is a group of proteins that work together to destroy the foreign substance. Antibody formation is a crucial part of the immune system's defense against infections and diseases. It is also an important aspect of the development of vaccines, which stimulate the immune system to produce antibodies against specific pathogens before the person is exposed to the actual pathogen.

In the medical field, "remission, spontaneous" refers to the natural recovery or improvement of a disease or condition without any specific treatment or intervention. It is a spontaneous return to a state of health or wellness that occurs without any external influence or medical intervention. Spontaneous remission can occur in various medical conditions, including cancer, autoimmune diseases, and mental health disorders. It is often seen as a positive outcome for patients, as it can reduce the need for medical treatment and improve their quality of life. However, it is important to note that spontaneous remission is not a guarantee of long-term recovery and that the underlying cause of the disease or condition may still be present. Therefore, it is essential to continue monitoring the patient's condition and seeking appropriate medical care as needed.

Chemokines, CXC are a family of small proteins that play a crucial role in the immune system. They are secreted by various cells in response to infection, injury, or inflammation and act as chemoattractants to recruit immune cells to the site of injury or infection. CXC chemokines are characterized by the presence of a conserved cysteine (C) at the first position and a glutamine (Q) or glutamic acid (E) at the second position in their amino acid sequence. They are classified into four subfamilies based on the position of the second cysteine residue: CX3C, CXCL, CXCL1, and CXCL2. CXC chemokines play a critical role in the recruitment and activation of immune cells, including neutrophils, monocytes, and lymphocytes, to the site of infection or injury. They also play a role in the development of chronic inflammatory diseases, such as asthma, rheumatoid arthritis, and atherosclerosis. In the medical field, CXC chemokines are used as diagnostic markers for various diseases, including cancer, infectious diseases, and autoimmune disorders. They are also being investigated as potential therapeutic targets for the treatment of these diseases.

Receptors, Antigen, B-Cell are a type of immune cell receptors found on the surface of B cells in the immune system. These receptors are responsible for recognizing and binding to specific antigens, which are foreign substances such as viruses, bacteria, or other pathogens. When a B cell encounters an antigen that matches its receptor, it becomes activated and begins to produce antibodies, which are proteins that can recognize and neutralize the specific antigen. The production of antibodies by B cells is a key part of the adaptive immune response, which helps the body to defend against infections and other harmful substances.

Daunorubicin is an anthracycline chemotherapy drug that is used to treat various types of cancer, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and some types of solid tumors such as breast cancer, ovarian cancer, and sarcomas. It works by interfering with the ability of cancer cells to divide and grow, ultimately leading to their death. Daunorubicin is usually administered intravenously, and its side effects can include nausea, vomiting, hair loss, low white blood cell count, and damage to the heart muscle.

Opportunistic infections (OIs) are infections that occur when a person's immune system is weakened or compromised, making them more susceptible to infections caused by normally harmless microorganisms. These infections can occur in people with weakened immune systems due to a variety of factors, including HIV/AIDS, cancer, organ transplantation, and certain medications. Opportunistic infections can affect any part of the body and can range from mild to life-threatening. Some common examples of opportunistic infections include pneumonia caused by the fungus Cryptococcus neoformans, tuberculosis caused by Mycobacterium tuberculosis, and candidiasis caused by the yeast Candida albicans. The treatment of opportunistic infections depends on the specific infection and the underlying cause of the weakened immune system. In many cases, antifungal, antiviral, or antibiotic medications are used to treat the infection. In some cases, the underlying cause of the weakened immune system may need to be addressed in order to prevent further infections.

In the medical field, "Antigens, Neoplasm" refers to proteins or other molecules that are produced by cancer cells (neoplasms) and are recognized by the immune system as foreign. These antigens can be used as targets for cancer immunotherapy, which aims to stimulate the immune system to attack and destroy cancer cells. Antigens, neoplasm can also be used as diagnostic markers to identify cancer cells in the body or to monitor the effectiveness of cancer treatment.

Thrombocytosis is a medical condition characterized by an abnormally high level of platelets in the blood. Platelets are small, disc-shaped cells that play a crucial role in blood clotting. When there are too many platelets in the blood, it can increase the risk of blood clots forming, which can lead to serious health problems such as stroke, heart attack, and pulmonary embolism. Thrombocytosis can be primary or secondary. Primary thrombocytosis is caused by a genetic disorder that affects the production of platelets in the bone marrow. Secondary thrombocytosis is caused by other medical conditions or medications that stimulate the production of platelets. The diagnosis of thrombocytosis typically involves a complete blood count (CBC) test, which measures the number of platelets in the blood. Treatment for thrombocytosis depends on the underlying cause and the severity of the condition. In some cases, no treatment may be necessary if the platelet count is not causing any problems. However, if the platelet count is very high or if there is an increased risk of blood clots, medications may be prescribed to lower the platelet count or prevent blood clots from forming. In severe cases, a procedure called phlebotomy may be performed to remove excess platelets from the blood.

Integrin alpha4beta1, also known as very late antigen-4 (VLA-4), is a cell surface protein that plays a crucial role in the adhesion and migration of immune cells, particularly leukocytes, to the endothelium of blood vessels. It is composed of two subunits, alpha4 and beta1, which are encoded by different genes. In the context of the immune system, integrin alpha4beta1 is involved in the homing of immune cells to specific tissues, such as the lymph nodes, spleen, and bone marrow. It also plays a role in the activation and differentiation of immune cells, as well as in the regulation of inflammation and immune responses. In addition to its role in the immune system, integrin alpha4beta1 has been implicated in various diseases, including cancer, autoimmune disorders, and infectious diseases. For example, it has been shown to be involved in the metastasis of certain types of cancer cells, as well as in the pathogenesis of multiple sclerosis and rheumatoid arthritis. Overall, integrin alpha4beta1 is a key regulator of immune cell function and has important implications for the development and treatment of various diseases.

Chondrogenesis is a process of cartilage formation that occurs during embryonic development. It is the process by which mesenchymal cells differentiate into chondrocytes, which are the cells that make up cartilage. Chondrogenesis involves the production of extracellular matrix, which provides the structural support for the developing cartilage. This process is critical for the formation of many of the cartilaginous structures in the body, including the nose, ears, and trachea, as well as the growth plates in long bones. In the medical field, chondrogenesis is also studied as a potential therapeutic strategy for the repair and regeneration of damaged cartilage tissue.

Osteomyelitis is a type of bone infection that occurs when bacteria enter the bone and cause inflammation and damage to the bone tissue. It can affect any bone in the body, but it is most commonly seen in the long bones of the arms and legs, as well as in the spine and pelvis. Osteomyelitis can be acute or chronic, and it can be caused by a variety of factors, including bacterial infections, fungal infections, and viral infections. It can also be caused by traumatic injuries, such as fractures or punctures, or by medical procedures, such as surgery or the insertion of a catheter. Symptoms of osteomyelitis may include fever, chills, fatigue, and pain in the affected bone. In some cases, there may be no symptoms at all until the infection has progressed significantly. Treatment for osteomyelitis typically involves antibiotics to kill the bacteria causing the infection. In some cases, surgery may be necessary to remove infected tissue or to drain abscesses. Physical therapy may also be recommended to help restore strength and mobility to the affected bone.

Disease progression refers to the worsening or progression of a disease over time. It is a natural course of events that occurs in many chronic illnesses, such as cancer, heart disease, and diabetes. Disease progression can be measured in various ways, such as changes in symptoms, physical examination findings, laboratory test results, or imaging studies. In some cases, disease progression can be slowed or stopped through medical treatment, such as medications, surgery, or radiation therapy. However, in other cases, disease progression may be inevitable, and the focus of treatment may shift from trying to cure the disease to managing symptoms and improving quality of life. Understanding disease progression is important for healthcare providers to develop effective treatment plans and to communicate with patients about their condition and prognosis. It can also help patients and their families make informed decisions about their care and treatment options.

Leukemia, Hairy Cell is a type of cancer that affects the white blood cells, specifically the B-lymphocytes. It is a rare type of leukemia, accounting for less than 1% of all leukemias. The hallmark feature of hairy cell leukemia is the presence of abnormal white blood cells, called hairy cells, which have a distinctive appearance under a microscope. These cells are larger than normal white blood cells and have a characteristic "hairy" appearance due to the presence of cytoplasmic projections. Hairy cell leukemia is typically a slow-growing cancer, and symptoms may not appear until the disease is advanced. Common symptoms include fatigue, weakness, fever, night sweats, and weight loss. Treatment for hairy cell leukemia typically involves chemotherapy, which can be effective in eliminating the cancer cells. In some cases, targeted therapies or immunotherapies may also be used. The prognosis for hairy cell leukemia is generally good, with a high rate of remission and long-term survival.

Aneurysmal bone cysts are benign (non-cancerous) bone tumors that occur most commonly in children and young adults. They are characterized by the presence of a fluid-filled sac (cyst) in the bone, which can cause the bone to weaken and become fragile. The cysts are often found in the long bones of the arms and legs, but can also occur in the spine, pelvis, and other bones. Aneurysmal bone cysts are thought to be caused by abnormal blood vessel growth in the bone. The cysts can grow rapidly and cause pain, swelling, and bone deformities. In some cases, the cysts may also cause fractures or other complications. Treatment for aneurysmal bone cysts typically involves draining the fluid from the cyst and then filling the cyst with a substance that helps to stabilize the bone. In some cases, surgery may be necessary to remove the cyst or stabilize the affected bone. The prognosis for aneurysmal bone cysts is generally good, and most people are able to recover fully with appropriate treatment.

Cartilage is a type of connective tissue that is found in various parts of the body, including the joints, ears, nose, and larynx. It is a flexible and resilient tissue that provides support and cushioning to bones and other structures. In the medical field, cartilage is often used to refer specifically to the type of connective tissue that lines the surfaces of joints, such as the knee and hip. This type of cartilage, called articular cartilage, is smooth and slippery, allowing bones to glide over each other with minimal friction. It also helps to distribute the forces of movement across the joint, reducing the risk of injury. Cartilage can also become damaged or diseased, leading to conditions such as osteoarthritis, where the cartilage breaks down and the bones of the joint rub against each other, causing pain and inflammation. In such cases, medical treatments such as physical therapy, medications, or surgery may be used to manage the condition and alleviate symptoms.

Immunoglobulins, also known as antibodies, are proteins produced by the immune system in response to the presence of foreign substances, such as viruses, bacteria, and toxins. They are Y-shaped molecules that recognize and bind to specific antigens, which are molecules found on the surface of pathogens. There are five main classes of immunoglobulins: IgG, IgA, IgM, IgD, and IgE. Each class has a unique structure and function, and they are produced by different types of immune cells in response to different types of pathogens. Immunoglobulins play a critical role in the immune response by neutralizing pathogens, marking them for destruction by other immune cells, and activating the complement system, which helps to destroy pathogens. They are also used in medical treatments, such as immunoglobulin replacement therapy for patients with primary immunodeficiencies, and in the development of vaccines and monoclonal antibodies for the treatment of various diseases.

Osteitis deformans, also known as Paget's disease of bone, is a chronic disorder of the skeletal system characterized by increased bone turnover and abnormal bone remodeling. It typically affects older adults and is more common in men than women. The disease is characterized by periods of increased bone resorption (breakdown) and formation (rebuilding), leading to thickening and weakening of the bone. This can cause bone pain, deformities, and an increased risk of fractures. The exact cause of osteitis deformans is not fully understood, but it is thought to be related to genetic and environmental factors. Treatment typically involves medications to slow down bone turnover and relieve symptoms, as well as physical therapy to maintain bone strength and prevent fractures.

Receptors, Thrombopoietin (TPO) are proteins found on the surface of certain cells in the bone marrow that are responsible for the production of platelets, also known as thrombocytes. Thrombopoietin is a hormone that stimulates the production and maturation of platelets in the bone marrow. The TPO receptors on the surface of the cells in the bone marrow bind to TPO, which triggers a signaling cascade that leads to the production and release of platelets into the bloodstream. TPO receptors are also found on other cells, such as endothelial cells and megakaryocytes, which are involved in the production of platelets. Abnormalities in TPO receptors or the production of TPO can lead to disorders of platelet production, such as thrombocytopenia or thrombocytosis.

Transforming Growth Factor beta (TGF-β) is a family of cytokines that play a crucial role in regulating cell growth, differentiation, and migration. TGF-βs are secreted by a variety of cells, including immune cells, fibroblasts, and epithelial cells, and act on neighboring cells to modulate their behavior. TGF-βs have both pro-inflammatory and anti-inflammatory effects, depending on the context in which they are released. They can promote the differentiation of immune cells into effector cells that help to fight infections, but they can also suppress the immune response to prevent excessive inflammation. In addition to their role in immune regulation, TGF-βs are also involved in tissue repair and fibrosis. They can stimulate the production of extracellular matrix proteins, such as collagen, which are essential for tissue repair. However, excessive production of TGF-βs can lead to fibrosis, a condition in which excessive amounts of connective tissue accumulate in the body, leading to organ dysfunction. Overall, TGF-βs are important signaling molecules that play a critical role in regulating a wide range of cellular processes in the body.

Essential thrombocythemia (ET) is a rare blood disorder characterized by an abnormally high level of platelets in the blood. Platelets are small blood cells that play a crucial role in blood clotting. In ET, the bone marrow produces too many platelets, leading to an increased risk of blood clots. ET is usually a chronic condition, meaning it persists over a long period of time. It can cause a variety of symptoms, including fatigue, weakness, joint pain, and bruising or bleeding easily. In some cases, ET can lead to more serious complications, such as blood clots in the lungs, brain, or other organs. The exact cause of ET is not fully understood, but it is thought to be related to genetic mutations that affect the production of platelets. ET is typically diagnosed through blood tests that measure platelet levels and other blood parameters. Treatment for ET may include medications to lower platelet levels, blood thinners to prevent blood clots, and in some cases, surgery to remove excess platelets from the blood.

In the medical field, a chronic disease is a long-term health condition that persists for an extended period, typically for more than three months. Chronic diseases are often progressive, meaning that they tend to worsen over time, and they can have a significant impact on a person's quality of life. Chronic diseases can affect any part of the body and can be caused by a variety of factors, including genetics, lifestyle, and environmental factors. Some examples of chronic diseases include heart disease, diabetes, cancer, chronic obstructive pulmonary disease (COPD), and arthritis. Chronic diseases often require ongoing medical management, including medication, lifestyle changes, and regular monitoring to prevent complications and manage symptoms. Treatment for chronic diseases may also involve rehabilitation, physical therapy, and other supportive care.

Intercellular signaling peptides and proteins are molecules that are secreted by cells and act as messengers to communicate with other cells. These molecules can be hormones, growth factors, cytokines, or other signaling molecules that are capable of transmitting information between cells. They play a crucial role in regulating various physiological processes, such as cell growth, differentiation, and apoptosis, as well as immune responses and inflammation. In the medical field, understanding the function and regulation of intercellular signaling peptides and proteins is important for developing new treatments for various diseases and disorders, including cancer, autoimmune diseases, and neurological disorders.

Burkitt lymphoma is a type of aggressive and fast-growing cancer that affects the lymphatic system, which is a part of the immune system. It is named after Denis Parsons Burkitt, a British surgeon who first described the disease in African children in the 1950s. Burkitt lymphoma can occur in different parts of the body, including the lymph nodes, bone marrow, and gastrointestinal tract. It is most common in children and young adults, particularly in Africa, Asia, and Central and South America. The exact cause of Burkitt lymphoma is not fully understood, but it is believed to be related to a combination of genetic and environmental factors. Some of the risk factors for developing Burkitt lymphoma include exposure to the Epstein-Barr virus (EBV), which is a common virus that can cause infectious mononucleosis, and certain genetic mutations. Treatment for Burkitt lymphoma typically involves a combination of chemotherapy, radiation therapy, and sometimes stem cell transplantation. The prognosis for Burkitt lymphoma depends on several factors, including the stage of the cancer at diagnosis, the patient's age and overall health, and the response to treatment. With appropriate treatment, the majority of people with Burkitt lymphoma can achieve long-term remission or even a cure.

Lymphoma, follicular is a type of cancer that affects the lymphatic system, which is a part of the immune system. It is a slow-growing cancer that typically affects the lymph nodes, but it can also affect other parts of the body, such as the spleen, liver, and bone marrow. Follicular lymphoma is the most common type of non-Hodgkin lymphoma, accounting for about one-third of all cases. It is usually diagnosed in people over the age of 50, and it is slightly more common in women than in men. The symptoms of follicular lymphoma can vary depending on the stage and location of the cancer. Some people may not experience any symptoms at all, while others may have swollen lymph nodes, fatigue, fever, night sweats, and weight loss. Treatment for follicular lymphoma typically involves a combination of chemotherapy, radiation therapy, and targeted therapy. The goal of treatment is to shrink the cancer and control its growth, but it is not curable. However, many people with follicular lymphoma are able to live for many years with the disease.

Antibody-producing cells, also known as B cells, are a type of white blood cell that plays a crucial role in the immune system. These cells are responsible for producing antibodies, which are proteins that help the body fight off infections and diseases. B cells are produced in the bone marrow and mature in the spleen. When a B cell encounters a foreign substance, such as a virus or bacteria, it becomes activated and begins to divide rapidly. As the B cells divide, they differentiate into plasma cells, which are specialized cells that produce large amounts of antibodies. The antibodies produced by B cells are specific to the foreign substance that triggered their activation. They bind to the substance and mark it for destruction by other immune cells, such as macrophages and neutrophils. This process helps to neutralize the foreign substance and prevent it from causing harm to the body. In summary, antibody-producing cells, or B cells, are an essential component of the immune system that play a critical role in protecting the body against infections and diseases.

Cord Blood Stem Cell Transplantation (CBSC Transplantation) is a medical procedure that involves the transplantation of stem cells from a donor's umbilical cord blood into a patient who has a damaged or diseased bone marrow or blood system. The stem cells are collected from the umbilical cord blood after a baby is born and are then cryopreserved for future use. CBSC transplantation is used to treat a variety of conditions, including leukemia, lymphoma, myelodysplastic syndrome, and sickle cell disease. The procedure is typically performed in a hospital setting and involves the administration of high-dose chemotherapy or radiation to the patient's bone marrow and blood system to destroy the diseased cells. The cryopreserved stem cells are then infused into the patient's bloodstream, where they can engraft and repopulate the patient's bone marrow and blood system with healthy, functioning cells. CBSC transplantation is considered a less invasive and less toxic alternative to traditional bone marrow transplantation, as it does not require the collection of stem cells from the patient's bone marrow or the use of a matched donor. However, the success of CBSC transplantation depends on the availability of a suitable donor and the patient's overall health and medical condition.

The Philadelphia chromosome, also known as the t(9;22) translocation, is a genetic abnormality that occurs when a piece of chromosome 22 breaks off and attaches to chromosome 9. This results in the formation of a new chromosome, called the Philadelphia chromosome, which carries the oncogene BCR-ABL. The Philadelphia chromosome is a hallmark of chronic myeloid leukemia (CML), a type of blood cancer that affects the bone marrow and produces too many abnormal white blood cells. The BCR-ABL oncogene causes the cells to divide and multiply uncontrollably, leading to the accumulation of abnormal white blood cells in the blood and bone marrow. The discovery of the Philadelphia chromosome and the BCR-ABL oncogene was a major breakthrough in the understanding and treatment of CML. Targeted therapies, such as imatinib (Gleevec), have been developed to specifically inhibit the activity of the BCR-ABL oncogene, leading to improved outcomes for patients with CML.

Core binding factor alpha 1 subunit, also known as CBFα1 or RUNX1, is a transcription factor that plays a critical role in the development and function of hematopoietic stem cells and their descendants, including red blood cells, white blood cells, and platelets. It is encoded by the "RUNX1" gene and is a member of the runt-related transcription factor family. In the context of medical research, CBFα1 is often studied in the context of hematological disorders such as acute myeloid leukemia (AML), where mutations in the "RUNX1" gene are frequently observed. These mutations can lead to abnormal regulation of CBFα1 and disrupt normal hematopoiesis, contributing to the development of the disease. CBFα1 is also involved in the regulation of other biological processes, including cell differentiation, proliferation, and apoptosis. As such, it has potential therapeutic applications in the treatment of various diseases, including cancer and autoimmune disorders.

In the medical field, a syndrome is a set of symptoms and signs that occur together and suggest the presence of a particular disease or condition. A syndrome is often defined by a specific pattern of symptoms that are not caused by a single underlying disease, but rather by a combination of factors, such as genetic, environmental, or hormonal. For example, Down syndrome is a genetic disorder that is characterized by a specific set of physical and intellectual characteristics, such as a flattened facial profile, short stature, and intellectual disability. Similarly, the flu syndrome is a set of symptoms that occur together, such as fever, cough, sore throat, and body aches, that suggest the presence of an influenza virus infection. Diagnosing a syndrome involves identifying the specific set of symptoms and signs that are present, as well as ruling out other possible causes of those symptoms. Once a syndrome is diagnosed, it can help guide treatment and management of the underlying condition.

Doxorubicin is an anthracycline chemotherapy drug that is used to treat a variety of cancers, including breast cancer, ovarian cancer, and leukemia. It works by interfering with the production of DNA and RNA, which are essential for the growth and division of cancer cells. Doxorubicin is usually administered intravenously, and its side effects can include nausea, vomiting, hair loss, and damage to the heart and kidneys. It is a powerful drug that can be effective against many types of cancer, but it can also have serious side effects, so it is typically used in combination with other treatments or in low doses.

Glycoproteins are a type of protein that contains one or more carbohydrate chains covalently attached to the protein molecule. These carbohydrate chains are made up of sugars and are often referred to as glycans. Glycoproteins play important roles in many biological processes, including cell signaling, cell adhesion, and immune response. They are found in many different types of cells and tissues throughout the body, and are often used as markers for various diseases and conditions. In the medical field, glycoproteins are often studied as potential targets for the development of new drugs and therapies.

Infection is a disease caused by the invasion and multiplication of pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, in the body. These microorganisms can enter the body through various routes, such as the respiratory system, digestive system, skin, or bloodstream. Infections can cause a wide range of symptoms, depending on the type of microorganism and the affected body. Common symptoms of infections include fever, chills, fatigue, body aches, cough, sore throat, runny nose, diarrhea, vomiting, and skin rashes. Infections can be treated with antibiotics, antiviral drugs, antifungal medications, or antiparasitic drugs, depending on the type of microorganism causing the infection. In some cases, supportive care, such as rest, fluids, and pain relief, may be necessary to help the body fight off the infection. Preventing infections is also important, and can be achieved through good hygiene practices, such as washing hands regularly, covering the mouth and nose when coughing or sneezing, and avoiding close contact with sick individuals. Vaccines can also be used to prevent certain types of infections, such as influenza, measles, and pneumonia.

Proto-oncogenes are normal genes that are involved in regulating cell growth and division. When these genes are mutated or overexpressed, they can become oncogenes, which can lead to the development of cancer. Proto-oncogenes are also known as proto-oncogene proteins.

Blood transfusion is a medical procedure in which blood or blood components are transferred from one person (the donor) to another person (the recipient) to replace lost blood or to treat a medical condition. Blood transfusions are typically performed in a hospital setting and are usually done under the supervision of a medical professional. There are several types of blood transfusions, including whole blood transfusions, red blood cell transfusions, platelet transfusions, and plasma transfusions. Whole blood transfusions involve the transfer of whole blood from a donor to a recipient, while red blood cell transfusions involve the transfer of red blood cells only. Platelet transfusions involve the transfer of platelets, which are important for blood clotting, while plasma transfusions involve the transfer of plasma, which contains proteins and other substances that are important for maintaining the body's immune system. Blood transfusions are typically performed to treat a variety of medical conditions, including anemia, bleeding disorders, and certain types of cancer. They can also be used to treat patients who have lost a significant amount of blood due to injury or surgery. However, blood transfusions carry some risks, including the risk of allergic reactions, the transmission of infectious diseases, and the development of antibodies that can cause future transfusions to be less effective.

Red-cell aplasia, pure, is a medical condition characterized by a decrease in the production of red blood cells (erythrocytes) in the bone marrow. In this condition, the bone marrow fails to produce enough red blood cells to meet the body's oxygen-carrying needs, leading to anemia. Pure red-cell aplasia is different from other forms of anemia because it affects only the production of red blood cells, while other forms of anemia may also involve a decrease in the production of white blood cells or platelets. The cause of pure red-cell aplasia can be idiopathic (unknown), or it may be associated with certain medical conditions, such as autoimmune disorders, infections, or exposure to certain medications or toxins. Symptoms of pure red-cell aplasia may include fatigue, weakness, shortness of breath, and pale skin. Treatment for pure red-cell aplasia typically involves administering red blood cell transfusions to replace the deficient red blood cells, as well as addressing any underlying medical conditions that may be contributing to the condition. In some cases, immunosuppressive therapy may be used to suppress the immune system and promote the production of red blood cells in the bone marrow.

CD4-positive T-lymphocytes, also known as CD4+ T-cells or T-helper cells, are a type of white blood cell that plays a critical role in the immune system. They are a subset of T-cells that express the CD4 protein on their surface, which allows them to recognize and bind to antigens presented by other immune cells. CD4+ T-cells are involved in many aspects of the immune response, including the activation and proliferation of other immune cells, the production of cytokines (chemical messengers that regulate immune responses), and the regulation of immune tolerance. They are particularly important in the response to infections caused by viruses, such as HIV, and in the development of autoimmune diseases. In HIV infection, the virus specifically targets and destroys CD4+ T-cells, leading to a decline in their numbers and a weakened immune system. This is why CD4+ T-cell count is an important marker of HIV disease progression and treatment response.

Immunoglobulin M (IgM) is a type of antibody that is produced by B cells in response to an infection or foreign substance. It is the first antibody to be produced during an immune response and is present in the blood and other body fluids in relatively low concentrations. IgM antibodies are large, Y-shaped molecules that can bind to multiple antigens at once, making them highly effective at neutralizing pathogens and marking them for destruction by other immune cells. They are also able to activate the complement system, a series of proteins that can directly destroy pathogens or mark them for destruction by immune cells. IgM antibodies are often used as a diagnostic tool in medical testing, as they are typically the first antibodies to be produced in response to a new infection. They can also be used to monitor the effectiveness of vaccines and to detect the presence of certain diseases, such as viral or bacterial infections, autoimmune disorders, and certain types of cancer.

Immunoglobulin heavy chains (IgH chains) are the larger of the two subunits that make up the immunoglobulin (Ig) molecule, which is a type of protein that plays a critical role in the immune system. The Ig molecule is composed of two identical heavy chains and two identical light chains, which are connected by disulfide bonds. The heavy chains are responsible for the specificity of the Ig molecule, as they contain the variable regions that interact with antigens (foreign substances that trigger an immune response). The heavy chains also contain the constant regions, which are involved in the effector functions of the immune system, such as activating complement and binding to Fc receptors on immune cells. There are five different classes of Ig molecules (IgA, IgD, IgE, IgG, and IgM), which are distinguished by the type of heavy chain they contain. Each class of Ig molecule has a different set of functions and is produced by different types of immune cells in response to different types of antigens.

Dexamethasone is a synthetic glucocorticoid hormone that is used in the medical field as an anti-inflammatory, immunosuppressive, and antipyretic agent. It is a potent corticosteroid that has a wide range of therapeutic applications, including the treatment of allergic reactions, inflammatory diseases, autoimmune disorders, and cancer. Dexamethasone is available in various forms, including tablets, injections, and inhalers, and is used to treat a variety of conditions, such as asthma, COPD, rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease. It is also used to treat severe cases of COVID-19, as it has been shown to reduce inflammation and improve outcomes in patients with severe illness. However, dexamethasone is a potent drug that can have significant side effects, including weight gain, fluid retention, high blood pressure, increased risk of infection, and mood changes. Therefore, it is typically prescribed only when other treatments have failed or when the potential benefits outweigh the risks.

Adipocytes, also known as fat cells, are specialized cells in the body that store energy in the form of fat. They are found in adipose tissue, which is the most common type of connective tissue in the body. Adipocytes are responsible for regulating energy balance by storing and releasing fat as needed. They also play a role in the production of hormones, such as leptin and adiponectin, which help to regulate appetite and metabolism. In medical terms, the study of adipocytes is known as adipocyte biology or adipocyte research.

FLT3 (Fms-like tyrosine kinase 3) is a type of protein that plays a role in the development and function of blood cells. It is a receptor tyrosine kinase, which means that it is a type of protein that is activated when it binds to a specific molecule (ligand) and then triggers a series of chemical reactions within the cell. FLT3 is expressed on the surface of certain types of blood cells, including white blood cells (leukocytes) and stem cells, and is involved in the process of cell growth and division. Mutations in the FLT3 gene can lead to the production of abnormal versions of the protein that may contribute to the development of certain types of blood cancers, such as acute myeloid leukemia (AML).

Antibodies, also known as immunoglobulins, are proteins produced by the immune system in response to the presence of foreign substances, such as viruses, bacteria, and other pathogens. Antibodies are designed to recognize and bind to specific molecules on the surface of these foreign substances, marking them for destruction by other immune cells. There are five main classes of antibodies: IgG, IgA, IgM, IgD, and IgE. Each class of antibody has a unique structure and function, and they are produced by different types of immune cells in response to different types of pathogens. Antibodies play a critical role in the immune response, helping to protect the body against infection and disease. They can neutralize pathogens by binding to them and preventing them from entering cells, or they can mark them for destruction by other immune cells. In some cases, antibodies can also help to stimulate the immune response by activating immune cells or by recruiting other immune cells to the site of infection. Antibodies are often used in medical treatments, such as in the development of vaccines, where they are used to stimulate the immune system to produce a response to a specific pathogen. They are also used in diagnostic tests to detect the presence of specific pathogens or to monitor the immune response to a particular treatment.

Osteoporosis, postmenopausal, is a medical condition characterized by a decrease in bone density and strength, leading to an increased risk of fractures. It typically occurs in women after menopause, when estrogen levels decline, and bone loss accelerates. The condition can also affect men, but it is more common in women. Postmenopausal osteoporosis is caused by a combination of factors, including hormonal changes, aging, and lifestyle factors such as lack of physical activity and poor nutrition. The bones become porous and fragile, making them more susceptible to fractures, especially in the spine, hips, and wrists. Diagnosis of postmenopausal osteoporosis is typically made through a bone density test, which measures the amount of bone mineral density in the hip and spine. Treatment options include lifestyle changes such as regular exercise and a healthy diet, as well as medications to slow bone loss and increase bone density. In severe cases, surgery may be necessary to repair fractures.

Edema is a medical condition characterized by the accumulation of excess fluid in the body's tissues. It can occur in any part of the body, but is most commonly seen in the feet, ankles, legs, and hands. Edema can be caused by a variety of factors, including heart failure, kidney disease, liver disease, hormonal imbalances, pregnancy, and certain medications. It can also be a symptom of other medical conditions, such as cancer or lymphedema. Edema can be diagnosed through physical examination and medical imaging, and treatment depends on the underlying cause.

Lymphopenia is a medical condition characterized by a reduced number of lymphocytes, a type of white blood cell, in the blood. Lymphocytes are an important part of the immune system and play a crucial role in fighting infections and diseases. Lymphopenia can be caused by a variety of factors, including infections, autoimmune disorders, certain medications, and cancer treatments. It can also be a sign of an underlying medical condition, such as HIV/AIDS, leukemia, or lymphoma. Symptoms of lymphopenia may include fatigue, weakness, fever, and an increased susceptibility to infections. Treatment for lymphopenia depends on the underlying cause and may include medications, lifestyle changes, or medical procedures.

Inflammation is a complex biological response of the body to harmful stimuli, such as pathogens, damaged cells, or irritants. It is a protective mechanism that helps to eliminate the cause of injury, remove damaged tissue, and initiate the healing process. Inflammation involves the activation of immune cells, such as white blood cells, and the release of chemical mediators, such as cytokines and prostaglandins. This leads to the characteristic signs and symptoms of inflammation, including redness, heat, swelling, pain, and loss of function. Inflammation can be acute or chronic. Acute inflammation is a short-term response that lasts for a few days to a few weeks and is usually beneficial. Chronic inflammation, on the other hand, is a prolonged response that lasts for months or years and can be harmful if it persists. Chronic inflammation is associated with many diseases, including cancer, cardiovascular disease, and autoimmune disorders.

Interleukin-1 (IL-1) is a type of cytokine, which is a signaling molecule that plays a crucial role in the immune system. IL-1 is produced by various types of immune cells, including macrophages, monocytes, and dendritic cells, in response to infection, injury, or inflammation. IL-1 has multiple functions in the immune system, including promoting the activation and proliferation of immune cells, enhancing the production of other cytokines, and regulating the inflammatory response. It can also stimulate the production of fever, which helps to fight off infections. In the medical field, IL-1 is often studied in the context of various diseases, including autoimmune disorders, inflammatory bowel disease, and rheumatoid arthritis. It is also being investigated as a potential target for the development of new treatments for these conditions.

In the medical field, "age factors" refer to the effects of aging on the body and its various systems. As people age, their bodies undergo a variety of changes that can impact their health and well-being. These changes can include: 1. Decreased immune function: As people age, their immune system becomes less effective at fighting off infections and diseases. 2. Changes in metabolism: Aging can cause changes in the way the body processes food and uses energy, which can lead to weight gain, insulin resistance, and other metabolic disorders. 3. Cardiovascular changes: Aging can lead to changes in the heart and blood vessels, including increased risk of heart disease, stroke, and high blood pressure. 4. Cognitive changes: Aging can affect memory, attention, and other cognitive functions, which can lead to conditions such as dementia and Alzheimer's disease. 5. Joint and bone changes: Aging can cause changes in the joints and bones, including decreased bone density and increased risk of osteoporosis and arthritis. 6. Skin changes: Aging can cause changes in the skin, including wrinkles, age spots, and decreased elasticity. 7. Hormonal changes: Aging can cause changes in hormone levels, including decreased estrogen in women and decreased testosterone in men, which can lead to a variety of health issues. Overall, age factors play a significant role in the development of many health conditions and can impact a person's quality of life. It is important for individuals to be aware of these changes and to take steps to maintain their health and well-being as they age.

Biocompatible materials are materials that are designed to interact with living tissues in a way that is safe and non-toxic. These materials are used in a variety of medical applications, including implants, prosthetics, and drug delivery systems. Biocompatible materials must be able to withstand the harsh conditions of the human body, including exposure to bodily fluids, enzymes, and bacteria. They must also be able to integrate with the surrounding tissue and promote healing, rather than causing inflammation or rejection. Some examples of biocompatible materials include metals such as titanium and stainless steel, polymers such as polyethylene and polypropylene, and ceramics such as hydroxyapatite. These materials are often used in the manufacturing of medical devices and implants, such as hip replacements, dental implants, and pacemakers. It is important to note that while a material may be biocompatible, it may not be suitable for all medical applications. The choice of material depends on a variety of factors, including the intended use of the device, the patient's individual needs and health status, and the specific requirements of the medical procedure.

Micronuclei, chromosome-defective are small nuclear bodies that contain chromosomal material that has not been incorporated into the main nucleus of a cell. They are often formed as a result of DNA damage or errors in cell division, and can be used as a biomarker of genomic instability and cancer risk. In the medical field, the presence of micronuclei, chromosome-defective can be used to assess the genotoxicity of environmental or occupational exposures, as well as to monitor the effectiveness of cancer treatments.

In the medical field, bone plates are surgical implants used to stabilize and repair fractures or other injuries to bones. They are typically made of metal, such as titanium or stainless steel, and are designed to fit precisely onto the bone to provide support and promote healing. Bone plates are usually secured to the bone using screws, pins, or other types of fixation devices. They can be used to treat a wide range of bone injuries, including fractures, dislocations, and osteotomies (surgical cuts made in bones to realign them). The use of bone plates has revolutionized the treatment of bone injuries, allowing for faster and more accurate healing, and reducing the risk of complications such as nonunion (failure of the bone to heal) or malunion (healing of the bone in the wrong position).

In the medical field, antigens are substances that can trigger an immune response in the body. They are typically proteins or carbohydrates that are found on the surface of cells or viruses, bacteria, and other microorganisms. When the immune system encounters an antigen, it produces antibodies that can recognize and bind to the antigen, marking it for destruction by immune cells. Antigens can be classified into two main categories: 1. Exogenous antigens: These are antigens that come from outside the body, such as bacteria, viruses, and toxins. They can cause an immune response when they enter the body. 2. Endogenous antigens: These are antigens that are produced by the body itself, such as cancer cells or damaged cells. They can also trigger an immune response if they are recognized as foreign by the immune system. Antigens play a crucial role in the immune system's ability to protect the body against infections and diseases. They are also used in medical treatments such as vaccines, where they are introduced into the body to stimulate an immune response and provide protection against future infections.

Sialic Acid Binding Ig-like Lectin 3 (SIGLEC3) is a protein that is expressed on the surface of immune cells, such as macrophages and dendritic cells. It is a member of the SIGLEC family of proteins, which are involved in the recognition and binding of sialic acid, a type of carbohydrate found on the surface of many types of cells. SIGLEC3 has been shown to play a role in the immune response to infections, as well as in the regulation of inflammation and the development of certain types of cancer. It has also been implicated in the pathogenesis of autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. In the medical field, SIGLEC3 is being studied as a potential target for the development of new therapies for a variety of diseases, including cancer and autoimmune disorders.

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (PBL) is a type of cancer that affects the white blood cells, specifically the B-cells, which are a type of immune cell that helps the body fight infections. PBL is a type of acute lymphoblastic leukemia (ALL), which is a cancer that affects the bone marrow and causes the production of too many immature white blood cells, or lymphoblasts. PBL is most commonly diagnosed in children and young adults, and it is characterized by the rapid growth of abnormal B-cells in the bone marrow, which can then spread to other parts of the body, such as the lymph nodes, spleen, and liver. The symptoms of PBL can include fever, fatigue, weight loss, and swelling of the lymph nodes. Treatment for PBL typically involves a combination of chemotherapy, radiation therapy, and stem cell transplantation. The goal of treatment is to destroy the abnormal B-cells and prevent them from multiplying, while also preserving as much of the patient's healthy bone marrow as possible. The prognosis for PBL is generally good, with a high cure rate, although the specific outcome depends on various factors, including the age and overall health of the patient, the stage of the disease, and the response to treatment.

Adult stem cells are a type of stem cell that are found in various tissues and organs of the adult body. These cells have the ability to self-renew and differentiate into specialized cell types, such as muscle cells, nerve cells, or blood cells, depending on the signals they receive from their environment. There are several types of adult stem cells, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells. Hematopoietic stem cells are responsible for producing all types of blood cells, while mesenchymal stem cells can differentiate into a variety of cell types, including bone, cartilage, and fat cells. Neural stem cells can differentiate into neurons and glial cells, which support and protect neurons in the brain and spinal cord. Adult stem cells have potential therapeutic applications in regenerative medicine, as they can be used to repair or replace damaged or diseased tissues and organs. For example, mesenchymal stem cells have been used in clinical trials to treat a variety of conditions, including heart disease, diabetes, and spinal cord injuries. However, more research is needed to fully understand the potential of adult stem cells and to develop safe and effective treatments using these cells.

Vascular Endothelial Growth Factor A (VEGF-A) is a protein that plays a crucial role in the growth and development of blood vessels. It is produced by a variety of cells, including endothelial cells, fibroblasts, and smooth muscle cells, and is involved in a number of physiological processes, including wound healing, angiogenesis (the formation of new blood vessels), and tumor growth. VEGF-A binds to receptors on the surface of endothelial cells, triggering a signaling cascade that leads to the proliferation and migration of these cells, as well as the production of new blood vessels. This process is essential for the growth and development of tissues, but it can also contribute to the formation of tumors and other pathological conditions. In the medical field, VEGF-A is often targeted as a potential therapeutic agent for a variety of diseases, including cancer, cardiovascular disease, and eye disorders. Anti-VEGF-A therapies, such as monoclonal antibodies and small molecule inhibitors, are used to block the activity of VEGF-A and its receptors, thereby inhibiting angiogenesis and tumor growth.

Biomechanical phenomena refer to the study of the mechanical properties and behavior of living organisms, particularly in relation to movement and function. In the medical field, biomechanical phenomena are often studied in the context of musculoskeletal disorders, sports injuries, and rehabilitation. This involves analyzing the forces and movements involved in various activities, such as walking, running, or lifting, and how they affect the body's tissues and structures. Biomechanical engineers and researchers use a variety of techniques, including computer simulations, imaging technologies, and physical measurements, to study biomechanical phenomena and develop new treatments and interventions for a range of medical conditions.

Integrin-Binding Sialoprotein (IBSP) is a protein that plays a role in bone formation and remodeling. It is also known as osteoblast-specific factor 2 (OSF-2) or bone sialoprotein (BSP). IBSP is synthesized by osteoblasts, which are cells responsible for forming new bone tissue, and is secreted into the extracellular matrix where it binds to integrins, which are cell surface receptors that mediate cell adhesion and migration. IBSP has been shown to regulate bone mineralization, cell proliferation, and differentiation, and is involved in the formation of the dentin matrix in teeth. It is also expressed in other tissues, including the placenta, lung, and kidney, where it may play a role in tissue development and repair.

Leukemia, radiation-induced is a type of cancer that develops in the blood-forming cells of the bone marrow as a result of exposure to ionizing radiation. Ionizing radiation is a type of energy that has enough force to remove tightly bound electrons from atoms, causing them to become ionized. This type of radiation is commonly used in medical treatments such as radiation therapy for cancer, but it can also be caused by exposure to nuclear accidents, nuclear weapons, and certain types of medical imaging procedures. Radiation-induced leukemia typically develops several years after exposure to radiation, and the risk of developing the disease increases with the dose and duration of exposure. The most common type of radiation-induced leukemia is chronic lymphocytic leukemia (CLL), which is a type of cancer that affects the white blood cells called lymphocytes. Other types of radiation-induced leukemia include acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). Treatment for radiation-induced leukemia typically involves chemotherapy, which uses drugs to kill cancer cells, and sometimes radiation therapy to target the cancer cells. In some cases, a stem cell transplant may be necessary to replace the damaged bone marrow with healthy cells. The prognosis for radiation-induced leukemia depends on several factors, including the type and stage of the cancer, the patient's overall health, and the response to treatment.

Histiocytosis, Non-Langerhans-Cell (NLH) is a rare disorder characterized by the accumulation of abnormal histiocytes (a type of white blood cell) in various organs and tissues throughout the body. NLH can be classified into several subtypes, including Letterer-Siwe disease, Hand-Schüller-Christian disease, and eosinophilic granuloma complex. NLH can affect people of all ages, but it is most commonly diagnosed in children. The symptoms of NLH can vary depending on the affected organs and tissues, but they may include fever, fatigue, weight loss, and swelling in the lymph nodes, liver, spleen, or other organs. NLH is typically diagnosed through a combination of physical examination, blood tests, imaging studies, and biopsy of affected tissues. Treatment for NLH depends on the subtype and severity of the disease, but may include chemotherapy, radiation therapy, and surgery. In some cases, NLH may be managed with supportive care, such as pain relief and symptom management.

Interferon-gamma (IFN-γ) is a type of cytokine, which is a signaling molecule that plays a crucial role in the immune system. It is produced by various immune cells, including T cells, natural killer cells, and macrophages, in response to viral or bacterial infections, as well as in response to certain types of cancer. IFN-γ has a wide range of effects on the immune system, including the activation of macrophages and other immune cells, the inhibition of viral replication, and the promotion of T cell differentiation and proliferation. It also plays a role in the regulation of the immune response, helping to prevent excessive inflammation and tissue damage. In the medical field, IFN-γ is used as a therapeutic agent in the treatment of certain types of cancer, such as Hodgkin's lymphoma and multiple myeloma. It is also being studied as a potential treatment for other conditions, such as autoimmune diseases and viral infections.

Immunoglobulin G (IgG) is a type of protein that is produced by the immune system in response to the presence of foreign substances, such as bacteria, viruses, and toxins. It is the most abundant type of immunoglobulin in the blood and is responsible for the majority of the body's defense against infections. IgG is produced by B cells, which are a type of white blood cell that plays a key role in the immune response. When a B cell encounters a foreign substance, it produces IgG antibodies that can recognize and bind to the substance, marking it for destruction by other immune cells. IgG antibodies can also be transferred from mother to child through the placenta during pregnancy, providing the baby with some protection against infections during the first few months of life. In addition, some vaccines contain IgG antibodies to help stimulate the immune system and provide protection against specific diseases. Overall, IgG is an important component of the immune system and plays a critical role in protecting the body against infections and diseases.

Osteonecrosis is a medical condition characterized by the death of bone tissue due to a lack of blood supply to the bone. It can occur in any bone in the body, but it is most commonly seen in the femoral head (the ball-shaped portion of the hip joint) and the upper end of the tibia (the shinbone). Osteonecrosis can be caused by a variety of factors, including trauma, alcohol abuse, long-term use of corticosteroids, and certain medical conditions such as sickle cell disease and hypercoagulability disorders. The condition can also occur spontaneously, without an apparent cause. Symptoms of osteonecrosis may include pain in the affected bone, difficulty walking or bearing weight, and swelling or tenderness in the affected area. In some cases, osteonecrosis may be asymptomatic and only discovered through imaging tests such as X-rays or MRI. Treatment for osteonecrosis depends on the severity and location of the affected bone, as well as the underlying cause of the condition. Options may include medications to reduce pain and inflammation, physical therapy, and surgery to remove damaged bone or to fuse the joint. In some cases, a hip or knee replacement may be necessary.

Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences and controlling the transcription of genetic information from DNA to RNA. They play a crucial role in the development and function of cells and tissues in the body. In the medical field, transcription factors are often studied as potential targets for the treatment of diseases such as cancer, where their activity is often dysregulated. For example, some transcription factors are overexpressed in certain types of cancer cells, and inhibiting their activity may help to slow or stop the growth of these cells. Transcription factors are also important in the development of stem cells, which have the ability to differentiate into a wide variety of cell types. By understanding how transcription factors regulate gene expression in stem cells, researchers may be able to develop new therapies for diseases such as diabetes and heart disease. Overall, transcription factors are a critical component of gene regulation and have important implications for the development and treatment of many diseases.

CD11b is a type of protein found on the surface of certain immune cells, such as neutrophils and monocytes. It is a member of the integrin family of proteins, which are involved in cell adhesion and signaling. CD11b is also known as the alpha chain of the integrin receptor Mac-1 (Macrophage-1 antigen). Antigens, CD11b are molecules that bind to CD11b on the surface of immune cells. These antigens can be foreign substances, such as bacteria or viruses, or they can be self-molecules that have been altered in some way. When CD11b binds to an antigen, it triggers a series of signaling events that activate the immune cell and cause it to respond to the presence of the antigen. This response can include the production of inflammatory molecules, the recruitment of other immune cells to the site of the antigen, and the destruction of the antigen. CD11b and its antigens play an important role in the immune response and are the subject of ongoing research in the field of immunology.

Alendronate is a medication used to treat and prevent osteoporosis, a condition in which the bones become weak and brittle. It works by slowing down the process of bone breakdown and increasing bone density. Alendronate is typically taken orally in the form of a tablet or liquid, and is usually prescribed once a week. It is also used to treat Paget's disease of the bone, a condition in which the bone tissue is overactive and breaks down too quickly. Alendronate is generally well-tolerated, but can cause side effects such as heartburn, nausea, and difficulty swallowing.

CD8-positive T-lymphocytes, also known as cytotoxic T-cells, are a type of white blood cell that plays a crucial role in the immune system's response to infections and diseases. These cells are a subtype of T-lymphocytes, which are a type of immune cell that plays a central role in cell-mediated immunity. CD8-positive T-lymphocytes are characterized by the presence of a protein called CD8 on their surface, which helps them to recognize and bind to infected cells or cancer cells. Once bound, these cells release toxic substances that can kill the infected or cancerous cells. CD8-positive T-lymphocytes are an important part of the immune system's response to viral infections, such as HIV and herpes, and to some types of cancer. They are also involved in the immune response to bacterial infections and in the regulation of immune responses to prevent autoimmune diseases. In the medical field, CD8-positive T-lymphocytes are often studied as a way to understand the immune system's response to infections and diseases, and to develop new treatments for these conditions.

Antigens, Differentiation, B-Lymphocyte is a term used in the medical field to describe a specific type of antigen that is recognized by B-lymphocytes, a type of white blood cell that plays a key role in the immune system. B-lymphocytes are responsible for producing antibodies, which are proteins that recognize and bind to specific antigens, such as viruses, bacteria, and other foreign substances. Antigens, Differentiation, B-Lymphocyte are antigens that are specific to B-lymphocytes and are used to stimulate their differentiation and proliferation, leading to the production of antibodies. These antigens are often used in medical research and clinical practice to study the immune system and to develop vaccines and other treatments for infectious diseases. They are also used in diagnostic tests to detect the presence of B-lymphocytes or antibodies in the body, which can provide information about the immune system's response to a particular infection or disease.

Splenic neoplasms refer to tumors or growths that develop in the spleen, a vital organ in the immune system located in the upper left part of the abdomen. These neoplasms can be either benign (non-cancerous) or malignant (cancerous) in nature. Benign splenic neoplasms include hemangiomas, lymphangiomas, and fibromas, which are usually slow-growing and do not spread to other parts of the body. Malignant splenic neoplasms, on the other hand, are less common but can be more aggressive and potentially life-threatening. These include lymphomas, leukemias, and sarcomas. Symptoms of splenic neoplasms may include abdominal pain, swelling, fatigue, fever, and weight loss. Diagnosis typically involves imaging studies such as ultrasound, CT scan, or MRI, as well as biopsy to confirm the presence of a tumor. Treatment for splenic neoplasms depends on the type, size, and location of the tumor, as well as the patient's overall health. Options may include surgery, radiation therapy, chemotherapy, or targeted therapy. In some cases, a splenectomy (removal of the spleen) may be necessary to remove the tumor or alleviate symptoms.

Sialoglycoproteins are a type of glycoprotein that are found in the saliva of humans and other animals. They are composed of a protein core and one or more carbohydrate chains attached to the protein. Sialoglycoproteins play important roles in a variety of biological processes, including the lubrication and protection of the oral mucosa, the breakdown of food in the mouth, and the immune response. They are also involved in the development and progression of certain diseases, such as cancer and autoimmune disorders. In the medical field, sialoglycoproteins are often studied as potential biomarkers for these and other conditions.

Gaucher disease is a genetic disorder that affects the body's ability to break down and recycle a fatty substance called glucocerebroside. This leads to the accumulation of the substance in certain cells and organs, particularly in the liver, spleen, and bone marrow. There are three main types of Gaucher disease: type 1, type 2, and type 3. Type 1 is the most common and typically presents in childhood, while type 2 and type 3 are less common and may not appear until adulthood. Symptoms of Gaucher disease can include an enlarged liver and spleen, fatigue, bone pain, and an increased risk of infections. Treatment options for Gaucher disease include enzyme replacement therapy, substrate reduction therapy, and bone marrow transplantation.

Thalassemia is a genetic blood disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. There are two main types of thalassemia: alpha and beta. In alpha thalassemia, the body produces less alpha globin chains, which are necessary for the production of hemoglobin. This leads to anemia, fatigue, and other symptoms. In beta thalassemia, the body produces less beta globin chains, which also leads to anemia. However, beta thalassemia can also cause the red blood cells to become misshapen and break down more quickly, leading to jaundice, enlarged spleen, and other complications. Thalassemia is typically inherited from one or both parents and is more common in people of Mediterranean, Middle Eastern, Southeast Asian, and African descent. Treatment for thalassemia may include blood transfusions, iron chelation therapy to remove excess iron from the body, and bone marrow transplantation in severe cases.

DNA-binding proteins are a class of proteins that interact with DNA molecules to regulate gene expression. These proteins recognize specific DNA sequences and bind to them, thereby affecting the transcription of genes into messenger RNA (mRNA) and ultimately the production of proteins. DNA-binding proteins play a crucial role in many biological processes, including cell division, differentiation, and development. They can act as activators or repressors of gene expression, depending on the specific DNA sequence they bind to and the cellular context in which they are expressed. Examples of DNA-binding proteins include transcription factors, histones, and non-histone chromosomal proteins. Transcription factors are proteins that bind to specific DNA sequences and regulate the transcription of genes by recruiting RNA polymerase and other factors to the promoter region of a gene. Histones are proteins that package DNA into chromatin, and non-histone chromosomal proteins help to organize and regulate chromatin structure. DNA-binding proteins are important targets for drug discovery and development, as they play a central role in many diseases, including cancer, genetic disorders, and infectious diseases.

Autoimmune diseases are a group of disorders in which the immune system mistakenly attacks healthy cells and tissues in the body. In a healthy immune system, the body recognizes and attacks foreign substances, such as viruses and bacteria, to protect itself. However, in autoimmune diseases, the immune system becomes overactive and begins to attack the body's own cells and tissues. There are over 80 different types of autoimmune diseases, and they can affect various parts of the body, including the joints, skin, muscles, blood vessels, and organs such as the thyroid gland, pancreas, and liver. Some common examples of autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, and inflammatory bowel disease. The exact cause of autoimmune diseases is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Treatment for autoimmune diseases typically involves managing symptoms and reducing inflammation, and may include medications, lifestyle changes, and in some cases, surgery.

In the medical field, "arm bones" typically refers to the bones that make up the upper limb of the human body. These bones include the humerus, radius, and ulna, which are the three long bones of the arm. The humerus is the largest bone in the upper limb and is located in the upper arm. It articulates (joins) with the shoulder blade (scapula) at the shoulder joint and with the radius and ulna at the elbow joint. The radius and ulna are the two bones that make up the lower arm. The radius is located on the thumb side of the arm and articulates with the humerus at the elbow joint and with the carpal bones at the wrist joint. The ulna is located on the little finger side of the arm and articulates with the humerus at the elbow joint and with the carpal bones at the wrist joint. Together, the arm bones provide support and mobility to the upper limb, allowing us to perform a wide range of activities such as lifting, carrying, and throwing.

Beta-thalassemia is a genetic blood disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. In people with beta-thalassemia, the beta globin chain of hemoglobin is either not produced at all or is produced in reduced amounts, leading to a deficiency in the overall amount of hemoglobin in the blood. There are two main types of beta-thalassemia: beta-thalassemia major and beta-thalassemia intermedia. Beta-thalassemia major is a more severe form of the disorder, characterized by severe anemia, jaundice, and enlarged liver and spleen. People with beta-thalassemia major may require regular blood transfusions and iron chelation therapy to manage their symptoms. Beta-thalassemia intermedia is a less severe form of the disorder, characterized by milder anemia and fewer symptoms. However, people with beta-thalassemia intermedia may still require occasional blood transfusions and iron chelation therapy to manage their symptoms. Beta-thalassemia is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) to develop the disorder. It is most common in people of Mediterranean, Middle Eastern, Southeast Asian, and African descent.

In the medical field, bone screws are a type of orthopedic implant used to stabilize and secure bones during surgery. They are typically made of metal and are designed to be inserted into the bone to provide support and hold the bone in place while it heals. Bone screws are commonly used in orthopedic procedures such as fracture repair, joint replacement, and spinal surgery. They are usually inserted using a specialized surgical tool, and may be secured with a plate or other type of fixation device to provide additional stability. There are many different types of bone screws, including cortical screws, cancellous screws, and pedicle screws, which are used in different parts of the body and for different types of procedures. The specific type of bone screw used will depend on the location and severity of the injury or condition being treated, as well as the surgeon's preference and experience.

Radioisotopes are isotopes of an element that emit radiation, such as alpha particles, beta particles, or gamma rays. In the medical field, radioisotopes are used in a variety of diagnostic and therapeutic applications. In diagnostic imaging, radioisotopes are used to create images of the body's internal structures. For example, a radioisotope such as technetium-99m can be injected into the bloodstream and then detected by a gamma camera to create an image of the heart, lungs, or other organs. This type of imaging is commonly used to diagnose conditions such as cancer, heart disease, and bone disorders. Radioisotopes are also used in therapeutic applications, such as radiation therapy for cancer. In this treatment, a radioisotope is introduced into the body, usually by injection or inhalation, and then targeted to a specific area of the body where it emits radiation that destroys cancer cells. Radioisotopes are also used in targeted radionuclide therapy, where a radioisotope is attached to a molecule that specifically targets cancer cells, allowing for more precise delivery of radiation. Overall, radioisotopes play a critical role in medical imaging and therapy, allowing for the diagnosis and treatment of a wide range of conditions.

Interleukin-2 (IL-2) is a cytokine, a type of signaling molecule that plays a crucial role in the immune system. It is produced by activated T cells, a type of white blood cell that plays a central role in the body's defense against infection and disease. IL-2 has several important functions in the immune system. It promotes the growth and differentiation of T cells, which helps to increase the number of immune cells available to fight infection. It also stimulates the production of other cytokines, which can help to amplify the immune response. IL-2 is used in the treatment of certain types of cancer, such as melanoma and kidney cancer. It works by stimulating the immune system to attack cancer cells. It is typically given as an injection or infusion, and can cause side effects such as fever, chills, and flu-like symptoms. In addition to its use in cancer treatment, IL-2 has also been studied for its potential role in treating other conditions, such as autoimmune diseases and viral infections.

Keratins are a family of fibrous proteins that are primarily found in the epidermis and hair of mammals. They are responsible for providing strength and protection to the skin and hair, and are also involved in the formation of nails and claws. In the medical field, keratins are often studied in relation to various skin conditions, such as psoriasis, eczema, and skin cancer. They are also used as markers for the differentiation of various types of skin cells, and as a diagnostic tool for identifying different types of cancer. Keratins are also found in other tissues, such as the gastrointestinal tract, respiratory tract, and the eye. In these tissues, they play important roles in maintaining the integrity and function of the epithelial lining. Overall, keratins are an important component of the skin and other tissues, and their study is important for understanding the function and health of these tissues.

Articular cartilage is a type of connective tissue that covers the ends of bones in synovial joints, such as the knee, hip, and shoulder. It is a smooth, slippery tissue that provides a cushioning effect between the bones, allowing them to move smoothly and with minimal friction. Articular cartilage is composed of cells called chondrocytes, which produce and maintain the matrix of the tissue, as well as a network of collagen fibers that provide strength and support. The matrix of articular cartilage is rich in water and proteoglycans, which give it its characteristic smooth, slippery texture. Articular cartilage is essential for the proper functioning of synovial joints, as it helps to reduce friction and absorb shock during movement. However, it is also prone to damage and degeneration, which can lead to conditions such as osteoarthritis.

Chemotaxis is a process by which cells move in response to chemical gradients. In the medical field, chemotaxis is an important mechanism that cells use to migrate to specific locations in the body in response to chemical signals. For example, immune cells such as neutrophils and macrophages use chemotaxis to migrate to sites of infection or inflammation. In this way, chemotaxis plays a critical role in the body's immune response.

In the medical field, peptides are short chains of amino acids that are linked together by peptide bonds. They are typically composed of 2-50 amino acids and can be found in a variety of biological molecules, including hormones, neurotransmitters, and enzymes. Peptides play important roles in many physiological processes, including growth and development, immune function, and metabolism. They can also be used as therapeutic agents to treat a variety of medical conditions, such as diabetes, cancer, and cardiovascular disease. In the pharmaceutical industry, peptides are often synthesized using chemical methods and are used as drugs or as components of drugs. They can be administered orally, intravenously, or topically, depending on the specific peptide and the condition being treated.

NAD+ Nucleosidase is an enzyme that catalyzes the hydrolysis of NAD+ (nicotinamide adenine dinucleotide) to form nicotinamide and adenosine monophosphate (AMP). This enzyme is involved in the metabolism of NAD+ and plays a role in the regulation of cellular energy metabolism. In the medical field, NAD+ Nucleosidase has been studied in relation to various diseases, including cancer, neurodegenerative disorders, and viral infections. For example, changes in the activity of NAD+ Nucleosidase have been observed in certain types of cancer cells, and inhibitors of this enzyme have been shown to have potential as anti-cancer agents. Additionally, NAD+ Nucleosidase has been implicated in the pathogenesis of some viral infections, such as HIV and hepatitis B.

Cell transformation, neoplastic refers to the process by which normal cells in the body undergo genetic changes that cause them to become cancerous or malignant. This process involves the accumulation of mutations in genes that regulate cell growth, division, and death, leading to uncontrolled cell proliferation and the formation of tumors. Neoplastic transformation can occur in any type of cell in the body, and it can be caused by a variety of factors, including exposure to carcinogens, radiation, viruses, and inherited genetic mutations. Once a cell has undergone neoplastic transformation, it can continue to divide and grow uncontrollably, invading nearby tissues and spreading to other parts of the body through the bloodstream or lymphatic system. The diagnosis of neoplastic transformation typically involves a combination of clinical examination, imaging studies, and biopsy. Treatment options for neoplastic transformation depend on the type and stage of cancer, as well as the patient's overall health and preferences. Common treatments include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

Antigens, Differentiation, T-Lymphocyte refers to a group of proteins that are expressed on the surface of T-lymphocytes, a type of white blood cell that plays a central role in the immune system. These antigens are used by the immune system to distinguish between self and non-self cells, and to identify and target specific pathogens or foreign substances for destruction. The differentiation antigens on T-lymphocytes are proteins that are expressed during the development and maturation of these cells in the thymus gland. These antigens are important for the proper functioning of the immune system, as they allow T-lymphocytes to recognize and respond to specific antigens presented by other cells in the body. There are several different types of differentiation antigens on T-lymphocytes, including CD4 and CD8, which are markers for helper T-cells and cytotoxic T-cells, respectively. Other differentiation antigens include CD28, which is important for T-cell activation, and CD25, which is involved in the regulation of T-cell responses. Overall, the antigens, differentiation, and T-lymphocyte are important components of the immune system, and play a critical role in the body's ability to defend against infection and disease.

Oncogene proteins, fusion refers to the abnormal combination of two or more genes that results in the production of a new protein that is not normally present in the body. These fusion proteins are often associated with the development of cancer, as they can disrupt normal cellular processes and lead to uncontrolled cell growth and division. Fusion proteins can occur as a result of genetic mutations or chromosomal rearrangements, such as translocations or inversions. They can be detected through various diagnostic tests, including molecular genetic testing and immunohistochemistry. Examples of oncogene proteins, fusion include BCR-ABL1 in chronic myeloid leukemia, EML4-ALK in non-small cell lung cancer, and NPM-ALK in anaplastic large cell lymphoma. Targeted therapies that specifically inhibit the activity of these fusion proteins are often used in the treatment of these cancers.

CD3 is a protein complex that is found on the surface of T cells, a type of white blood cell that plays a central role in the immune system. CD3 is a component of the T cell receptor (TCR), which is responsible for recognizing and binding to specific antigens on the surface of other cells. Antigens, CD3 refers to antigens that are recognized by the CD3 component of the TCR. These antigens are typically proteins or other molecules that are present on the surface of cells, and they can be either self-antigens (present on the body's own cells) or foreign antigens (present on the cells of pathogens or other foreign substances). When a T cell encounters an antigen that is recognized by its CD3 receptor, it becomes activated and begins to divide and differentiate into various types of effector T cells, which can then mount an immune response against the pathogen or foreign substance.

In the medical field, aging refers to the natural process of physical, biological, and psychological changes that occur over time in living organisms, including humans. These changes can affect various aspects of an individual's health and well-being, including their metabolism, immune system, cardiovascular system, skeletal system, and cognitive function. Aging is a complex process that is influenced by a combination of genetic, environmental, and lifestyle factors. As people age, their bodies undergo a gradual decline in function, which can lead to the development of age-related diseases and conditions such as arthritis, osteoporosis, cardiovascular disease, diabetes, and dementia. In the medical field, aging is studied in the context of geriatrics, which is the branch of medicine that focuses on the health and well-being of older adults. Geriatricians work to identify and manage age-related health issues, promote healthy aging, and improve the quality of life for older adults.

Antineoplastic agents, alkylating are a class of chemotherapy drugs that work by damaging the DNA of cancer cells, which prevents them from dividing and growing. These drugs are called alkylating agents because they contain a group of atoms that can attach to DNA and alter its structure. Alkylating agents are often used to treat a variety of cancers, including leukemia, lymphoma, and ovarian cancer. They can be given by mouth, injection, or infusion, and they may be used alone or in combination with other cancer treatments. However, alkylating agents can also cause side effects, such as nausea, vomiting, hair loss, and an increased risk of infection.

Cyclosporins are a group of immunosuppressive drugs that are commonly used to prevent organ rejection in transplant patients. They work by inhibiting the activation of T-cells, which are a type of white blood cell that plays a key role in the immune response. Cyclosporins are also used to treat autoimmune diseases, such as rheumatoid arthritis and psoriasis, and to prevent rejection of bone marrow transplants. They are typically administered orally in the form of capsules or tablets.

Antigens, Differentiation, Myelomonocytic refers to a group of antigens that are expressed on the surface of myelomonocytic cells, which are a type of white blood cell that includes monocytes and macrophages. These antigens are used to identify and distinguish between different types of myelomonocytic cells and to study their development and function. They are also used in diagnostic tests to detect and monitor certain diseases and conditions, such as leukemia and other blood disorders.

Cell adhesion molecules (CAMs) are proteins that mediate the attachment of cells to each other or to the extracellular matrix. They play a crucial role in various physiological processes, including tissue development, wound healing, immune response, and cancer progression. There are several types of CAMs, including cadherins, integrins, selectins, and immunoglobulin superfamily members. Each type of CAM has a unique structure and function, and they can interact with other molecules to form complex networks that regulate cell behavior. In the medical field, CAMs are often studied as potential targets for therapeutic interventions. For example, drugs that block specific CAMs have been developed to treat cancer, autoimmune diseases, and cardiovascular disorders. Additionally, CAMs are used as diagnostic markers to identify and monitor various diseases, including cancer, inflammation, and neurodegenerative disorders.

In the medical field, "Animals, Newborn" typically refers to animals that are less than 28 days old. This age range is often used to describe the developmental stage of animals, particularly in the context of research or veterinary medicine. Newborn animals may require specialized care and attention, as they are often more vulnerable to illness and injury than older animals. They may also have unique nutritional and behavioral needs that must be addressed in order to promote their growth and development. In some cases, newborn animals may be used in medical research to study various biological processes, such as development, growth, and disease. However, the use of animals in research is highly regulated, and strict ethical guidelines must be followed to ensure the welfare and safety of the animals involved.

Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia (AML) that is characterized by the accumulation of abnormal white blood cells called promyelocytes in the bone marrow. These cells do not mature properly and are unable to function normally, leading to a deficiency in the production of healthy red blood cells, white blood cells, and platelets. APL is a rare but aggressive form of leukemia, and it is typically diagnosed in adults, although it can occur in children as well. The symptoms of APL can vary depending on the severity of the condition, but they may include fever, fatigue, weakness, easy bruising or bleeding, and shortness of breath. Treatment for APL typically involves chemotherapy and the use of a drug called all-trans retinoic acid (ATRA), which can help to induce the differentiation of the abnormal promyelocytes into healthy cells. In some cases, a stem cell transplant may also be necessary. With appropriate treatment, the prognosis for APL is generally good, with a high rate of remission and cure.

CD20 is a protein found on the surface of certain types of white blood cells, including B cells. Antigens, CD20 refers to molecules that bind specifically to the CD20 protein on the surface of these cells. These antigens can be used as targets for immunotherapy, which is a type of cancer treatment that uses the body's immune system to fight cancer cells. One example of a drug that targets CD20 is rituximab (Rituxan), which is used to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Osteitis is a medical term that refers to the inflammation of bone tissue. It can be caused by a variety of factors, including infection, injury, autoimmune disorders, and certain medications. Symptoms of osteitis may include pain, swelling, redness, and warmth around the affected bone. In some cases, osteitis can lead to the destruction of bone tissue and the development of bone deformities. Treatment for osteitis depends on the underlying cause and may include antibiotics, anti-inflammatory medications, physical therapy, and surgery.

Leukemia, Myelomonocytic, Chronic (M4) is a type of cancer that affects the bone marrow and blood cells. It is a type of myeloid leukemia, which means that it affects the myeloid stem cells that give rise to white blood cells, red blood cells, and platelets. In M4 leukemia, the bone marrow produces too many abnormal myelomonocytic cells, which are a type of white blood cell that is involved in fighting infections. These abnormal cells do not function properly and can build up in the bone marrow and bloodstream, crowding out healthy blood cells and making it difficult for the body to fight infections. Symptoms of M4 leukemia may include fatigue, weakness, fever, night sweats, and weight loss. Other symptoms may include easy bruising or bleeding, pale skin, shortness of breath, and an enlarged spleen or liver. Treatment for M4 leukemia typically involves chemotherapy, which uses drugs to kill the abnormal myelomonocytic cells. In some cases, a stem cell transplant may also be recommended, in which healthy blood-forming cells are transplanted into the patient to replace the abnormal cells. The prognosis for M4 leukemia depends on various factors, including the age and overall health of the patient, the stage of the disease, and the response to treatment.

Heterocyclic compounds are organic compounds that contain at least one ring composed of atoms other than carbon. In the medical field, heterocyclic compounds are often used as pharmaceuticals due to their ability to interact with biological targets and produce therapeutic effects. Examples of heterocyclic compounds used in medicine include: 1. Pyrimidines: These are a class of heterocyclic compounds that include thymine, cytosine, and uracil. They are important components of DNA and RNA and are used in the development of antiviral and anticancer drugs. 2. Purines: These are another class of heterocyclic compounds that include adenine and guanine. They are also important components of DNA and RNA and are used in the development of antiviral and anticancer drugs. 3. Imidazoles: These are heterocyclic compounds that contain a nitrogen atom and a carbon atom in a six-membered ring. They are used in the development of antifungal and anti-inflammatory drugs. 4. Quinolines: These are heterocyclic compounds that contain a nitrogen atom and two carbon atoms in a six-membered ring. They are used in the development of antimalarial and antituberculosis drugs. Overall, heterocyclic compounds play an important role in the development of new drugs and therapies in the medical field.

Prednisolone is a synthetic glucocorticoid hormone that is used in the medical field to treat a variety of conditions. It is a potent anti-inflammatory and immunosuppressive agent that is commonly used to treat inflammatory diseases such as rheumatoid arthritis, lupus, and psoriasis. It is also used to treat allergies, asthma, and other respiratory conditions, as well as to reduce swelling and inflammation in the body. In addition, prednisolone is used to treat certain types of cancer, such as lymphoma and leukemia, and to prevent rejection of transplanted organs. It is available in various forms, including tablets, injections, and eye drops, and is typically prescribed by a doctor or other healthcare professional.

Giant Cell Tumor of Bone (GCTB) is a benign, slow-growing tumor that affects the bones. It is also known as osteoclastoma, giant cell tumor, or giant cell reparative granuloma. The tumor is characterized by the presence of multinucleated giant cells, which are large cells with multiple nuclei. GCTB typically occurs in the long bones of the lower extremities, particularly the femur and tibia, but it can also occur in other bones such as the humerus, pelvis, and skull. The tumor is most commonly seen in young adults between the ages of 20 and 40, although it can occur in children and older adults as well. The exact cause of GCTB is not known, but it is believed to be related to abnormal bone growth and repair. The tumor usually presents as a painless mass that can cause swelling and tenderness in the affected bone. In some cases, the tumor can cause bone fractures or deformities. Treatment for GCTB typically involves surgical removal of the tumor, followed by radiation therapy to prevent recurrence. In some cases, the tumor may recur or become malignant, requiring more aggressive treatment such as chemotherapy or amputation.

Cytogenetic analysis is a type of medical test that examines the structure and number of chromosomes in a person's cells. It is used to diagnose and monitor a variety of genetic disorders, including Down syndrome, Turner syndrome, and Klinefelter syndrome. The test involves collecting a sample of cells from a person's blood, skin, or other tissues, and then examining them under a microscope to look for abnormalities in the chromosomes. Cytogenetic analysis can also be used to detect genetic changes that may be associated with an increased risk of certain types of cancer, such as leukemia and lymphoma.

Ischemia is a medical condition that occurs when there is a lack of blood flow to a particular part of the body. This can happen when the blood vessels that supply blood to the affected area become narrowed or blocked, either due to a physical obstruction or a decrease in blood pressure. Ischemia can affect any part of the body, but it is most commonly associated with the heart and brain. In the heart, ischemia can lead to a condition called angina, which is characterized by chest pain or discomfort. If the blood flow to the heart is completely blocked, it can result in a heart attack. In the brain, ischemia can cause a stroke, which can lead to permanent damage or even death if not treated promptly. Ischemia can also occur in other organs, such as the kidneys, limbs, and intestines, and can cause a range of symptoms depending on the affected area. Treatment for ischemia typically involves addressing the underlying cause of the blockage or narrowing of the blood vessels, such as through medication, surgery, or lifestyle changes.

Osteopontin (OPN) is a protein that is involved in various biological processes, including bone remodeling, inflammation, and cancer. In the medical field, OPN is often studied in relation to diseases such as osteoporosis, rheumatoid arthritis, and cancer. OPN is synthesized by a variety of cells, including osteoblasts (cells that form bone), osteoclasts (cells that break down bone), and immune cells such as macrophages and T cells. It is secreted into the extracellular matrix, where it can interact with other proteins and cells to regulate bone remodeling and inflammation. In osteoporosis, OPN is thought to play a role in bone loss by promoting osteoclast activity and inhibiting osteoblast activity. In rheumatoid arthritis, OPN is involved in the inflammatory response and may contribute to joint damage. In cancer, OPN is often upregulated in tumors and can promote tumor growth, invasion, and metastasis. Overall, OPN is a complex protein with multiple functions in the body, and its role in various diseases is an active area of research in the medical field.

Alkylating agents are a class of chemotherapy drugs that work by forming covalent bonds with DNA, which leads to the disruption of DNA replication and transcription, ultimately causing cell death. These drugs are commonly used to treat various types of cancer, including leukemia, lymphoma, and solid tumors such as breast, ovarian, and testicular cancer. Alkylating agents can be further classified into two categories: nitrogen mustards and alkyl sulfonates. Nitrogen mustards are the oldest and most widely used alkylating agents, while alkyl sulfonates are newer and have fewer side effects. The mechanism of action of alkylating agents involves the formation of alkyl radicals, which react with the DNA molecule to form covalent bonds. These bonds can cause DNA damage, including cross-linking of DNA strands, which can interfere with DNA replication and transcription. Alkylating agents can also cause damage to other cellular components, such as proteins and lipids. The use of alkylating agents in cancer treatment is associated with significant side effects, including nausea, vomiting, hair loss, and an increased risk of developing secondary cancers. However, the benefits of these drugs in treating cancer often outweigh the risks, and they remain an important part of the cancer treatment arsenal.

Monoclonal Gammopathy of Undetermined Significance (MGUS) is a condition characterized by the presence of an abnormal protein, called a monoclonal gammopathy, in the blood or urine. The protein is produced by a single clone of abnormal white blood cells, called plasma cells, in the bone marrow. MGUS is considered a premalignant condition, meaning that it has the potential to develop into a more serious disease, such as multiple myeloma or Waldenstrom's macroglobulinemia. However, most people with MGUS do not experience any symptoms and the condition is often discovered incidentally during a routine blood test. Treatment for MGUS is typically not necessary unless the protein levels become too high or the condition progresses to a more serious disease.

Thiotepa is a chemotherapy drug that is used to treat certain types of cancer, including ovarian cancer, breast cancer, and lung cancer. It works by interfering with the growth and division of cancer cells, which can slow down or stop the growth of tumors. Thiotepa is usually given intravenously (into a vein) or as a solution that is injected directly into the tumor. It can also be given orally (by mouth) in some cases. Thiotepa can cause side effects, including nausea, vomiting, hair loss, and a low white blood cell count. It is important to follow your doctor's instructions carefully when taking thiotepa, as it can be toxic if not used properly.

HLA-DR antigens are a group of proteins that are expressed on the surface of cells of the immune system. They play a crucial role in the recognition and presentation of antigens to T cells, which is a key step in the immune response. HLA-DR antigens are encoded by the HLA-DR gene, which is located on chromosome 6. There are many different HLA-DR antigens, each with a unique sequence of amino acids that determines its specificity for different antigens. HLA-DR antigens are also known as human leukocyte antigen (HLA) DR antigens or major histocompatibility complex (MHC) class II DR antigens.

Lipopolysaccharides (LPS) are a type of complex carbohydrate found on the surface of gram-negative bacteria. They are composed of a lipid A moiety, a core polysaccharide, and an O-specific polysaccharide. LPS are important components of the bacterial cell wall and play a role in the innate immune response of the host. In the medical field, LPS are often studied in the context of sepsis, a life-threatening condition that occurs when the body's response to an infection causes widespread inflammation. LPS can trigger a strong immune response in the host, leading to the release of pro-inflammatory cytokines and other mediators that can cause tissue damage and organ failure. As a result, LPS are often used as a model for studying the pathophysiology of sepsis and for developing new treatments for this condition. LPS are also used in research as a tool for studying the immune system and for developing vaccines against bacterial infections. They can be purified from bacterial cultures and used to stimulate immune cells in vitro or in animal models, allowing researchers to study the mechanisms of immune responses to bacterial pathogens. Additionally, LPS can be used as an adjuvant in vaccines to enhance the immune response to the vaccine antigen.

Etidronic acid is a medication that is used to treat and prevent osteoporosis, a condition in which the bones become weak and brittle. It works by increasing the amount of calcium in the bones and making them stronger. Etidronic acid is usually taken as a tablet or a liquid that is swallowed. It is usually taken once a day, with or without food. It is important to follow the instructions of your doctor or pharmacist when taking etidronic acid.

Lymphoma, T-cell is a type of cancer that affects the T-cells, which are a type of white blood cell that plays a crucial role in the immune system. T-cells are responsible for identifying and attacking foreign substances, such as viruses and bacteria, in the body. In T-cell lymphoma, the T-cells become abnormal and start to grow uncontrollably, forming tumors in the lymph nodes, spleen, and other parts of the body. There are several subtypes of T-cell lymphoma, including peripheral T-cell lymphoma,, and anaplastic large cell lymphoma. T-cell lymphoma can present with a variety of symptoms, including fever, night sweats, weight loss, fatigue, and swollen lymph nodes. Treatment options for T-cell lymphoma depend on the subtype and stage of the disease, and may include chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation.

Iron radioisotopes are radioactive isotopes of iron that are used in medical imaging and treatment. These isotopes are typically produced by bombarding iron targets with high-energy particles, such as protons or neutrons. The resulting radioisotopes have a short half-life, meaning that they decay quickly and emit radiation that can be detected by medical imaging equipment. Iron radioisotopes are used in a variety of medical applications, including: 1. Diagnostic imaging: Iron radioisotopes can be used to create images of the body's organs and tissues. For example, iron-59 is often used to study the liver and spleen, while iron-62 is used to study the bone marrow. 2. Radiation therapy: Iron radioisotopes can also be used to treat certain types of cancer. For example, iron-59 is used to treat liver cancer, while iron-62 is used to treat multiple myeloma. 3. Research: Iron radioisotopes are also used in research to study the metabolism and distribution of iron in the body. Overall, iron radioisotopes play an important role in the diagnosis and treatment of various medical conditions, and are a valuable tool in the field of nuclear medicine.

Lymphohistiocytosis, hemophagocytic (LCH) is a rare disorder characterized by the accumulation of abnormal immune cells called histiocytes and lymphocytes in various tissues of the body. These cells can cause inflammation and damage to organs such as the liver, spleen, bone marrow, and central nervous system. One of the hallmark features of LCH is the presence of hemophagocytosis, which is the consumption of normal blood cells by the abnormal immune cells. This can lead to anemia, low platelet counts, and other complications. LCH can occur in both children and adults, and its symptoms can vary widely depending on the affected organs and the severity of the disease. Some common symptoms include fever, fatigue, weight loss, and swollen lymph nodes. There are several different types of LCH, including Letterer-Siwe disease (LS), Hand-Schüller-Christian disease (HSC), and eosinophilic granuloma complex (EGC). Treatment for LCH typically involves a combination of medications, such as corticosteroids, chemotherapy, and targeted therapies, depending on the type and severity of the disease.

Neprilysin (also known as neutral endopeptidase or NEP) is an enzyme that is found in the body and is involved in the breakdown of certain peptides, which are chains of amino acids. These peptides include some that have a role in regulating blood pressure, and neprilysin helps to control the levels of these peptides in the body. In the medical field, neprilysin is sometimes used as a target for the development of drugs. For example, some drugs that are designed to lower blood pressure work by inhibiting neprilysin, which can help to increase the levels of certain peptides that help to relax blood vessels and lower blood pressure. Neprilysin inhibitors have been approved for the treatment of heart failure and have also been studied for the treatment of other conditions, such as Alzheimer's disease and depression.

In the medical field, "Antigens, CD8" refers to a group of proteins found on the surface of certain immune cells called CD8+ T cells, also known as cytotoxic T cells. These proteins, called major histocompatibility complex (MHC) class I molecules, bind to specific antigens (foreign substances) that have been processed and presented by antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells. When CD8+ T cells encounter an APC presenting an antigen that matches one of their CD8 receptors, they become activated and differentiate into effector cells that can directly kill infected or cancerous cells. This process is a key part of the immune response to infections and cancer. Antigens, CD8 are important targets for the development of vaccines and cancer immunotherapies, as they can stimulate the immune system to recognize and attack cancer cells or pathogens.

In the medical field, an amino acid sequence refers to the linear order of amino acids in a protein molecule. Proteins are made up of chains of amino acids, and the specific sequence of these amino acids determines the protein's structure and function. The amino acid sequence is determined by the genetic code, which is a set of rules that specifies how the sequence of nucleotides in DNA is translated into the sequence of amino acids in a protein. Each amino acid is represented by a three-letter code, and the sequence of these codes is the amino acid sequence of the protein. The amino acid sequence is important because it determines the protein's three-dimensional structure, which in turn determines its function. Small changes in the amino acid sequence can have significant effects on the protein's structure and function, and this can lead to diseases or disorders. For example, mutations in the amino acid sequence of a protein involved in blood clotting can lead to bleeding disorders.

Receptors, Granulocyte Colony-Stimulating Factor (G-CSF) are proteins found on the surface of certain cells in the body, including granulocytes (a type of white blood cell) and other immune cells. These receptors bind to the hormone G-CSF, which is produced by the body in response to infection or injury. When G-CSF binds to its receptors, it stimulates the production and maturation of granulocytes, which are important for fighting off infections and inflammation. G-CSF receptors are also used in medical treatments to stimulate the production of white blood cells in people with certain types of cancer or other conditions that can cause a decrease in white blood cell counts.

In the medical field, "culture techniques" refer to the methods used to grow and isolate microorganisms, such as bacteria, viruses, and fungi, from clinical samples. These techniques are essential for diagnosing infectious diseases and determining the most effective treatment options. Culture techniques typically involve collecting a sample from a patient, such as blood, urine, or sputum, and then transferring it to a nutrient-rich medium where the microorganisms can grow. The medium is incubated in a controlled environment, and the growth of the microorganisms is monitored over time. There are several types of culture techniques, including: 1. Direct microscopy: This technique involves examining a sample under a microscope to identify microorganisms without the need for culturing. 2. Culture on solid media: This technique involves growing microorganisms on a solid surface, such as agar, where they can be observed and identified. 3. Culture in liquid media: This technique involves growing microorganisms in a liquid medium, where they can be observed and identified using various techniques, such as spectrophotometry or enzyme assays. 4. Molecular techniques: This technique involves using DNA or RNA analysis to identify microorganisms without the need for culturing. Overall, culture techniques are a critical part of medical diagnosis and treatment, allowing healthcare providers to identify and treat infectious diseases effectively.

Immunoglobulin kappa-chains are a type of light chain that are found in antibodies, also known as immunoglobulins. They are one of two types of light chains that make up antibodies, the other being immunoglobulin lambda-chains. Immunoglobulin kappa-chains are encoded by the kappa light chain gene, which is located on chromosome 2. They are responsible for binding to specific antigens, or foreign substances, and are an important part of the immune system's defense against infection.

Neovascularization, pathologic, refers to the abnormal growth of new blood vessels in the body. This can occur in response to a variety of factors, including injury, inflammation, and certain diseases. In some cases, neovascularization can be a normal part of the healing process, but in other cases it can be a sign of a more serious underlying condition. Pathologic neovascularization is often associated with conditions such as cancer, diabetes, and age-related macular degeneration. It can also be seen in the development of certain types of tumors, where the new blood vessels help to provide the tumor with the nutrients and oxygen it needs to grow. Treatment for pathologic neovascularization may involve medications, laser therapy, or surgery, depending on the underlying cause and the severity of the condition.

Adoptive Transfer is a medical treatment that involves taking immune cells from a donor and introducing them into the recipient's body to boost their immune response against a specific disease or cancer. The immune cells, typically T cells, are collected from the donor's blood and then activated in a laboratory to enhance their ability to recognize and attack cancer cells or other pathogens. The activated immune cells are then infused back into the recipient's bloodstream, where they can migrate to the site of the disease and mount an immune response against it. Adoptive transfer has been used successfully to treat various types of cancer, including melanoma, leukemia, and lymphoma, and is an active area of research in the field of immunotherapy.

In the medical field, body weight refers to the total mass of an individual's body, typically measured in kilograms (kg) or pounds (lbs). It is an important indicator of overall health and can be used to assess a person's risk for certain health conditions, such as obesity, diabetes, and heart disease. Body weight is calculated by measuring the amount of mass that a person's body contains, which includes all of the organs, tissues, bones, and fluids. It is typically measured using a scale or other weighing device, and can be influenced by factors such as age, gender, genetics, and lifestyle. Body weight can be further categorized into different types, such as body mass index (BMI), which takes into account both a person's weight and height, and waist circumference, which measures the size of a person's waist. These measures can provide additional information about a person's overall health and risk for certain conditions.

Acute Monocytic Leukemia (AML) is a type of cancer that affects the bone marrow and blood cells. It is characterized by the rapid growth of abnormal white blood cells called monocytoid cells, which do not function properly and can build up in the blood and bone marrow, crowding out healthy blood cells. AML is a type of leukemia that is classified as acute because it progresses rapidly and requires prompt treatment. It is also classified as monocytic because the abnormal white blood cells are primarily monocytoid cells. Symptoms of AML may include fatigue, weakness, fever, night sweats, weight loss, and easy bruising or bleeding. Diagnosis is typically made through a combination of blood tests, bone marrow biopsy, and imaging studies. Treatment for AML typically involves chemotherapy, radiation therapy, and/or stem cell transplantation. The goal of treatment is to destroy the abnormal white blood cells and restore normal blood cell production. The prognosis for AML depends on various factors, including the age and overall health of the patient, the type and stage of the disease, and the response to treatment.

Proteins are complex biomolecules made up of amino acids that play a crucial role in many biological processes in the human body. In the medical field, proteins are studied extensively as they are involved in a wide range of functions, including: 1. Enzymes: Proteins that catalyze chemical reactions in the body, such as digestion, metabolism, and energy production. 2. Hormones: Proteins that regulate various bodily functions, such as growth, development, and reproduction. 3. Antibodies: Proteins that help the immune system recognize and neutralize foreign substances, such as viruses and bacteria. 4. Transport proteins: Proteins that facilitate the movement of molecules across cell membranes, such as oxygen and nutrients. 5. Structural proteins: Proteins that provide support and shape to cells and tissues, such as collagen and elastin. Protein abnormalities can lead to various medical conditions, such as genetic disorders, autoimmune diseases, and cancer. Therefore, understanding the structure and function of proteins is essential for developing effective treatments and therapies for these conditions.

Integrin alpha4 is a protein that plays a crucial role in the immune system and is involved in the adhesion of immune cells to the blood vessels and tissues. It is a member of the integrin family of proteins, which are transmembrane receptors that mediate cell-cell and cell-extracellular matrix interactions. In the medical field, integrin alpha4 is often studied in the context of autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis, where it is thought to play a role in the migration of immune cells into the central nervous system and the joints, respectively. It is also involved in the development and function of various immune cells, including T cells, B cells, and dendritic cells. Integrin alpha4 is also a target for therapeutic intervention in certain diseases. For example, monoclonal antibodies that block the interaction between integrin alpha4 and its ligand, VCAM-1, have been developed for the treatment of multiple sclerosis and other autoimmune diseases.

Radiation injuries refer to damage to living tissue caused by exposure to ionizing radiation. Ionizing radiation is a type of energy that has enough energy to remove tightly bound electrons from atoms, creating ions. This can cause damage to cells and tissues, leading to a range of symptoms and health problems. Radiation injuries can occur from a variety of sources, including medical procedures such as radiation therapy, nuclear accidents, and exposure to radioactive materials. The severity of radiation injuries depends on the dose of radiation received, the duration of exposure, and the type of tissue affected. Symptoms of radiation injuries can include skin burns, hair loss, nausea, vomiting, diarrhea, fatigue, and an increased risk of developing cancer. In severe cases, radiation injuries can be life-threatening and may require medical intervention, such as surgery or supportive care. Treatment for radiation injuries depends on the severity of the injury and the underlying cause. In some cases, treatment may involve medications to manage symptoms, wound care, and physical therapy. In more severe cases, surgery may be necessary to remove damaged tissue or repair injuries.

In the medical field, minerals are essential nutrients that are required for the proper functioning of the body. They are typically obtained through the diet and are necessary for a wide range of bodily processes, including building and maintaining bones, muscles, and other tissues, transmitting nerve impulses, and regulating fluid balance. There are many different minerals that are important for human health, including calcium, phosphorus, magnesium, potassium, sodium, chloride, iron, zinc, copper, selenium, and iodine. Each of these minerals has specific functions within the body and is required in different amounts depending on age, sex, and overall health. Deficiencies in certain minerals can lead to a range of health problems, including osteoporosis, anemia, and heart disease. On the other hand, excessive intake of certain minerals can also be harmful and can lead to toxicity or other health issues. Therefore, it is important to maintain a balanced diet that provides adequate amounts of all essential minerals.

Leishmaniasis, visceral is a serious and potentially life-threatening infection caused by the protozoan parasite Leishmania donovani. It is also known as kala-azar, which is a term that originated in India and means "black fever" due to the characteristic black spots that can appear on the skin of infected individuals. Visceral leishmaniasis primarily affects the internal organs, particularly the liver, spleen, and bone marrow. The disease is transmitted to humans through the bite of infected sandflies, which are found in many parts of the world, including Africa, Asia, and South America. Symptoms of visceral leishmaniasis can include fever, fatigue, weight loss, anemia, and enlargement of the liver and spleen. In severe cases, the disease can lead to organ failure and death if left untreated. Treatment for visceral leishmaniasis typically involves a combination of antimonial drugs and amphotericin B. Prevention measures include the use of insect repellent, bed nets, and indoor residual spraying to reduce sandfly populations, as well as public education about the risks of the disease and how to avoid it.

Hemoglobins are a group of proteins found in red blood cells (erythrocytes) that are responsible for carrying oxygen from the lungs to the body's tissues and carbon dioxide from the tissues back to the lungs. Hemoglobin is composed of four subunits, each of which contains a heme group that binds to oxygen. The oxygen binds to the iron atom in the heme group, allowing the hemoglobin to transport oxygen throughout the body. Hemoglobin also plays a role in regulating the pH of the blood and in the immune response. Abnormalities in hemoglobin can lead to various medical conditions, such as anemia, sickle cell disease, and thalassemia.

Podophyllotoxin is a naturally occurring compound found in several plants, including the Mayapple (Podophyllum peltatum) and the Blueberry Bush (Vaccinium myrtillus). It has been used in the medical field as an anti-cancer agent, particularly in the treatment of leukemias and lymphomas. Podophyllotoxin works by inhibiting the activity of topoisomerase II, an enzyme involved in DNA replication and transcription. This inhibition leads to the accumulation of double-stranded DNA breaks, which can trigger cell death. Podophyllotoxin is often used in combination with other chemotherapy drugs to enhance their effectiveness. It can also be used topically to treat warts and other skin conditions. However, it can cause side effects such as nausea, vomiting, and hair loss, and may also increase the risk of developing secondary cancers.

Chondrocytes are specialized cells found in the cartilage tissue of the body. They are responsible for producing and maintaining the extracellular matrix of cartilage, which provides support and cushioning to joints and other structures. Chondrocytes are found in the center of cartilage structures, surrounded by a matrix of collagen fibers and proteoglycans. They are typically smaller and more numerous in areas of the cartilage that are subjected to greater stress, such as the ends of long bones. In the medical field, chondrocytes are often studied in the context of cartilage repair and regeneration, as they have the ability to divide and produce new cartilage tissue.

CD44 is a cell surface glycoprotein that is expressed on many different types of cells, including immune cells, epithelial cells, and cancer cells. It is a member of the immunoglobulin superfamily of cell adhesion molecules and plays a role in cell-cell interactions, cell migration, and signaling. In the context of the immune system, CD44 is a receptor for hyaluronic acid, a large glycosaminoglycan that is found in the extracellular matrix. CD44 is expressed on the surface of many immune cells, including T cells, B cells, and macrophages, and is involved in the adhesion and migration of these cells to sites of inflammation or infection. CD44 is also expressed on many types of cancer cells, where it can play a role in tumor growth, invasion, and metastasis. In some cases, CD44 can be used as a marker to identify and target cancer cells for therapy.

Cytomegalovirus (CMV) is a common virus that belongs to the herpesvirus family. It is a large, enveloped virus that can infect a wide range of hosts, including humans, animals, and birds. In humans, CMV is usually asymptomatic or causes mild flu-like symptoms in healthy individuals. However, it can cause serious complications in immunocompromised individuals, such as those with HIV/AIDS, organ transplant recipients, and pregnant women. CMV can infect various organs and tissues in the body, including the liver, spleen, lungs, and central nervous system. It can also cause congenital CMV infection, which occurs when a pregnant woman is infected with CMV and passes the virus to her fetus. Congenital CMV infection can lead to hearing loss, vision problems, and developmental delays in the affected child. In addition to its impact on human health, CMV is also an important model organism for studying herpesvirus biology and pathogenesis.

The complement system is a complex network of proteins that plays a crucial role in the immune system's defense against infections. Complement system proteins are a group of proteins that are produced by the liver and other cells in the body and circulate in the blood. These proteins work together to identify and destroy invading pathogens, such as bacteria and viruses, by forming a membrane attack complex (MAC) that punctures the pathogen's cell membrane, causing it to burst and die. There are several different types of complement system proteins, including: 1. Complement proteins: These are the primary components of the complement system and include C1, C2, C3, C4, C5, C6, C7, C8, and C9. 2. Complement regulatory proteins: These proteins help to control the activation of the complement system and prevent it from attacking healthy cells. Examples include C1 inhibitor, C4 binding protein, and decay-accelerating factor. 3. Complement receptors: These proteins are found on the surface of immune cells and help to bind to and activate complement proteins. Examples include CR1, CR2, and CR3. Complement system proteins play a critical role in the immune response and are involved in a wide range of diseases, including autoimmune disorders, infections, and cancer.

Deoxyuridine (dU) is a nucleoside that is a component of DNA. It is formed by the removal of a hydroxyl group from thymidine, another nucleoside found in DNA. Deoxyuridine is not found in RNA, which is the other type of nucleic acid found in cells. In the medical field, deoxyuridine is sometimes used as a medication. For example, it has been used to treat certain types of cancer, such as breast cancer and non-Hodgkin's lymphoma. It works by inhibiting the synthesis of DNA, which can slow the growth of cancer cells. Deoxyuridine is also used as a diagnostic tool in the laboratory. It can be incorporated into DNA during replication, and then detected using techniques such as PCR (polymerase chain reaction) or sequencing. This can be useful for studying the function and regulation of genes, as well as for identifying genetic mutations that may be associated with disease.

Histocompatibility antigens class II are a group of proteins found on the surface of certain cells in the immune system. These proteins play a crucial role in the immune response by presenting foreign substances, such as bacteria or viruses, to immune cells called T cells. The class II antigens are encoded by a group of genes called the major histocompatibility complex (MHC) class II genes. These genes are located on chromosome 6 in humans and are highly polymorphic, meaning that there are many different versions of the genes. This diversity of MHC class II antigens allows the immune system to recognize and respond to a wide variety of foreign substances.

A leukemoid reaction is a condition in which the bone marrow produces an abnormally high number of white blood cells, similar to the way that leukemia does. This can be caused by a variety of factors, including infections, inflammation, and certain medications. A leukemoid reaction is usually a temporary condition and can resolve on its own, but in some cases it may be a sign of a more serious underlying condition. It is important to note that a leukemoid reaction is not the same as leukemia, which is a type of cancer that affects the bone marrow and blood cells.

Methylprednisolone is a synthetic glucocorticoid hormone that is used in the medical field to treat a variety of conditions. It is a potent anti-inflammatory and immunosuppressive agent that is commonly used to reduce inflammation and swelling, as well as to suppress the immune system. Methylprednisolone is often prescribed to treat conditions such as asthma, allergies, autoimmune disorders, and inflammatory diseases such as rheumatoid arthritis and lupus. It is also used to treat severe allergic reactions, as well as to reduce inflammation and swelling after surgery. Methylprednisolone is available in various forms, including tablets, injections, and inhalers, and is typically administered orally or by injection.

In the medical field, cell shape refers to the three-dimensional structure of a cell, including its size, shape, and overall configuration. The shape of a cell can vary depending on its function and the environment in which it exists. For example, red blood cells are disc-shaped to maximize their surface area for oxygen exchange, while nerve cells have long, branching extensions called dendrites and axons to facilitate communication with other cells. Changes in cell shape can be indicative of disease or abnormal cell function, and are often studied in the context of cancer, inflammation, and other medical conditions.

Anemia, Megaloblastic is a type of anemia characterized by the presence of abnormally large and immature red blood cells (megaloblasts) in the bone marrow. This type of anemia is caused by a deficiency of vitamin B12 or folate, which are essential nutrients for the production of healthy red blood cells. Symptoms of megaloblastic anemia may include fatigue, weakness, pale skin, shortness of breath, and an enlarged spleen. Treatment typically involves supplementing the body with vitamin B12 or folate, either through diet or medication.

Immunoglobulin lambda-chains are a type of light chain found in some immunoglobulins (antibodies) produced by B cells. They are composed of two identical polypeptide chains, each containing about 210 amino acids, and are encoded by the IGL gene locus on chromosome 22. Immunoglobulin lambda-chains are typically associated with the lambda isotype of immunoglobulins, which are a subset of antibodies that have a lambda light chain paired with a heavy chain. These antibodies are produced by a subset of B cells called lambda B cells, and they are involved in the immune response to certain types of pathogens, such as viruses and bacteria. Immunoglobulin lambda-chains are important for the function of lambda immunoglobulins, as they play a role in the binding of antigens and the activation of immune cells. Mutations in the IGL gene locus can lead to the production of abnormal lambda immunoglobulins, which can cause a variety of immune disorders, such as agammaglobulinemia, hypogammaglobulinemia, and autoimmune diseases.

Acute Megakaryoblastic Leukemia (AMKL) is a type of cancer that affects the bone marrow and blood cells. It is a rare and aggressive form of leukemia that affects the cells that produce platelets, which are essential for blood clotting. AMKL is typically seen in children, but it can also occur in adults. The symptoms of AMKL include fatigue, fever, weight loss, and easy bruising or bleeding. Treatment for AMKL typically involves chemotherapy and sometimes a stem cell transplant.

In the medical field, carrier proteins are proteins that transport molecules across cell membranes or within cells. These proteins bind to specific molecules, such as hormones, nutrients, or waste products, and facilitate their movement across the membrane or within the cell. Carrier proteins play a crucial role in maintaining the proper balance of molecules within cells and between cells. They are involved in a wide range of physiological processes, including nutrient absorption, hormone regulation, and waste elimination. There are several types of carrier proteins, including facilitated diffusion carriers, active transport carriers, and ion channels. Each type of carrier protein has a specific function and mechanism of action. Understanding the role of carrier proteins in the body is important for diagnosing and treating various medical conditions, such as genetic disorders, metabolic disorders, and neurological disorders.

Syndecan-1 is a type of cell surface proteoglycan that plays a role in cell adhesion, migration, and signaling. It is expressed on the surface of many different types of cells, including epithelial cells, endothelial cells, and fibroblasts. Syndecan-1 is composed of a core protein and a number of covalently attached glycosaminoglycan chains, which give it a complex and dynamic structure. In the medical field, syndecan-1 is of interest because it is involved in a number of different diseases and conditions, including cancer, cardiovascular disease, and inflammatory disorders. It is also being studied as a potential therapeutic target for the treatment of these conditions.

Bone Morphogenetic Protein 3 (BMP3) is a protein that plays a crucial role in the development and maintenance of bone tissue in the human body. It is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, which are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. BMP3 is primarily expressed in bone-forming cells, such as osteoblasts, and is involved in the regulation of bone formation and remodeling. It has been shown to stimulate the differentiation of osteoblasts from precursor cells, promote bone matrix mineralization, and regulate the activity of other bone-related proteins. In addition to its role in bone tissue, BMP3 has also been implicated in the development of other tissues, including cartilage, muscle, and fat. It has been shown to play a role in the regulation of cell proliferation, differentiation, and migration in these tissues as well. BMP3 is also involved in a number of physiological processes, including wound healing, angiogenesis, and the regulation of the immune system. It has been shown to play a role in the development of various diseases, including osteoporosis, osteoarthritis, and certain types of cancer. Overall, BMP3 is a critical protein in the regulation of bone and other tissue development and function, and its dysregulation has been implicated in a number of diseases and conditions.

CD7 is a protein that is found on the surface of certain types of immune cells, including T cells and natural killer cells. It is a member of the immunoglobulin superfamily of proteins and plays a role in the development and function of these immune cells. Antigens, CD7 are molecules that bind to the CD7 protein on the surface of immune cells. These antigens can be found on the surface of viruses, bacteria, and other pathogens, as well as on cancer cells and other abnormal cells in the body. When an immune cell recognizes an antigen, it can become activated and begin to attack the cell that is displaying the antigen. In the medical field, CD7 antigens are often used as targets for immunotherapy, which is a type of treatment that uses the body's own immune system to fight cancer and other diseases. By targeting CD7 antigens, immunotherapy drugs can help to activate and enhance the immune response against cancer cells or other abnormal cells in the body.

Thymidine is a nucleoside that is a building block of DNA and RNA. It is composed of a deoxyribose sugar molecule and a thymine base. Thymidine is an essential component of DNA and is involved in the replication and transcription of genetic material. It is also a precursor to the synthesis of thymine triphosphate (dTTP), which is a nucleotide used in DNA and RNA synthesis. In the medical field, thymidine is used as a diagnostic tool to detect and measure the activity of certain enzymes involved in DNA synthesis, and it is also used as a component of certain antiviral drugs.

Osteoarthritis, also known as degenerative joint disease, is a common condition that affects the knee joint. It is a type of arthritis that occurs when the cartilage that cushions the ends of bones in the joint breaks down, leading to inflammation, pain, and stiffness. Over time, the bones may rub against each other, causing damage to the joint and reducing its ability to move freely. Osteoarthritis of the knee is a common cause of knee pain and disability, particularly in older adults. It can affect one or both knees and can be caused by a variety of factors, including age, injury, and genetics. Treatment options for osteoarthritis of the knee may include medications, physical therapy, and in severe cases, surgery.

Hypergammaglobulinemia is a medical condition characterized by an abnormally high level of gamma globulins, a type of protein found in the blood. Gamma globulins are a component of the immune system and are produced by specialized white blood cells called plasma cells. Hypergammaglobulinemia can be caused by a variety of factors, including infections, autoimmune disorders, certain types of cancer, and genetic disorders. In some cases, the cause of hypergammaglobulinemia may not be identified. Symptoms of hypergammaglobulinemia may include fatigue, weakness, joint pain, and swelling. In some cases, hypergammaglobulinemia may be asymptomatic and be discovered through routine blood tests. Treatment for hypergammaglobulinemia depends on the underlying cause. In some cases, no treatment may be necessary if the condition is asymptomatic. However, if hypergammaglobulinemia is caused by an underlying condition, such as an infection or autoimmune disorder, treatment for that condition may be necessary. In some cases, medications may be used to lower the level of gamma globulins in the blood.

Analysis of Variance (ANOVA) is a statistical method used to compare the means of three or more groups. In the medical field, ANOVA can be used to compare the effectiveness of different treatments, interventions, or medications on a particular outcome or variable of interest. For example, a researcher may want to compare the effectiveness of three different medications for treating a particular disease. They could use ANOVA to compare the mean response (e.g., improvement in symptoms) between the three groups of patients who received each medication. If the results show a significant difference between the groups, it would suggest that one medication is more effective than the others. ANOVA can also be used to compare the means of different groups of patients based on a categorical variable, such as age, gender, or race. For example, a researcher may want to compare the mean blood pressure of patients in different age groups. They could use ANOVA to compare the mean blood pressure between the different age groups and determine if there are significant differences. Overall, ANOVA is a powerful statistical tool that can be used to compare the means of different groups in the medical field, helping researchers to identify which treatments or interventions are most effective and to better understand the factors that influence health outcomes.

A bony callus is a hard, dense mass of bone tissue that forms on the surface of a bone in response to injury or healing. It is a natural process that occurs when the bone is broken or damaged, and new bone tissue is laid down to repair the injury. The bony callus helps to stabilize the bone and prevent further damage, and it eventually fades away as the bone heals completely. Bony calluses can also form on the ends of long bones, such as the femur or tibia, in response to repetitive stress or overuse. They are typically asymptomatic and do not require treatment unless they cause pain or interfere with normal function.

CD31 is a protein that is expressed on the surface of certain cells in the immune system, including platelets and certain types of white blood cells. It is also known as platelet endothelial cell adhesion molecule-1 (PECAM-1) or cluster of differentiation 31 (CD31). In the medical field, CD31 is often used as a marker to identify and study certain types of cells, particularly those involved in the immune response. It is also used as a diagnostic tool to help diagnose and monitor certain medical conditions, such as cancer and cardiovascular disease. CD31 is also used in research to study the function of immune cells and to develop new treatments for various diseases. For example, it has been shown to play a role in the formation of new blood vessels, which is important for wound healing and tissue repair. It is also involved in the regulation of the immune response and the development of certain types of cancer.

Recombinant fusion proteins are proteins that are produced by combining two or more genes in a single molecule. These proteins are typically created using genetic engineering techniques, such as recombinant DNA technology, to insert one or more genes into a host organism, such as bacteria or yeast, which then produces the fusion protein. Fusion proteins are often used in medical research and drug development because they can have unique properties that are not present in the individual proteins that make up the fusion. For example, a fusion protein might be designed to have increased stability, improved solubility, or enhanced targeting to specific cells or tissues. Recombinant fusion proteins have a wide range of applications in medicine, including as therapeutic agents, diagnostic tools, and research reagents. Some examples of recombinant fusion proteins used in medicine include antibodies, growth factors, and cytokines.

Bromodeoxyuridine (BrdU) is a synthetic analog of the nucleoside thymidine, which is a building block of DNA. It is commonly used in the medical field as a marker for DNA synthesis and cell proliferation. BrdU is incorporated into newly synthesized DNA during the S phase of the cell cycle, when DNA replication occurs. This makes it possible to detect cells that are actively dividing by staining for BrdU. BrdU staining is often used in immunohistochemistry and flow cytometry to study the proliferation of cells in various tissues and organs, including the brain, bone marrow, and skin. BrdU is also used in some cancer treatments, such as chemotherapy and radiation therapy, to target rapidly dividing cancer cells. By inhibiting DNA synthesis, BrdU can slow down or stop the growth of cancer cells, making them more susceptible to treatment. However, it is important to note that BrdU can also cause DNA damage and has been associated with an increased risk of cancer in some studies. Therefore, its use in medical research and treatment should be carefully monitored and regulated.

Infectious bone diseases are conditions that affect the bones and are caused by infections. These infections can be caused by bacteria, viruses, fungi, or other microorganisms. The most common types of infectious bone diseases include osteomyelitis, which is an infection of the bone and bone marrow, and septic arthritis, which is an infection of the joint. Other types of infectious bone diseases include osteonecrosis, which is a condition in which the bone tissue dies, and osteoradionecrosis, which is a condition that occurs in people who have had radiation therapy to the head or neck. These diseases can be serious and may require prompt medical treatment to prevent complications.

Eosinophilia is a medical condition characterized by an increase in the number of eosinophils, a type of white blood cell, in the blood. Eosinophils are a type of granulocyte, which are immune cells that play a role in fighting off infections and parasites. Eosinophilia can be caused by a variety of factors, including allergies, parasitic infections, autoimmune disorders, and certain types of cancer. It can also be a side effect of certain medications, such as corticosteroids and some chemotherapy drugs. Eosinophilia can be classified as either absolute eosinophilia, which is an increase in the number of eosinophils in the blood regardless of the total number of white blood cells, or relative eosinophilia, which is an increase in the proportion of eosinophils to other types of white blood cells. Eosinophilia can be a sign of an underlying medical condition, and it is important to identify and treat the underlying cause in order to manage the symptoms and prevent complications. Treatment may involve medications to reduce inflammation or to target the underlying cause of the eosinophilia, as well as supportive care to manage symptoms.

Lectins are a class of proteins that are found in many plants, animals, and microorganisms. They are characterized by their ability to bind to specific carbohydrates, such as sugars and starches, on the surface of cells. In the medical field, lectins have been studied for their potential therapeutic applications. For example, some lectins have been shown to have antiviral, antibacterial, and antifungal properties, and may be useful in the development of new drugs to treat infections. Lectins have also been used as research tools to study cell-cell interactions and to identify specific cell surface markers. In addition, some lectins have been used in diagnostic tests to detect specific diseases or conditions, such as cancer or diabetes. However, it is important to note that not all lectins are safe or effective for medical use, and some may even be toxic. Therefore, the use of lectins in medicine requires careful consideration and testing to ensure their safety and efficacy.

... examination is the pathologic analysis of samples of bone marrow obtained via biopsy and bone marrow aspiration. ... Bone marrow transplants can be conducted to treat severe diseases of the bone marrow, including certain forms of cancer such as ... In adult humans, bone marrow is primarily located in the ribs, vertebrae, sternum, and bones of the pelvis. Bone marrow ... Several types of stem cells are related to bone marrow. Hematopoietic stem cells in the bone marrow can give rise to ...
... or marrow spoon), often of silver and with a long, thin bowl, as a table implement for removing marrow from a bone. Bone marrow ... with the marrow still inside the bone. Beef marrow bones are often included in the French pot-au-feu broth, the cooked marrow ... one of the most preferred being smoked bone marrow.[citation needed] Many cultures have used bone marrow as food throughout ... Humans widely use the bone marrow of animals as food. It consists of yellow marrow contained in long bones. There is also red ...
... in both children and adults can be either inherited or acquired. Inherited bone marrow failure is often the ... A maturation defect in genes is a common cause of inherited bone marrow failure. The most common cause of acquired bone marrow ... "Bone Marrow Failure In Children". Thomson Reuters (2011): 1-5. Retrieved 7 Nov 2011. Besa, Emmanuel C. "Bone Marrow Failure". ... One in ten individuals with bone marrow failure have unsuspected Fanconi anemia (FA). FA is the most common inherited bone ...
... refers to the pathologic analysis of samples of bone marrow obtained by bone marrow biopsy (often ... Sometimes, a bone marrow examination will include both an aspirate and a biopsy. The aspirate yields semi-liquid bone marrow, ... 2020). "Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors". Ann Hematol. ... Bone Marrow Aspiration and Biopsy". Article last updated April 7, 2008. What to Expect During a Bone Marrow Aspirate and Biopsy ...
Because the bone marrow is the manufacturing center of blood cells, the suppression of bone marrow activity causes a deficiency ... leading to chronic anemia with B19 viremia due to chronic marrow suppression. Bone marrow suppression due to azathioprine can ... Bone marrow suppression due to anti-cancer chemotherapy is much harder to treat and often involves hospital admission, strict ... Bone marrow suppression also known as myelotoxicity or myelosuppression, is the decrease in production of cells responsible for ...
Bone Marrow Transplantation is a peer-reviewed medical journal covering transplantation of bone marrow in humans. It is ... According to the Journal Citation Reports, Bone Marrow Transplantation has a 2020 impact factor of 5.483. Bone Marrow ... "Bone Marrow Transplantation". 2020 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021. Official ...
... is a condition which may be found in the body of the mandible. It is usually painless and found ... It is a localized increase of hematopoietic bone marrow that creates a radiolucent radiographic defect. They occur more ...
"A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells". PLOS ONE. 5 (12): ... Undifferentiated bone marrow cells are cultured in the presence of macrophage colony-stimulating factor (M-CSF; CSF-1). M-CSF ... Bone-marrow-derived macrophage (BMDM) refers to macrophage cells that are generated in a research laboratory from mammalian ... Since BMDMs are derived from bone marrow, withdrawn cells are healthy and naïve (or unactivated), regardless of the condition ...
"New insights into bone marrow adipocytes: Report from the First European Meeting on Bone Marrow Adiposity (BMA 2015)". Bone. 93 ... Bone marrow adipose tissue (BMAT), sometimes referred to as marrow adipose tissue (MAT), is a type of fat deposit in bone ... "Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise". Bone. 64: 39-46. doi:10.1016/j.bone. ... and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow ...
Allmusic - Marrow of a Bone Sputnikmusic "Dir En Grey - The Marrow of a Bone" Metalsucks "DIR EN GREY "THE MARROW OF A BONE" ... "Dir En Grey - The Marrow of a Bone Review". About.com. "Marrow of a Bone - Dir en Grey". Allmusic. "The Marrow of a Bone - DIR ... The Marrow of a Bone (stylized THE MARROW OF A BONE) is the sixth studio album by Japanese heavy metal band Dir En Grey. It was ... The Marrow of a Bone liner notes at Direngrey.co.jp The Marrow of a Bone (disc 2) at MusicBrainz (CS1 Japanese-language sources ...
... is located in Vandergriff Park in Arlington, Texas, United States. It was added to the ... Media related to Marrow Bone Spring Archeological Site at Wikimedia Commons v t e (Articles using NRISref without a reference ...
In HDC, the bone marrow transplantation was used to maximise chemotherapeutic dosage. By harvesting and freezing bone marrow, ... High-dose chemotherapy and bone marrow transplant (HDC/BMT), also high-dose chemotherapy with autologous bone marrow transplant ... The International Bone Marrow Transplant Registry estimated that at least 4,000 women were treated with HDC/BMT from 1989 ... With an overall idea that more is better, this process involved taking cells from the person's bone marrow to store in a lab, ...
... a German bone marrow registry, also operates a large US bone marrow registry. "Financials". www.giftoflife.org. Retrieved 2019- ... Bone Marrow: Marrow is found in the hollow cavities of the body's large bones. Donation involves withdrawing 2-3 percent of the ... The Gift of Life Marrow Registry is a public bone marrow and blood stem cell registry headquartered in Boca Raton, Florida. ... "Bone-marrow donors give a 'huge gift of hope'". WCVB. March 28, 2016. Retrieved June 25, 2016. "Saving a Life is Easier Than ...
Bone marrow and PBSCs come from living adult donors. Bone marrow is extracted from the donor's pelvic bones while the donor is ... Confer, D.; Robinett, P. (August 2008). "D. Confer and P. Robinett: The US National Marrow Donor Program" (PDF). Bone Marrow ... the American extension of the world's largest bone marrow donor center www.giftoflife.org, Gift of Life Marrow Registry (All ... present and future of the National Marrow Donor Program" (PDF). "Donating Bone Marrow Is Easy and Important: Here's Why". ...
"Bone Marrow". Nintendo of America. Retrieved November 5, 2021. "Bone Marrow". Nintendo Europe. Retrieved November 5, 2021. " ...
"DEATH DOWN UNDER 4 BRISBANE: Misery , Puncture Wound , Bone Marrow , Dying Sun". Live at Your Local. Retrieved 10 February 2023 ... "Death Down Under 4 - Brisbane Misery , Burial Chamber , Puncture Wound , Bone Marrow". AllEvents.in. Retrieved 10 February 2023 ...
Bone Marrow; King's Singers; Rotting Foods (December 9, 1995) Wild Lion Vet; Bicycles; Fish Breathing; Insect Warfare (December ... Funny Bone Chat; Onions & Tears Chat (November 19, 1983) Color Blindness; Taste Buds; Black Hole Chat (November 26, 1983) ...
Bone Marrow Transplant. 34 (8): 683-91. doi:10.1038/sj.bmt.1704602. PMID 15322567. "Sobi's StemGen page". Archived from the ...
"Accelerated and longterm hematopoietic engraftment in mice transplanted with ex-vivo expanded bone marrow". Bone Marrow ... However, only IL-3 treatment in bone marrow failure disorders such as myelodysplastic syndrome (MDS) and aplastic anemia (AA) ... IL-3 is secreted by basophils and activated T cells to support growth and differentiation of T cells from the bone marrow in an ... Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ (1996). "Ex-vivo expansion of murine marrow cells with IL-3, Il-6, Il-11 and ...
A bone marrow biopsy provides a sample of bone marrow, usually from the lower back of the pelvis bone. The sample is extracted ... "Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia". Bone Marrow Transplant. 23 (7): 747-9. ... Bone marrow tumour cells express the following antigen targets CD20 (98.3%), CD22 (88.3%), CD40 (83.3%), CD52 (77.4%), IgM ( ... Autologous bone marrow transplantation is a treatment option. Zanubrutinib is indicated for the treatment of adults with ...
Aggressive treatment with antibiotics is required and bone marrow transplant is common. Patients undergoing bone marrow ... HLA non-identical bone marrow transplants in a series of 10 patients". Bone Marrow Transplantation. 29 (9): 759-762. doi: ... Bone marrow product is infused through a central vein over a period of several hours. The hematopoietic cells are able to go to ... This cure is commonly used in patients who are awaiting bone marrow transplantation. Response to this cure can vary. Those with ...
... requiring the extraction of bone marrow samples from the hip bone to determine the presence of lymphoma cells in bone marrow. ... Bone marrow biopsy is used to show the extent of disease, known as staging in pathology. The process takes about 10-15 minutes ... "Lymphoma Action , Bone marrow biopsy". Lymphoma Action. Retrieved 2020-04-26. "Understanding Mature T-Cell Lymphoma - Fact ... High dosage of chemotherapy may damage the bone marrow, in which autologous stem cell therapy is a recommended follow-up ...
Bone Marrow Transplantation. 37 (2): 207-212. doi:10.1038/sj.bmt.1705218. ISSN 0268-3369. PMID 16284610. (Wikipedia articles ... was found to correlate with the absence of GvHD after bone marrow transplantation, while decreased numbers of Tr1 markedly ...
"Unexpected complications after bone marrow transplantation in transfusion-dependent children". Bone Marrow Transplantation. 12 ... Bone marrow transplantation (BMT) can cure hematological aspects of DBA. This option may be considered when patients become ... This is in contrast to Shwachman-Bodian-Diamond syndrome, in which the bone marrow defect results primarily in neutropenia, and ... a diagnosis of DBA is made through a blood count and a bone marrow biopsy. A diagnosis of DBA is made on the basis of anemia, ...
Bone marrow transplant may be possible for Severe Combined Immune Deficiency and other severe immunodeficiences. Virus-specific ... June 2008). "Stem cell transplantation for primary immunodeficiencies". Bone Marrow Transplantation. 41 (Suppl 2): S83-S86. doi ...
"Bone marrow suppression". Chemotherapy Principles: An In-depth Discussion. American Cancer Society. Archived from the original ...
The active substance in Libmeldy is stem cells, (CD34+ cells), derived from the patient's own bone marrow or blood, that have ... can consider bone marrow transplantation (including stem cell transplantation), which may slow down the progression of the ... Bone Marrow Transplant. 42 Suppl 2: S2-6. doi:10.1038/bmt.2008.275. PMID 18978739. Orchard, Therapeutics (21 December 2020). " ... Several trials are underway to continue to improve the effectiveness and reduce the risks of bone marrow and stem cell ...
In adults, haematopoiesis occurs in the red bone marrow, in the core of most bones. The red bone marrow is derived from the ... may travel in the blood from the bone marrow in one bone to another bone. If they settle in the thymus, they may develop into T ... Stem cell self-renewal is thought to occur in the stem cell niche in the bone marrow, and it is reasonable to assume that key ... Hematopoietic stem cells are found in the bone marrow of adults, especially in the pelvis, femur, and sternum. They are also ...
"G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept". Bone Marrow Transplantation. 50 ( ... White blood cells The G-CSF-receptor is present on precursor cells in the bone marrow, and, in response to stimulation by G-CSF ... Hematopoietic System G-CSF is also a potent inducer of hematopoietic stem cell (HSC) mobilization from the bone marrow into the ... Tay J, Levesque JP, Winkler IG (December 2016). "Cellular players of hematopoietic stem cell mobilization in the bone marrow ...
At St Mary's, Bain developed a training program on haematology, covering topics such as the analysis of blood and bone marrow ... Bain, Barbara J. (2019). Bone marrow pathology. Wiley. ISBN 9781119398127. Bain, Barbara J. (2020). Haemoglobinopathy Diagnosis ...
Bone marrow tests are used to diagnose and monitor bone marrow diseases, blood disorders, and certain types of cancer. Learn ... What Are Bone Marrow Tests?. Bone marrow is a soft, spongy tissue found in the center of most bones. Bone marrow makes ... Why do I need a bone marrow test?. Your health care provider may order a bone marrow aspiration and a bone marrow biopsy if ... What happens during a bone marrow test?. Bone marrow aspiration and bone marrow biopsy procedures are usually done at the same ...
The bone marrow failure syndromes include a group of disorders than can be either inherited or acquired. These diseases are ... The prognosis of bone marrow failure depends on the duration of the marrow function abnormality. Most inherited forms of bone ... Inherited bone marrow failure syndromes. The genetic abnormalities in the inherited bone marrow failure syndromes (IBMFS) have ... encoded search term (Bone Marrow Failure) and Bone Marrow Failure What to Read Next on Medscape ...
Create healthcare diagrams like this example called Hemopoiesis in Bone Marrow in minutes with SmartDraw. SmartDraw includes ... Hemopoiesis in Bone Marrow. Create healthcare diagrams like this example called Hemopoiesis in Bone Marrow in minutes with ... Hemopoiesis in Bone Marrow. Illustration of process of hemopoiesis in bone marrow.. LifeART Collection Images Copyright © 1989- ...
Patient ResourcesBone Marrow Transplant Overview Bone Marrow Transplantation is a common therapy to cure some forms of cancer ... Johns Hopkins Bone Marrow Transplant Program. Our Bone Marrow Transplant Program has revolutionized the care of patients ... We perform bone marrow transplants at the Sidney Kimmel Cancer Centers Weinberg Building in Baltimore, MD. ... Why Choose Johns Hopkins for Bone Marrow Transplantation? Our center is a National Cancer Institute-designated Comprehensive ...
multiple myelomabone cancerbone marrow transplantclinical trialstargeted treatmentstreatmentbone health ... multiple myelomabone cancerbone marrow transplantclinical trialstargeted treatmentstreatmentbone health ... Connect Education Workshops About Bone Marrow Transplant. You can also browse all resources about bone marrow transplant» ... multiple myelomatreatmentbone marrow transplantbone healthclinical trialsdoctor-patient communicationneuropathypainside effects ...
... the spongy liquid part of the bone where blood cells are made. ... aspiration and biopsy are performed to examine bone marrow, ... In a bone marrow biopsy, a small piece of intact bone marrow is removed so the structure of the bone marrow inside its bony ... Bone marrow aspirations and biopsies are performed to examine bone marrow, the spongy liquid part of the bone where blood cells ... In a bone marrow aspiration, a small amount of liquid marrow is taken from inside the bone so the cells can be examined under a ...
We review the process and recovery for donating bone marrow or PBSC and answer some common questions. ... Bone marrow. Bone marrow donation takes place in an operating room. You will receive general or local anesthetic to minimize ... Is donating bone marrow painful?. Youll be under general or local anesthesia during bone marrow donation. You should not feel ... Do you need to register to donate bone marrow?. If you want to volunteer for anyone who may be a match for your bone marrow, ...
Myelofibrosis is bone marrow cancer that results in formation of fibrous scar tissue and can lead to thrombocytopenia and ...
A prototype developed by scientists shows artificial bone marrow may be used to reproduce hematopoietic stem cells ... The newly developed artificial bone marrow that possesses major properties of natural bone marrow can now be used by the ... Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of ... Artificial Bone Marrow Developed by Researchers. Published: 2014-01-20. Author: Helmholtz Association - Contact: Kosta ...
... the identity of SSCs in young bone marrow and how they coordinate active bone formation remains unclear. Here we show that bone ... perivascular stromal cells provide a major source of bone-forming osteoblasts in adult and aged bone marrow. However, ... This study identified a new class of skeletal stem cells in the endosteal space of bone marrow, which are abundant in young ... Therefore, Fgfr3+ endosteal SSCs are abundant in young bone marrow and provide a robust source of osteoblasts, contributing to ...
Elaine Cakebread, a teacher at Sacred Heart, invited DKMS, which helps find stem cell and bone marrow donors around the world, ... A Coventry couple are desperately trying to find a bone marrow donor for their son who is battling a rare disease. ... Aplastic anaemia can be treated with a bone marrow transplant, provided the donor has the same tissue type as the recipient. ... Coventry familys desperate appeal for bone marrow transplant. The family have endured more than one health woe in recent years ...
Takes unhealthy stem cells out of the bone marrow and replaces them with healthy stem cells. ... A blood and bone marrow transplant takes unhealthy stem cells out of the bone marrow and replaces them with healthy stem cells ... Autologous Bone Marrow Transplant. When the child is the donor, its called an "autologous bone marrow transplant" (or " ... Complications of Blood and Bone Marrow Transplants in Children. Blood and bone marrow transplants significantly impact the ...
... underwent bone marrow biopsy using a Jamshidi needle, regular type. 32 (16%) biopsies were positive for bone marrow metastases ... to obtain a bone marrow biopsy for the detection of bone marrow micrometastases in asymptomatic cancer patients with negative ... who complained of bone pain had a positive bone marrow biopsy. 17 of 46 (36.9%) patients with 3 positive parameters had a ... Retroperitoneal Hematoma after Bone Marrow Biopsy: The First Cut Should Not Be the Deepest Oncol Res Treat (April,2019) ...
2006-2023 Exophase.com Created by Mike Bendel Design by Xamantu Steam data provided by Valve ...
Donate bone marrow. You could be a possible match for a patient in need of a bone marrow transplant. Learn more about how you ... During African American Bone Marrow Awareness Month 10-Year-Old Texas Boy Makes Appeal for More Blood Stem Cell and Marrow ... After bone marrow or PBSC donation, most donors are back to their normal routine in a few days. Learn more about the recovery ... Possible match for a patient in need of a bone marrow transplant When you join Be The Match Registry, your tissue type is added ...
ICD-10 code Z94.81 for Bone marrow transplant status is a medical classification as listed by WHO under the range -Persons with ... ICD-10-CM Code for Bone marrow transplant status Z94.81 ICD-10 code Z94.81 for Bone marrow transplant status is a medical ...
In a bone marrow transplant, the patients diseased bone marrow is destroyed and healthy bone marrow stem cells are infused ... About Bone Marrow Stem Cell Transplant. Bone marrow transplant (BMT) can strengthen the body to fight cancer by replacing the ... There are several types of bone marrow transplants, also referred to as stem-cell transplants. Which type is used for any given ... In a successful BMT transplant, the new bone marrow migrates to the cavities of the large bones and begins producing healthy, ...
General availability of bone marrow transplantation in the public health system (Noncommunicable diseases). This indicator is ... General availability of bone marrow transplantation in the public health system (Noncommunicable diseases) ...
Association conference that shell be taking leave from her post in late August or early September to undergo a bone marrow ...
Bone marrow - neoplastic myeloid. General:books flow cytometry how to do a bone marrow biopsy (procedure) (pending) WHO-HAEM5 ... Bone marrow neoplastic stains & molecular markers:. Lymphoblastic initial panel: CD1a CD3 CD4 CD5 CD7 CD8 CD10 CD20 CD34 PAX5 ... Bone marrow neoplastic. Last staff update: 27 September 2023. Copyright: 2001-2023, PathologyOutlines.com, Inc.. HemePath ... Bone marrow - plasma cell and lymphoid neoplasms. Plasma cell neoplasms:heavy chain disease MGUS-IgM MGUS - non-IgM non ...
Please donate today to help the National bone Marrow Transplant Link continue to help patients and caregivers navigating the ... 2023 National Bone Marrow Transplant LINK (nbmtLINK). National Bone Marrow Transplant Link is a 501(c)(3) Non-Profit. Privacy ... Your gift to the National Bone Marrow Transplant Link will make a difference in the lives of BMT patients, caregivers and ... Since its founding in 1992, the National Bone Marrow Transplant Link (nbmtLINK) has helped thousands of individuals worldwide ...
A family in Colorado is advocating for blood marrow transfusions after their 2-year-old was diagnosed with a rare blood ... Their other option for Karina is a bone marrow transplant.. Karinas parents learned they arent matches for her, so the bone ... 23, their little girl had to have her first bone marrow biopsy. Originally, they were told it could be leukemia. They found out ... While the Haneys continue to decide what is best for their daughter, they estimate that a bone marrow transplant in Colorado, ...
Materials and methods: MSCs were isolated from bone marrow in mice femoral bone marrow. The effect of lycopene on MSCs during ... Lycopene protects bone marrow mesenchymal stem cells against ischemia-induced apoptosis in vitro Eur Rev Med Pharmacol Sci. ... Objective: Bone marrow mesenchymal stem cells (MSCs) have been identified to have the potential to differentiate into multiple ...
Learn about research and innovation from the Dana-Farber/Boston Childrens Bone Marrow Failure and Myelodysplastic Syndrome ... including collecting blood and bone marrow from patients to better understand the causes of bone marrow failure syndromes and ... Bone Marrow Failure and Myelodysplastic Syndrome Program clinical trials. For many children with rare or hard-to-treat ... With the support of funding from the National Institutes of Health, we established a nationwide Pediatric Bone Marrow Failure ...
... happens when our bone marrow does not make enough working blood cells. Changes in our genes cause BMFS. ... Bone Marrow Failure Syndromes are a group of blood disorders. They happen when our bone marrow is not working right. Bone ... This is a bone marrow transplant. *We suspect an acquired cause for your bone marrow disorder, such as aplastic anaemia. In ... Bone Marrow Failure Syndromes (BMFS) happens when our bone marrow does not make enough working blood cells. Changes in our ...
Shop Milk-Bone MaroSnacks Dog Snacks For All Sizes With Real Bone Marrow Box - 10 Oz from Safeway. Browse our wide selection of ... muffins bagels milk-bone small box milk-bone box milk-bone large box milk bone dog treat jar orig blue dog bakery gingerbread ... With the milk bone variety of treats. Marosnacks packed with joy with bone marrow delicious treats that you can feel good about ... Milk-Bone MaroSnacks Dog Snacks For All Sizes With Real Bone Marrow Box - 10 Oz. ...
Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis. 2001;33:338-43. DOI ... We have seen an increase in the number of bone marrow transplants performed, but there has been no major change in ... Our findings suggest routine use of 16S rRNA gene sequencing and increased numbers of bone marrow transplants as the major ... Leptotrichia trevisanii Sepsis after Bone Marrow Transplantation. Emerging Infectious Diseases. 2013;19(10):1690-1691. doi: ...
... these therapeutic gem crystals lay an energetic foundation for restoring the health of the bone marrow. ... enhancing the marrows ability to absorb nutrients, and nourishing the marrow with the indigo color ray, ... These healing gemstone necklaces from Gemisphere offer energetic support for resolving a bone marrow condition. By helping to ... these therapeutic gem crystals lay an energetic foundation for restoring the health of the bone marrow. ...
Researchers interested in Bone Marrow Failure Disorders ...
  • Bone marrow transplants can be conducted to treat severe diseases of the bone marrow, including certain forms of cancer such as leukemia. (wikipedia.org)
  • Our Bone Marrow Transplant Program has revolutionized the care of patients requiring blood or marrow transplants through many novel advancements including mismatched transplants and outpatient care of bone marrow transplantation. (hopkinsmedicine.org)
  • We perform bone marrow transplants at the Sidney Kimmel Cancer Center's Weinberg Building in Baltimore, MD. (hopkinsmedicine.org)
  • In 2020, there were more than 23,000 bone marrow or cord blood transplants in the United States. (healthline.com)
  • There are several types of bone marrow transplants, also referred to as stem-cell transplants. (emoryhealthcare.org)
  • Our findings suggest routine use of 16S rRNA gene sequencing and increased numbers of bone marrow transplants as the major reasons. (cdc.gov)
  • We have seen an increase in the number of bone marrow transplants performed, but there has been no major change in myeloablative regimens. (cdc.gov)
  • Sickle cell disease (SCD) specialists have performed bone marrow transplants in children since the 1990s. (medlineplus.gov)
  • Bone marrow transplants are not working in 100% of patients. (medlineplus.gov)
  • Why Choose Johns Hopkins for Bone Marrow Transplantation? (hopkinsmedicine.org)
  • Researchers continue to make advancements in bone marrow transplantation through the use of bench to bedside human clinical trials such those that developed half-matched or haploidentical transplantation. (hopkinsmedicine.org)
  • Based on a patient's condition, we perform different types of bone marrow transplantation . (hopkinsmedicine.org)
  • Our outpatient program allows patients undergoing bone marrow transplantation to remain home or stay at an outpatient facility instead of spending weeks in the hospital. (hopkinsmedicine.org)
  • Bone Marrow Transplantation is a common therapy to cure some forms of cancer and other diseases. (hopkinsmedicine.org)
  • Our clinic provides telemedicine services for patients undergoing bone marrow transplantation and transplant recipients. (hopkinsmedicine.org)
  • p>In addition to childhood cancers and blood disorders, Nemours treats nonmalignant bone marrow disorders, immune system deficiencies and some metabolic disorders with allogeneic blood and bone marrow transplantation. (nemours.org)
  • Be The Match® is a global leader in bone marrow transplantation. (bethematch.org)
  • In this context, the present study sought to analyze the effects of accompanying a patient who is undergoing a transplant at the INCA Bone Marrow Transplantation Center (INCA/CEMO). (bvsalud.org)
  • Hematopoietic stem cells in the bone marrow can give rise to hematopoietic lineage cells, and mesenchymal stem cells, which can be isolated from the primary culture of bone marrow stroma, can give rise to bone, adipose, and cartilage tissue. (wikipedia.org)
  • The bone marrow stroma contains mesenchymal stem cells (MSCs), which are also known as marrow stromal cells. (wikipedia.org)
  • Bone marrow mesenchymal stem cells (MSCs) have been identified to have the potential to differentiate into multiple types of cells. (nih.gov)
  • The bone marrow stroma contains mesenchymal stem cells. (medscape.com)
  • We searched PubMed without time restriction using key words bone marrow and fibrosis as the main stem against the terms growth factors , cytokines and chemokines , morphology, megakaryocytes and platelets , myeloproliferative disorders , myelodysplastic syndrome , collagen biosynthesis , mesenchymal stem cells , vitamins and minerals and hormones , and mechanism of tissue fibrosis . (bvsalud.org)
  • Fibrogenesis is initiated by mobilisation of special immunophenotypic subsets of mesenchymal stem cells in the marrow that transform into fibroblasts . (bvsalud.org)
  • Bone marrow is a semi-solid tissue found within the spongy (also known as cancellous) portions of bones. (wikipedia.org)
  • Bone marrow is a soft, spongy tissue found in the center of most bones. (medlineplus.gov)
  • Bone marrow aspirations and biopsies are performed to examine bone marrow, the spongy liquid part of the bone where blood cells are made. (kidshealth.org)
  • New blood cells (called "stem cells") begin in the bone marrow - the red spongy material found inside the bones - and are released to the bloodstream when mature. (nemours.org)
  • Bone marrow is the soft, spongy, gelatinous tissue found in the hollow spaces in the interior of bones. (medscape.com)
  • In a bone marrow biopsy , a small piece of intact bone marrow is removed so the structure of the bone marrow inside its bony framework can be examined. (kidshealth.org)
  • A small core of intact bone marrow is removed with a special bone marrow biopsy needle and sliced into thin sections that are examined under a microscope. (msdmanuals.com)
  • Our center is a National Cancer Institute-designated Comprehensive Cancer Center that is fully accredited by the National Marrow Donor Program. (hopkinsmedicine.org)
  • Donating bone marrow is relatively low risk for the donor. (healthline.com)
  • The National Marrow Donor Program requires you be between 18 and 40 years old to donate. (healthline.com)
  • A Coventry couple are desperately trying to find a bone marrow donor for their son who is battling a rare disease. (coventrytelegraph.net)
  • Aplastic anaemia can be treated with a bone marrow transplant, provided the donor has the same tissue type as the recipient. (coventrytelegraph.net)
  • But I didn't realize you could also sign up to be a bone marrow donor, too. (nbc29.com)
  • We are trying to create a state where instead of completely replacing bone marrow with that of their donors, we are creating a mixture of donor and patient cells because we now know that as low as 20% donor cells is enough to reverse sickle cell disease. (medlineplus.gov)
  • It is composed of hematopoietic cells, marrow adipose tissue, and supportive stromal cells. (wikipedia.org)
  • It is well-described that leptin receptor (LepR) + perivascular stromal cells provide a major source of bone-forming osteoblasts in adult and aged bone marrow. (nature.com)
  • These Fgfr3 + stem/stromal cells with OCT identities are abundant in the young bone marrow and depleted in the old bone marrow, denoting their transitional nature. (nature.com)
  • Overall, our findings indicate that Fgfr3 + endosteal stem/stromal cells with OCT identities dictate active and aggressive osteogenesis, identifying these cells as an important regulator of long-term bone homeostasis. (nature.com)
  • Progenitor cell (stem cell) lines in the bone marrow produce new blood cells and stromal cells. (medscape.com)
  • Some kids feel a quick sharp cramp as the liquid bone marrow is withdrawn for the aspiration or as the sample of bone marrow is removed for the biopsy. (kidshealth.org)
  • Sometimes a sample of bone marrow must be examined to determine why blood cells are abnormal or why there are too few or too many of a specific kind of blood cell. (msdmanuals.com)
  • People who register as donors agree to donate either bone marrow or PBSC, depending on the recipient's needs. (healthline.com)
  • Elaine Cakebread, a teacher at Sacred Heart, invited DKMS, which helps find stem cell and bone marrow donors around the world, to come to the school on Friday, May 3 between 3.30 and 8pm. (coventrytelegraph.net)
  • After bone marrow or PBSC donation, most donors are back to their normal routine in a few days. (bethematch.org)
  • I wanted to develop a way to have half-match donors contribute bone marrow and for the outcomes to be successful. (medlineplus.gov)
  • These derive from endothelial stem cells, which are also present in the bone marrow. (wikipedia.org)
  • The bone marrow aspirate shows what cells, normal and abnormal, are present in the bone marrow and provides information about their size, volume, and other characteristics. (msdmanuals.com)
  • A surgeon will use a needle to remove liquid bone marrow from either side of your pelvic bone. (healthline.com)
  • Doctors perform bone marrow aspirations and biopsies when they're concerned about a problem in the bone marrow. (kidshealth.org)
  • If you are chosen as the best match for a patient, the patient's doctor will request that you donate either bone marrow or peripheral blood stem cells (PBSC). (bethematch.org)
  • Bone marrow failure can be either inherited or acquired and can involve a single hematopoietic stem cell line or all three cell lines. (medscape.com)
  • They also may be done to collect a bone marrow sample for procedures (such as a stem cell transplant ) or other testing (such as chromosomal analysis). (kidshealth.org)
  • So far, this has been impossible, as these cells retain their stem cell properties in their natural environment only, i.e. in their niche of the bone marrow. (disabled-world.com)
  • Stem cell reproduction therefore requires an environment similar to the stem cell niche in the bone marrow. (disabled-world.com)
  • The composition of marrow is dynamic, as the mixture of cellular and non-cellular components (connective tissue) shifts with age and in response to systemic factors. (wikipedia.org)
  • The stroma of the bone marrow includes all tissue not directly involved in the marrow's primary function of hematopoiesis. (wikipedia.org)
  • Cell types that constitute the bone marrow stroma include: fibroblasts (reticular connective tissue) macrophages, which contribute especially to red blood cell production, as they deliver iron for hemoglobin production. (wikipedia.org)
  • The provider will twist the needle into the bone to take out a small piece, or core, of bone marrow tissue. (medlineplus.gov)
  • Myelofibrosis is bone marrow cancer that results in formation of fibrous scar tissue and can lead to thrombocytopenia and anemia, weakness, fatigue and an enlarged spleen and liver. (eturbonews.com)
  • are produced in the bone marrow, the soft fatty tissue inside bone cavities. (msdmanuals.com)
  • Bone marrow consists of stem cells, which are large, "primitive," undifferentiated cells supported by fibrous tissue called stroma. (medscape.com)
  • There are 2 main types of stem cells and, therefore, the bone marrow consists of 2 types of cellular tissue. (medscape.com)
  • Bone marrow can be 1 of 2 types, red or yellow, depending on whether it consists of mainly hematopoietic (and therefore, red-colored) tissue or fatty (and therefore a yellow-colored) tissue. (medscape.com)
  • Since the 1990s, to do a bone marrow transplant, a patient had to have a sibling with a complete tissue match and take a medication that suppresses their immune system (Cyclophosphamide), as well as high dose chemotherapy. (medlineplus.gov)
  • Tissue marrow fibrosis -related papers were short listed and analysed for the review . (bvsalud.org)
  • The tests can help diagnose and monitor bone marrow disorders , blood disorders , and certain types of cancer . (medlineplus.gov)
  • The bone marrow failure syndromes comprise a group of disorders than can be either inherited or acquired. (medscape.com)
  • These diseases are intrinsic disorders of the bone marrow involving disruption in the homeostasis and function of hematopoietic stem cells, resulting in inadequate production of either a single or multiple cell lines (erythroid for red cells, myeloid for white blood cells, megakaryocytic for platelets). (medscape.com)
  • The inherited bone marrow failure syndromes (IBMFS) include Fanconi anemia, dyskeratosis congenita, Diamond-Blackfan anemia, and other genetic disorders. (medscape.com)
  • Our multidisciplinary program collaborates with Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Children's Center to potentially cure children with a variety of cancers and other disorders of the blood, immune system and bone marrow. (hopkinsmedicine.org)
  • Orthopedists (bone specialists) and orthopedic surgeons at Nemours Center for Cancer and Blood Disorders make our pediatric orthopedics programs among the largest and most respected in the world. (nemours.org)
  • The Dana-Farber/Boston Children's Cancer and Blood Disorders Center has a long history of research and innovation associated with bone marrow failure conditions. (childrenshospital.org)
  • Bone Marrow Failure Syndromes are a group of blood disorders. (petermac.org)
  • The 'Inherited Bone Marrow Disorders' panel test comes into play here. (petermac.org)
  • In humans, marrow is colloquially characterized as "red" or "yellow" marrow (Latin: medulla ossium rubra, Latin: medulla ossium flava, respectively) depending on the prevalence of hematopoietic cells vs fat cells. (wikipedia.org)
  • For example, a newborn baby's bones exclusively contain hematopoietically active "red" marrow, and there is a progressive conversion towards "yellow" marrow with age. (wikipedia.org)
  • In circumstances of chronic hypoxia, the body can convert yellow marrow back to red marrow to increase blood cell production. (wikipedia.org)
  • Yellow marrow is found in the hollow interior of the diaphyseal portion or the shaft of long bones. (medscape.com)
  • By the time a person reaches old age, nearly all of the red marrow is replaced by yellow marrow. (medscape.com)
  • However, the yellow marrow can revert to red if there is increased demand for red blood cells, such as in instances of blood loss. (medscape.com)
  • Bone marrow donation can take place privately, where you directly contact a care center or transplant center caring for someone you know. (healthline.com)
  • Here at Winship Cancer Institute Bone Marrow Transplant Center we believe patient information is a vital part of the transplant process. (emoryhealthcare.org)
  • [ 1 ] The most common cause of acquired bone marrow failure is aplastic anemia . (medscape.com)
  • At the cellular level, the main functional component of bone marrow includes the progenitor cells which are destined to mature into blood and lymphoid cells. (wikipedia.org)
  • citation needed] The red bone marrow is a key element of the lymphatic system, being one of the primary lymphoid organs that generate lymphocytes from immature hematopoietic progenitor cells. (wikipedia.org)
  • The bone marrow and thymus constitute the primary lymphoid tissues involved in the production and early selection of lymphocytes. (wikipedia.org)
  • Furthermore, bone marrow performs a valve-like function to prevent the backflow of lymphatic fluid in the lymphatic system. (wikipedia.org)
  • Bone marrow is also an important part of the lymphatic system. (medscape.com)
  • What is the procedure for donating bone marrow? (healthline.com)
  • The procedure takes a few minutes and causes no lasting damage to the bone. (msdmanuals.com)
  • Marrow contains hematopoietic stem cells which give rise to the three classes of blood cells that are found in circulation: white blood cells (leukocytes), red blood cells (erythrocytes), and platelets (thrombocytes). (wikipedia.org)
  • Hematopoietic stem cells may also cross the bone marrow barrier, and may thus be harvested from blood. (wikipedia.org)
  • A prototype developed by scientists shows artificial bone marrow may be used to reproduce hematopoietic stem cells. (disabled-world.com)
  • Blood cells, such as erythrocytes or immune cells, are continuously replaced by new ones supplied by hematopoietic stem cells located in a specialized niche of the bone marrow. (disabled-world.com)
  • This three-dimensional environment does not only accommodate bone cells and hematopoietic stem cells but also various other cell types with which signal substances are exchanged. (disabled-world.com)
  • Then, the researchers introduced hematopoietic stem cells isolated from cord blood into this artificial bone marrow. (disabled-world.com)
  • Bone marrow supersedes the liver as the major hematopoietic organ at 32-36 weeks' gestation. (medscape.com)
  • In 30-50% of patients, the lymphoblasts infiltrate bone marrow, causing ineffective hematopoiesis. (medscape.com)
  • Human marrow produces approximately 500 billion blood cells per day, which join the systemic circulation via permeable vasculature sinusoids within the medullary cavity. (wikipedia.org)
  • Several types of stem cells are related to bone marrow. (wikipedia.org)
  • Human marrow produces approximately 500 billion blood cells per day. (wikipedia.org)
  • adipocytes (fat cells) osteoblasts (synthesize bone) osteoclasts (resorb bone) endothelial cells, which form the sinusoids. (wikipedia.org)
  • MSCs have been shown to differentiate, in vitro or in vivo, into osteoblasts, chondrocytes, myocytes, marrow adipocytes and beta-pancreatic islets cells. (wikipedia.org)
  • citation needed] The blood vessels of the bone marrow constitute a barrier, inhibiting immature blood cells from leaving the marrow. (wikipedia.org)
  • Bone marrow tests check to see if your bone marrow is working correctly and making normal amounts of blood cells. (medlineplus.gov)
  • Your health care provider may order a bone marrow aspiration and a bone marrow biopsy if other blood tests show your levels of red blood cells, white blood cells, or platelets are not normal. (medlineplus.gov)
  • Too many or too few blood cells may mean you have a medical condition, such as cancer that starts in your blood or bone marrow. (medlineplus.gov)
  • The provider will push the needle into the bone and use a syringe attached to the needle to pull out bone marrow fluid and cells. (medlineplus.gov)
  • This bone marrow film at 400X magnification demonstrates a complete absence of hemopoietic cells. (medscape.com)
  • In a bone marrow aspiration , a small amount of liquid marrow is taken from inside the bone so the cells can be examined under a microscope. (kidshealth.org)
  • Bone marrow is where your body makes blood cells. (healthline.com)
  • The porous structure possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells at the laboratory. (disabled-world.com)
  • In addition, they added protein building blocks similar to those existing in the matrix of the bone marrow for the cells to anchor. (disabled-world.com)
  • Analyses with various methods revealed that the cells really reproduce in the newly developed artificial bone marrow. (disabled-world.com)
  • Compared to standard cell cultivation methods, more stem cells retain their specific properties in the artificial bone marrow. (disabled-world.com)
  • The newly developed artificial bone marrow that possesses major properties of natural bone marrow can now be used by the scientists to study the interactions between materials and stem cells in detail at the laboratory. (disabled-world.com)
  • The bone marrow contains various populations of skeletal stem cells (SSCs) in the stromal compartment, which are important regulators of bone formation. (nature.com)
  • The term "transitional" emphasizes the unique feature of these cells that are particularly abundant in the young bone marrow. (nature.com)
  • p>A blood and bone marrow transplant takes unhealthy stem cells out of the bone marrow and replaces them with healthy stem cells, with the intent to treat childhood cancers and nonmalignant blood and bone marrow diseases. (nemours.org)
  • Bone marrow transplant (BMT) can strengthen the body to fight cancer by replacing the blood building cells in the body that are destroyed by chemotherapy and radiation treatments, which are used to kill the cancer cells, with healthy stem cells found in bone marrow. (emoryhealthcare.org)
  • In a bone marrow transplant, the patient's diseased bone marrow is destroyed and healthy bone marrow stem cells are infused into the patient's blood-stream. (emoryhealthcare.org)
  • In a successful BMT transplant, the new bone marrow migrates to the cavities of the large bones and begins producing healthy, normal blood cells. (emoryhealthcare.org)
  • Bone marrow is where our body makes all our blood cells (red, white and platelets). (petermac.org)
  • Bone Marrow Failure Syndromes (BMFS) happens when our bone marrow does not make enough working blood cells. (petermac.org)
  • The core biopsy removes an entire piece of bone marrow and shows not only what cells are present but also how full the bone marrow is with cells and where the cells are located within the marrow. (msdmanuals.com)
  • Objective: This study evaluated the osteogenic induction of human bone marrow cells by human recombinant bone morphogenetic protein-4 (rhBMP-4) and proteins released by Saos-2 (human osteosarcoma cell line). (bvsalud.org)
  • Study design: Osteoinduction in the presence or absence of Saos-2 and/or rhBMP-4 was evaluated in cultured human bone marrow cells. (bvsalud.org)
  • Results: Bone marrow cells were adherent since the first day of culture and were positive for osteonectin. (bvsalud.org)
  • Osteoblasts were obtained from human bone marrow cells even in the absence of growth factors and showed a typical morphology. (bvsalud.org)
  • Cells derived from bone marrow can undergo osteoinduction in vitro in the absence of osteoinductive factors such as bone morphogenetic proteins. (bvsalud.org)
  • Conclusions: This study showed that an osteoblastic cell lineage may be obtained from human bone marrow derived from adherent cells, and that the presence of the rhBMP-4 seems to have an effect during the first stages of differentiation only. (bvsalud.org)
  • Normally, only mature cells are released from the marrow into the bloodstream. (medscape.com)
  • These stem cells divide to eventually give rise to red blood cells, platelets, and most white blood cells in the red marrow. (medscape.com)
  • Bone marrow thus contains blood cells at varying stages of development. (medscape.com)
  • Illustration of the pelvis to show the site of bone marrow and blood cells derived from bone marrow. (medscape.com)
  • When the oxygen content of body tissues is low, if there is loss of blood or anemia, or if the number of red blood cells decreases, the kidneys produce and release erythropoietin, a hormone that stimulates the bone marrow to produce more red blood cells. (medscape.com)
  • Similarly, the bone marrow produces and releases more white blood cells in response to infections, and it produces and releases more platelets in response to bleeding. (medscape.com)
  • As age progresses, more of the red bone marrow turns into yellow bone marrow and the production of new blood cells becomes more difficult. (medscape.com)
  • The bone marrow biopsy uses a special hollow biopsy needle inserted through the same skin opening. (medlineplus.gov)
  • Most bone marrow samples are taken from the back of the hip bone, called the iliac crest. (medlineplus.gov)
  • Bone marrow samples are usually taken from the hipbone (iliac crest). (msdmanuals.com)
  • Here we show that bone marrow endosteal SSCs are defined by fibroblast growth factor receptor 3 ( Fgfr3 ) and osteoblast-chondrocyte transitional (OCT) identities with some characteristics of bone osteoblasts and chondrocytes. (nature.com)
  • Therefore, Fgfr3 + endosteal SSCs are abundant in young bone marrow and provide a robust source of osteoblasts, contributing to both normal and aberrant osteogenesis. (nature.com)
  • Bone marrow donation takes place in an operating room. (healthline.com)
  • Learn how marrow donation works, the steps of a patient transplant, steps of donation, and factors that can impact the likelihood of finding a match. (bethematch.org)
  • Check out FAQs about donation or call us at 1 (800) MARROW2 for more information about bone marrow donation. (bethematch.org)
  • COLORADO SPRINGS, Colo. ( KKTV /Gray News) - A young girl in a Colorado community is battling a rare blood disorder, and her parents want others to know how bone marrow donation can save a life. (nbc29.com)
  • As the Haneys do what they can, they want to remind others of how critical bone marrow donation can be. (nbc29.com)
  • Diseases that can present in a manner similar to acquired bone marrow failure include myelodysplastic syndromes , paroxysmal nocturnal hemoglobinuria , and large granular lymphocytic leukemia . (medscape.com)
  • If you are being treated for another type of cancer, these tests can find out if the cancer has spread to your bone marrow. (medlineplus.gov)
  • Bone marrow tests may also be used to see how well cancer treatment is working. (medlineplus.gov)
  • 205 patients with solid cancer, underwent bone marrow biopsy using a Jamshidi needle, regular type. (karger.com)
  • In our experience, it is of no value (unlike in malignant lymphoma and oat cell carcinoma of lung) to obtain a bone marrow biopsy for the detection of bone marrow micrometastases in asymptomatic cancer patients with negative skeletal radioisotope scan and negative bone X-ray films. (karger.com)
  • 32 (16%) biopsies were positive for bone marrow metastases. (karger.com)
  • The aspiration and biopsy are done by a trained medical practitioner (nurse or doctor) using a small needle inserted into a bone. (kidshealth.org)
  • A small amount of anesthetic medicine will be injected through the numb spot on the skin to prevent pain as the bone marrow needle is inserted through the skin and soft tissues. (kidshealth.org)
  • For the bone marrow aspiration, the doctor or nurse will carefully insert a needle into the biopsy site and will then attach a syringe to draw out a sample of fluid from inside the bone. (kidshealth.org)
  • For the biopsy, a different kind of needle will be inserted into the same area to remove a small sample of bone. (kidshealth.org)
  • After disinfecting the skin and numbing the area over the bone with a local anesthetic, the doctor inserts a needle into the bone and withdraws the marrow. (msdmanuals.com)
  • In very young children, bone marrow samples are occasionally taken from one of the bones in the lower leg (tibia). (msdmanuals.com)
  • Utilizing micro-computed tomography, analysis of tibia showed that loss of bone mineral density, volume, and deterioration of bone micro-architecture, and mechanical strength induced by inhalant ODE exposures in WT mice were absent in IL-6 KO animals. (cdc.gov)
  • In adult humans, bone marrow is primarily located in the ribs, vertebrae, sternum, and bones of the pelvis. (wikipedia.org)
  • In adults, red marrow is found mainly in the central skeleton, such as the pelvis, sternum, cranium, ribs, vertebrae and scapulae, and variably found in the proximal epiphyseal ends of long bones such as the femur and humerus. (wikipedia.org)
  • By helping to strengthen and purify the energies of your bones and blood, enhancing the marrow's ability to absorb nutrients, and nourishing the marrow with the indigo color ray, these therapeutic gem crystals lay an energetic foundation for restoring the health of the bone marrow. (gemisphere.com)
  • Compared to saline treatments, bone-resorbing osteoclasts and bone marrow osteoclast precursor populations were also increased in ODE-treated WT but not IL-6 KO mice. (cdc.gov)
  • These results show that the systemic IL-6 effector pathway mediates bone deterioration induced by repetitive inhalant ODE exposures through an effect on osteoclasts, but a positive role for IL-6 in the airway was not demonstrated. (cdc.gov)
  • Good Morning America" anchor Robin Roberts announced Thursday at the Television Critics Association conference that she'll be taking leave from her post in late August or early September to undergo a bone marrow transplant. (extratv.com)
  • p>Our combined expertise allows us to diagnose and treat common, rare and complex bone tumors in children. (nemours.org)
  • Although the aspirate often provides enough information for a diagnosis to be made, the process of drawing the marrow into the syringe breaks up the fragile bone marrow. (msdmanuals.com)
  • With the help of synthetic polymers, the scientists created a porous structure simulating the sponge-like structure of the bone in the area of the blood-forming bone marrow. (disabled-world.com)
  • Bone marrow comprises approximately 5% of total body mass in healthy adult humans, such that a man weighing 73 kg (161 lbs) will have around 3.7 kg (8 lbs) of bone marrow. (wikipedia.org)
  • In an adult, roughly half of the bone marrow is still red. (medscape.com)
  • About 18,000 people each year need a bone marrow or cord blood transplant to treat a life threatening illness. (healthline.com)
  • St Jude's describes the condition as a type of "bone marrow failure. (nbc29.com)
  • Our basic science and clinical research program offers unique access to clinical trials in which children can receive the newest bone marrow failure diagnostic evaluations and treatments. (childrenshospital.org)
  • With the support of funding from the National Institutes of Health , we established a nationwide Pediatric Bone Marrow Failure and MDS Registry. (childrenshospital.org)
  • Knowing the exact genetic cause of bone marrow failure syndrome is valuable. (petermac.org)
  • A health care provider will collect the marrow samples for testing. (medlineplus.gov)
  • Results were correlated with those of skeletal radioisotope scans, X-ray films and the complaint of bone pain, alone or combined. (karger.com)
  • citation needed] Biological compartmentalization is evident within the bone marrow, in that certain cell types tend to aggregate in specific areas. (wikipedia.org)